<SEC-DOCUMENT>0001104659-25-102252.txt : 20251027
<SEC-HEADER>0001104659-25-102252.hdr.sgml : 20251027
<ACCEPTANCE-DATETIME>20251027060126
ACCESSION NUMBER:		0001104659-25-102252
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20251024
FILED AS OF DATE:		20251027
DATE AS OF CHANGE:		20251027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CureVac N.V.
		CENTRAL INDEX KEY:			0001809122
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39446
		FILM NUMBER:		251417321

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		FRIEDRICH-MIESCHER-STRASSE 15
		CITY:			TUBINGEN
		NON US STATE TERRITORY:  	BADEN-WURTTEMBERG
		PROVINCE COUNTRY:   	2M
		ZIP:			72076
		BUSINESS PHONE:		49 7071 9883 0

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		FRIEDRICH-MIESCHER-STRASSE 15
		CITY:			TUBINGEN
		NON US STATE TERRITORY:  	BADEN-WURTTEMBERG
		PROVINCE COUNTRY:   	2M
		ZIP:			72076

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CureVac B.V.
		DATE OF NAME CHANGE:	20200410
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2529451d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;6-K</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER<BR>
PURSUANT TO RULE&nbsp;13a-16 OR 15d-16<BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of October&nbsp;2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number: 001-39446</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CureVac N.V.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<I>Exact Name of Registrant as Specified in Its
Charter</I>)</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Friedrich-Miescher-Strasse 15, 72076</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>T&uuml;bingen, Germany</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+49 7071 9883 0</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<I>Address of principal executive office</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form&nbsp;20-F&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#120;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On October&nbsp;24, 2025, CureVac N.V. (the &ldquo;Company&rdquo;)
convened an extraordinary general meeting of shareholders to be held on November&nbsp;25, 2025 and made available to its shareholders
certain other materials in connection with such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information included in this Form&nbsp;6-K (including Exhibit&nbsp;99.1,
Exhibit&nbsp;99.2, Exhibit&nbsp;99.3 and Exhibit&nbsp;99.4) shall not be deemed &ldquo;filed&rdquo; for purposes of Section&nbsp;18 of
the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities of that section, nor shall
it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CureVac N.V.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: October&nbsp;24, 2025</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Alexander Zehnder</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief
    Executive Officer</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT&nbsp;INDEX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 10%">EXHIBIT&nbsp;NO.</TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 88%">DESCRIPTION</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="tm2529451d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2529451d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convening notice to the extraordinary general meeting
    of shareholders including agenda and explanatory notes.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="tm2529451d1_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2529451d1_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting proxy.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="tm2529451d1_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2529451d1_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger proposal</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="tm2529451d1_ex99-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2529451d1_ex99-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Explanatory notes to the merger proposal</FONT></A></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2529451d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONVENING NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This is the convening notice for the extraordinary
general meeting of CureVac N.V. (the &ldquo;<B>Company</B>&rdquo;) to be held at the offices of NautaDutilh N.V. (address: Beethovenstraat
400, 1082 PR Amsterdam, the Netherlands) on November 25, 2025 at 14:00 Central European Time (the &ldquo;<B>EGM</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The agenda for the EGM is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Opening</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Explanation of the
                                            exchange offer by BioNTech SE (&ldquo;<B>Buyer</B>&rdquo;) for ordinary shares in the capital
                                            of the Company (the &ldquo;<B>Offer</B>&rdquo;) (<I>discussion item</I>)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">Consummation of post-offer
                                            reorganization (<I>voting items</I>)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">Conditional resolution to enter into
                                            a legal merger (<I>juridische fusie</I>) of the Company (as disappearing company) with and
                                            into CureVac Merger B.V. (as acquiring company surviving such merger) (&ldquo;<B>New Topco</B>&rdquo;),
                                            with New Topco issuing class A shares in its capital to the Company&rsquo;s shareholders
                                            (other than Buyer) and class B shares in its capital to Buyer, in accordance with Sections
                                            2:309 et seq. of the Dutch Civil Code (the &ldquo;<B>Legal Downstream Merger</B>&rdquo;)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">Conditional resolution to approve, to
                                            the extent required under applicable law and the Company&rsquo;s articles of association
                                            and bylaws (<I>reglementen</I>), (i) the Legal Downstream Merger, (ii) the subsequent sale
                                            and transfer of all outstanding shares in the capital of CureVac SE by New Topco to Buyer
                                            and (iii) the subsequent cancellation of all outstanding class A shares in the capital New
                                            Topco</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">Conditional release
                                            from liability (<I>voting items</I>)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: justify">Conditional release
                                            of managing directors from liability for the exercise of their duties</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: justify">Conditional release
                                            of supervisory directors from liability for the exercise of their duties</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">Conditional appointment
                                            of Ram&oacute;n Zapata Gomez as managing director of the Company (<I>voting item</I>)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">6.</TD><TD STYLE="text-align: justify">Conditional appointment
                                            of supervisory directors (<I>voting items</I>)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">a.</TD><TD>Conditional appointment of Sierk Poetting as supervisory director
                                            of the Company</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">b.</TD><TD>Conditional appointment of James Ryan as supervisory director of
                                            the Company</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">Conditional appointment of Annemarie
                                            Hanekamp as supervisory director of the Company</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">7.</TD><TD STYLE="text-align: justify">Closing</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No business shall be voted on at the EGM, except
such items as included in the abovementioned agenda.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The agenda for the EGM with the explanatory notes
thereto, the merger proposal and explanatory notes thereto relating to the Legal Downstream Merger and the other meeting information
are available as of the date hereof for inspection and can be obtained free of charge at the office address of the Company and from the
Company&rsquo;s website (http://www.curevac.com).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration date for the EGM is October
28, 2025 (the &ldquo;<B>Registration Date</B>&rdquo;). Those who are shareholders of the Company, or who otherwise have voting rights
and/or meeting rights with respect to shares in the Company&rsquo;s capital, on the Registration Date and who are recorded as such in
the Company&rsquo;s shareholders&rsquo; register and/or in the register maintained by the Company&rsquo;s U.S. transfer agent (the &ldquo;<B>Persons
with Meeting Rights</B>&rdquo;) may attend and, if relevant, vote at the EGM and exercise their voting rights on the voting items as
included in the abovementioned agenda.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Those who beneficially own shares in the Company&rsquo;s
capital in an account at a bank, broker, financial institution or other financial intermediary (the &ldquo;<B>Beneficial Owners</B>&rdquo;)
on the Registration Date, must request a proxy from their bank, broker, financial institution or other financial intermediary authorizing
the relevant Beneficial Owner to attend and, if relevant, exercise voting rights at the EGM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Persons with Meeting Rights and Beneficial Owners
who wish to attend the EGM, either in person or by proxy, must notify the Company of their identity and intention to attend the EGM by
sending notice to that effect to the Company by e-mail (addressed to <B>egm2025@curevac.com</B>). This notice must be received by the
Company no later than November 20, 2025 at 23:59 p.m. Central European Time (the &ldquo;<B>Cut-off Time</B>&rdquo;). Persons with Meeting
Rights and Beneficial Owners who have not complied with this requirement may be refused entry to the EGM. Beneficial Owners must enclose
with their attendance notice (i) proof of their beneficial ownership of the relevant underlying shares in the Company&rsquo;s capital
as of the Registration Date, such as a recent account statement, and (ii) their signed proxy from the relevant bank, broker, financial
institution or other financial intermediary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Persons with Meeting Rights and Beneficial Owners
who have duly registered for the EGM and who wish to have themselves represented at the EGM by a proxyholder, may do so through the use
of a written or electronically recorded proxy. They must submit their signed proxy to the Company no later than the Cut-off Time. A proxy
form can be downloaded from the Company&rsquo;s website (http://www.curevac.com). Persons with Meeting Rights and Beneficial Owners who
have duly registered for the EGM may also submit questions in advance of the EGM by sending an e-mail to the Company prior to the Cut-off
Time (addressed to <B>egm2025@curevac.com</B>), in which case the Company shall endeavor to respond to those questions at the EGM to
the extent possible and allowed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Sodali has been mandated by the
Company as information agent in connection with the EGM and is available for questions under the following contact details:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Email: </B>CureVac-EGM@investor.sodali.com<BR>
<B>Hotline: </B>+49 69 95179985</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Persons with Meeting Rights, Beneficial Owners
and their respective proxyholders who have not complied with these requirements may be refused entry to the EGM. In addition, only those
Persons with Meeting Rights and Beneficial Owners who have properly registered for the EGM are granted the possibility by the Company
to follow the EGM via webcast. In order to receive the link to stream the webcast, you will need to indicate to the Company by e-mail
(addressed to <B>egm2025@curevac.com</B>) prior to the Cut-off Time, that you would like to follow the EGM via webcast. It will not be
possible to vote or raise any questions during the live webcast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTES TO THE AGENDA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These are the explanatory notes to the agenda
for the extraordinary general meeting of CureVac N.V. (the &ldquo;<B>Company</B>&rdquo;) to be held at the offices of NautaDutilh N.V.
(address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands) on November 25, 2025 at 14:00 Central European Time (the &ldquo;<B>EGM</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Explanation of the exchange offer by BioNTech
                                            SE (&ldquo;Buyer&rdquo;) for ordinary shares in the capital of the Company (the &ldquo;Offer&rdquo;)</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Buyer and the Company have entered
into a purchase agreement dated 12 June 2025 relating to the Offer (the &ldquo;<B>Purchase Agreement</B>&rdquo;). Pursuant to the offer
to purchase dated October 21, 2025 (the &ldquo;<B>Offer to Purchase</B>&rdquo;), on October 21, 2025, Buyer commenced the Offer to purchase
(subject to the satisfaction or waiver (to the extent permissible) of the conditions set forth in the Purchase Agreement) any and all
of the ordinary shares, par value &euro;0.12 per share, in the capital of the Company (&ldquo;<B>Company Shares</B>&rdquo;) in exchange
for a number of American Depositary Shares of Buyer, each representing one share in the Buyer with a notional amount of &euro;1.00 (&ldquo;<B>Buyer
ADSs</B>&rdquo;), determined in accordance with the exchange ratio set forth in the Purchase Agreement and the Offer to Purchase (the
&ldquo;<B>Offer Consideration</B>&rdquo;), without interest and subject to applicable tax withholding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Offer will expire at 9:00 a.m.,
New York City time, on December 3, 2025 (the &ldquo;<B>Expiration Time</B>&rdquo;, unless the Offer is earlier terminated or extended
in accordance with the Purchase Agreement and the Offer to Purchase, in which event &ldquo;<B>Expiration Time</B>&rdquo; will mean the
latest time and date at which the Offer, as so extended, will expire).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the satisfaction or waiver
(to the extent permissible) of the conditions to the consummation of the Offer, Buyer shall, promptly following the Expiration Time (but
in any event within two (2) business days thereafter), accept for exchange (the time of acceptance for exchange, the &ldquo;<B>Acceptance
Time</B>&rdquo;) all Company Shares validly tendered and not properly withdrawn pursuant to the Offer as of the Expiration Time (the
&ldquo;<B>First Company Shares</B>&rdquo;). Within ten (10) business days following the effectiveness of the increase of Buyer&rsquo;s
share capital required for the exchange of the First Company Shares for the Offer Consideration, Buyer shall exchange the First Company
Shares for the Offer Consideration (and cash in lieu of fractional Buyer ADSs, if any) for those First Company Shares (the &ldquo;<B>Closing</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Following the Acceptance Time, Buyer
shall provide a subsequent offering period in accordance with the terms of the Purchase Agreement and the Offer to Purchase for a period
of no less than ten (10) business days to purchase additional Company Shares in exchange for the Offer Consideration (the &ldquo;<B>Subsequent
Offering Period</B>&rdquo;). Within ten (10) business Days following the effectiveness of the increase of Buyer&rsquo;s share capital
required for the exchange the Company Shares validly tendered during the Subsequent Offering Period (the &ldquo;<B>Second Company Shares</B>&rdquo;),
Buyer shall exchange the Second Company Shares for the Offer Consideration (and cash in lieu of fractional Buyer ADSs, if any) for those
Second Company Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Please see Buyer&rsquo;s Tender Offer
Statement on Schedule TO filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) on October 21, 2025, the
related Letter of Transmittal and the Company&rsquo;s Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on October
21, 2025 (the foregoing documents and other related materials, as each may be amended or supplemented from time to time collectively,
the &ldquo;<B>Offer Materials</B>&rdquo;) for more information about the Offer, including a detailed description of the terms of the
Purchase Agreement and the Offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&rsquo;s management board
(the &ldquo;<B>Management Board</B>&rdquo;) and supervisory board (the &ldquo;<B>Supervisory Board</B>&rdquo;) have (i) determined that
the Purchase Agreement and the transactions contemplated thereby are in the best interest of the Company and the sustainable success
of its business, having considered the interest of its shareholders, employees and other relevant stakeholders, (ii) approved and adopted
the Purchase Agreement (including the execution, delivery and performance thereof) and approved the transactions contemplated thereby
and (iii) resolved, on the terms and subject to the conditions set forth in the Purchase Agreement to support the Offer and the other
transactions contemplated by the Purchase Agreement and to recommend acceptance of the Offer by the shareholders of the Company and to
recommend approval and adoption of the voting items included on the agenda for the EGM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Consummation of post-offer reorganization
                                            (<I>voting items</I>)</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>a.</B></TD><TD STYLE="text-align: justify"><B>Conditional resolution to enter
                                            into a legal merger (<I>juridische fusie</I>) of the Company (as disappearing company) with
                                            and into CureVac Merger B.V. (as acquiring company surviving such merger) (&ldquo;New Topco&rdquo;),
                                            with New Topco issuing class A shares in its capital to the Company&rsquo;s shareholders
                                            (other than Buyer) and class B shares in its capital to Buyer, in accordance with Sections
                                            2:309 et seq. of the Dutch Civil Code (the &ldquo;Legal Downstream Merger&rdquo;)</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>b.</B></TD><TD STYLE="text-align: justify"><B>Conditional resolution to approve,
                                            to the extent required under applicable law and the Company&rsquo;s articles of association
                                            and bylaws (<I>reglementen</I>), (i) the Legal Downstream Merger, (ii) the subsequent sale
                                            and transfer of all outstanding shares in the capital of CureVac SE by New Topco to Buyer
                                            and (iii) the subsequent cancellation of all outstanding class A shares in the capital New
                                            Topco</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As promptly as practicable following
the closing of the Subsequent Offering Period, Buyer shall effectuate, or cause to be effectuated, in which case the Company and its
subsidiaries shall effectuate, a corporate reorganization of the Company and its subsidiaries (the &ldquo;<B>Post-Offer Reorganization</B>&rdquo;),
consisting of the Legal Downstream Merger, the Post-Downstream Merger Share Sale (as defined below) and the Cancellation (as defined
below), in that order, provided that each step of such Post-Offer Reorganization is permitted under applicable law (including Sections
2:316(4) and 2:318(1) of the Dutch Civil Code). The Post-Offer Reorganization shall be subject to the conditions set forth in the Purchase
Agreement and if these conditions are met, several steps shall be taken, including the following steps in the following order: (i) the
Legal Downstream Merger, which shall become effective as of 0:00 (local time in the Netherlands) on the day after the date on which the
deed of merger to effect the Legal Downstream Merger is executed (the &ldquo;<B>Merger Effective Time</B>&rdquo;), (ii) New Topco shall
sell all outstanding shares in the capital of CureVac SE to Buyer against payment of consideration by Buyer with a value equal to the
excess of (1) the aggregate Offer Consideration for all Company Shares over (2) the amount of cash and cash equivalents of the Company,
including any receivables, and any other assets net of any liabilities of the Company, provided that such consideration shall be payable
by Buyer in the form of (A) Buyer ADSs to enable New Topco to distribute to each holder of class A shares in the capital of New Topco
(&ldquo;New Topco A Shares&rdquo;), pursuant to the Cancellation (as defined below) determined as of 00:30 (local time in the Netherlands)
on the date the Legal Downstream Merger becomes effective (the &ldquo;<B>Cancellation Effective Time</B>&rdquo;) a number of Buyer ADS
and cash in lieu of fractional Buyer ADSs, determined in accordance with the Purchase Agreement (the &ldquo;<B>Cancellation Consideration</B>&rdquo;)
and (B) a loan note with a principal amount equal in value to the remaining part of the consideration payable by Buyer with respect to
the outstanding shares in the capital of CureVac SE (the &ldquo;<B>Post-Downstream Merger Share Sale</B>&rdquo;) and (iii) the subsequent
cancellation of all then-issued and outstanding New Topco A Shares effective as of the Cancellation Effective Time, against repayment
in kind consisting of the Cancellation Consideration (without interest and subject to applicable tax withholding) (the &ldquo;<B>Cancellation</B>&rdquo;),
in each case on the terms and subject to the conditions set forth in the Purchase Agreement. Buyer shall cause to be effectuated the
election by New Topco to be disregarded as an entity separate from Buyer for U.S. federal income tax purposes effective as of the day
following the completion of the Cancellation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Post-Offer Reorganization is subject
to certain conditions set forth in the Purchase Agreement, including the adoption of the voting items proposed under this agenda item
3 at the EGM (or a subsequent general meeting of the Company). In this respect, it is proposed that, subject to (A) the Acceptance Time
having occurred and the Subsequent Offering Period having expired and (B) the number of Company Shares validly tendered in accordance
with the terms of the Offer (including Company Shares tendered during the Subsequent Offering Period) and not properly withdrawn, together
with the Company Shares owned by Buyer or any of its affiliates, representing at least eighty percent (80%) of the Company&rsquo;s issued
and outstanding share capital (<I>geplaatst en uitstaand kapitaal</I>) immediately prior to the Expiration Time (the &ldquo;<B>Minimum
Condition</B>&rdquo;) or, if Buyer has amended the Minimum Condition in accordance with the Purchase Agreement, then at least seventy-five
percent (75%) of the Company&rsquo;s issued and outstanding share capital (<I>geplaatst en uitstaand kapitaal</I>) immediately prior
to the Expiration Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">the Company enter into the Legal Downstream
                                            Merger in accordance with the terms of the<BR>
                                            merger proposal as filed with the Dutch trade registry on October 22, 2025 and the accompanying
                                            explanatory notes as filed at the offices of the Company and New Topco on October 22, 2025;
                                            and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">to the extent required under applicable
                                            law and the Company&rsquo;s articles of association (<I>statuten</I>) and bylaws (<I>reglementen</I>),
                                            also within the meaning of Section 2:107a of the Dutch Civil Code and articles 18.10 and
                                            18.11 of the Company&rsquo;s articles of association, the Legal Downstream Merger, the Post-Downstream
                                            Merger Share Sale and the Cancellation be approved.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the Post-Offer Reorganization is
consummated, shareholders who did not tender their Company Shares in the Offer (including during the Subsequent Offering Period) will
receive the same consideration as shareholders who tendered their Company Shares in the Offer, which, as is the case with the Offer Consideration,
will be subject to applicable withholding taxes and without interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>Dutch withholding tax aspects</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No Dutch dividend withholding tax (&ldquo;<B>DDWHT</B>&rdquo;)
is applicable to the Offer Consideration paid for Company Shares tendered in the Offer, including during the Subsequent Offering Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">However, the withholding taxes applicable
to the Cancellation Consideration will in principle include DDWHT at a rate of 15% to the extent the Cancellation Consideration exceeds
the average paid-in capital recognized for DDWHT purposes (the &ldquo;<B>Fiscally Recognized Capital</B>&rdquo;) of the relevant cancelled
New Topco A Shares immediately prior to the Cancellation Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Fiscally Recognized Capital of
New Topco is, immediately following the Merger Effective Time, equal to (i) the Fiscally Recognized Capital of the Company at the time
of the Legal Downstream Merger, or (ii) if lower, the fair market value of the Company (the &ldquo;<B>Company FMV</B>&rdquo;) at such
time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">It is currently expected that the Fiscally
Recognized Capital of New Topco will be increased at most by an amount equal to the Company FMV at the time of the Legal Downstream Merger.
As a result, if and to the extent the Cancellation Consideration exceeds the Fiscally Recognized Capital of the relevant New Topco A
shares (calculated on the basis of the Company FMV) immediately prior to the Cancellation Effective Time, DDWHT will be withheld by New
Topco on the excess.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As long as New Topco has its place
of effective management in Germany and is therefore exclusively a tax resident of Germany under the double tax treaty between Germany
and the Netherlands, as currently expected, the Netherlands will be restricted from imposing DDWHT in respect of the Cancellation Consideration,
except in the event the Cancellation Consideration is paid to (i) a holder who is resident or deemed to be resident in the Netherlands
for Dutch corporate income tax purposes or Dutch income tax purposes (a &ldquo;<B>Dutch Resident Holder</B>&rdquo;), or (ii) a holder
who is not resident nor deemed to be resident in the Netherlands for Dutch corporate income tax purposes or Dutch income tax purposes
but who derives profits from an enterprise, which enterprise is carried on, in whole or in part, through a permanent establishment or
a permanent representative in the Netherlands to which its New Topco A shares are attributable (a &ldquo;<B>Dutch PE Holder</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In order to apply this regime correctly,
New Topco needs to identify its shareholders to assess whether they are Dutch Resident Holders or Dutch PE Holders. As a practical matter,
New Topco will not be able to make this confirmation with certainty prior to the Cancellation Effective Time. Therefore, by default,
DDWHT will be withheld on the Cancellation Consideration if and to the extent the Cancellation Consideration exceeds the Fiscally Recognized
Capital of the relevant New Topco A shares immediately prior to the Cancellation Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Any such DDWHT will be for the account
of such former CureVac shareholders. The exchange agent will be allowed to sell, or procure the sale of, in one or more transactions,
the minimum number of BioNTech ADSs to obtain a sufficient cash amount to remit to the Dutch tax authority the relevant amount of withholding
tax and will not be obliged to pay any additional amounts to a holder of New Topco A shares for any DDWHT effectively deducted from the
cancellation consideration. As a result, CureVac shareholders that do not tender their shares in the offer (including the subsequent
offering period) may receive a lower after-tax return than those who do.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Non-tendering holders of CureVac shares
may be able to reclaim any DDWHT withheld from their Cancellation Consideration. See the Offer Materials for more information on the
Dutch tax aspects of the Post-Offer Reorganization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">There can be no assurances as to the
success of any such reclaim or refund request. In any event, any amounts refunded will be in cash. Therefore, non-tendering shareholders
will not receive the investment benefit, if any, of receiving any Buyer ADSs sold by the Exchange Agent as described below to cover any
applicable DDWHT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>German (withholding) tax aspects</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For a description of certain German
(withholding) tax consequences for tendering shareholders and non-tendering shareholders, please see the section on <I>&quot;Material
German Tax Considerations&quot; </I>in the Offer to Purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Buyers ADSs Sale</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If New Topco is required to deduct
and withhold withholding taxes in respect of the Cancellation Consideration, Section 2.08(i) of the Purchase Agreement provides that
the exchange agent appointed by Buyer pursuant to the Purchase Agreement (the &ldquo;<B>Exchange Agent</B>&rdquo;) shall be instructed
and authorized, acting as agent of New Topco and as withholding agent for the account of the holders of New Topco A Shares as taxpayers
of any applicable withholding taxes, including DDWHT and any applicable German withholding taxes (the &ldquo;<B>Aggregate Withholding
Amount</B>&rdquo;), to sell, in one or more transactions, the minimum number of Buyer ADSs to which holder of New Topco A Shares would
otherwise be entitled as is necessary to obtain in U.S. dollars an amount in net cash proceeds that converted in Euros (at the applicable
exchange rate) is as close as possible to, but no less than, the Aggregate Withholding Amount (the &ldquo;<B>Buyer ADSs Sale</B>&rdquo;).
From the net cash proceeds obtained pursuant to the Buyer ADSs Sale, the Exchange Agent shall, as soon as possible, transfer to Buyer
the Aggregate Withholding Amount to enable New Topco as withholding agent to remit the Aggregate Withholding Amount to the applicable
taxing authority for the account of the holders of New Topco A Shares. In the event that the net cash proceeds obtained by the Exchange
Agent pursuant to the Buyer ADSs Sale exceed the Aggregate Withholding Amount, such surplus cash proceeds shall be paid to the holders
of New Topco A Shares, less any applicable withholding taxes, consistent with the procedures for payment of cash in lieu of fractional
Buyer ADSs; provided that the Buyer shall be entitled to any surplus if the amount thereof is <I>de minimis</I>, and any such surplus
amount shall not be treated for any purpose as consideration paid to any holder of New Topco A Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If withholding taxes will need to be
deducted or withheld, no reductions of, or exemptions from, any applicable withholding tax at source based on applicable law, including
the laws of the European Union or any treaty for the avoidance of double taxation and any regulations for claiming relief thereunder
will be applied by New Topco or the Exchange Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All amounts that are so deducted and
withheld as required by applicable tax law shall be treated for all purposes as having been paid to the relevant holder of New Topco
A Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Please see the Offer Materials for
more information about the Offer and the Post-Offer Reorganization, including a discussion of material tax consequences of the Offer
and the Post-Offer Reorganization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The adoption of these proposed resolutions is a condition
to the consummation of the Offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Conditional release from liability (<I>voting
                                            items</I>)</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>a.</B></TD><TD><B>Conditional release of managing directors from liability
                                            for the exercise of their duties</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>b.</B></TD><TD STYLE="text-align: justify"><B>Conditional release of supervisory
                                            directors from liability for the exercise of their duties</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">It is proposed that, effective upon
the Acceptance Time, each member of the Management Board and the Supervisory Board be provided full and final discharge for their acts
of management or supervision, as applicable, up to and including the date of the EGM to the fullest extent permitted under applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The adoption of these proposed resolutions
is <U>not</U> a condition to the consummation of the Offer Condition. If either or both of these resolutions is/are not adopted, the
Offer may still be consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Conditional appointment of Ram&oacute;n
                                            Zapata Gomez as managing director of the Company (<I>voting items</I>)</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Buyer and the Company have agreed that,
effective upon Closing, certain changes are to be made in the composition of the Management Board. The current members of the Management
Board will voluntarily resign their positions as members of the Management Board effective upon Closing. To replace them, Buyer has designated
Ram&oacute;n Zapata Gomez (the &ldquo;<B>Buyer Management Board Nominee</B>&rdquo;) to be appointed as member of the Management Board
and, accordingly, the Supervisory Board has made binding nomination to appoint the Buyer Management Board Nominee as member of the Management
Board effective upon Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Ram&oacute;n Zapata Gomez, is BioNTech&rsquo;s
Chief Financial Officer. He is a seasoned global finance executive with more than 25 years of experience in the pharmaceutical and consumer
goods industries. He has held leadership roles at leading global companies including Novartis AG, Sandoz AG, and Mondel&emacr;z International,
and has worked across Europe, North America, Latin America, and the Middle East. Throughout his career, Ram&oacute;n Zapata has led finance
functions enabling seamless execution from drug discovery through commercialization, including overseeing M&amp;A transactions and successful
integrations as well as driving digital finance transformations. Prior to joining BioNTEch, he served as Chief Financial Officer and
Head of Scientific Operations of BioMedical Research at Novartis, where he was responsible for the overall leadership of the division&rsquo;s
finance strategy and operations, portfolio realignment, cross-functional integration, and strategic external collaborations. Ram&oacute;n
Zapata holds dual citizenship of the United States and Mexico. He is a Certified Public Accountant (CPA) from Universidad Panamericana.
He holds an MBA from IPADE Business School, with academic credits earned at IESE Business School as part of the program. He also earned
a postgraduate diploma in Tax Legislation from ITAM and is currently pursuing a Master&rsquo;s degree in Industrial-Organizational Psychology
at Harvard University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The adoption of these proposed resolutions is a condition
to the consummation of the Offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>6.</B></TD><TD STYLE="text-align: justify"><B>Conditional appointment
                                            of supervisory directors (<I>voting items</I>)</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>a.</B></TD><TD><B>Conditional appointment of Sierk Poetting as supervisory
                                            director of the Company</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>b.</B></TD><TD><B>Conditional appointment of James Ryan as supervisory director
                                            of the Company</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>c.</B></TD><TD STYLE="text-align: justify"><B>Conditional appointment of Annemarie
                                            Hanekamp as supervisory director of the Company</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Buyer and the Company have agreed that,
effective upon Closing, certain changes are to be made in the composition of the Supervisory Board. The current members of the Supervisory
Board will voluntarily resign their positions as members of the Supervisory Board effective upon Closing, except for Debra Barker and
Mehdi Shahidi, who will continue to serve as members of the Supervisory Board until the earlier of (i) such time after the Acceptance
Time as Buyer and its Affiliates (as defined in the Purchase Agreement), in the aggregate, own one hundred percent (100%) of the issued
and outstanding Company Shares and (ii) the Merger Effective Time. To replace them, Buyer has designated Sierk Poetting, James Ryan and
Annemarie Hanekamp (the &ldquo;<B>Buyer Supervisory Board Nominees</B>&rdquo;) to be appointed as members of the Supervisory Board, with
Sierk Poetting to serve as chairperson of the Supervisory Board, and, accordingly, the Supervisory Board has made binding nominations
to appoint each of the Buyer Supervisory Board Nominees as members of the Supervisory Board effective upon Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Sierk Poetting, Ph.D. is BioNTech&rsquo;s
Chief Operating Officer. He joined BioNTech in September 2014 from Novartis (NYSE: NV), where he served in various positions from May
2012 to August 2014 as Vice President and Chief Financial Officer for the Sandoz Division in North America. Sierk Poetting started his
career as a consultant with McKinsey &amp; Company. A German citizen, Sierk Poetting holds a Master of Science in Optical Sciences from
the University of Arizona and a Ph.D. in Physics from the Ludwig-Maximilians University in Munich.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">James Ryan, Ph.D. is BioNTech&rsquo;s
Chief Legal Officer and Chief Business Officer. He brings nearly 20 years of global legal and IP expertise in the pharmaceutical industry
to BioNTech. James Ryan joined BioNTech in 2018 as General Counsel and Senior Vice President Legal &amp; IP and was appointed to Chief
Legal Officer and a Member of the Management Board in 2023 and to Chief Business Officer in July 2024. He has guided BioNTech through
a wide range of key business, IP and transactional activities, mergers and acquisitions, strategic collaborations and equity capital
markets transactions, including BioNTech&rsquo;s IPO in 2019. James Ryan and his teams played a pivotal role in the successful development
of the Pfizer-BioNTech COVID-19 vaccine, supporting every legal aspect of the program, its launch and commercialization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to joining BioNTech, he established
the legal group of GW Pharmaceuticals (NASDAQ: GWPH), where he also served as Head of Legal Affairs. Earlier in his career, James Ryan
worked for a number of UK and U.S. law firms, including Special Counsel at Covington &amp; Burling LLP, where he specialized in commercial
and strategic transactions with a focus on companies in the life sciences sector. James has a Ph.D. in epigenetics from the University
of St Andrews, is a member of the Law Society of England &amp; Wales and is a member of the Law Society of Ireland.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Annemarie Hanekamp is BioNTech&rsquo;s
Chief Commercial Officer. She joined BioNTech in 2024 and has more than 20 years of experience in the healthcare industry, including
15 years of commercial experience in companies ranging from early-stage biotechnology companies to full-scale pharmaceutical companies.
She successfully delivered significant value in a broad range of roles: at Novartis (NYSE: NV), she led the U.S. and global teams through
a time of strategic opportunities and operational headwinds following an unprecedented strong launch uptake of their novel treatment
for prostate cancer. She was also responsible for building a new global oncology organization following a company-wide transformation.
At Bristol-Myers Squibb Co. (NYSE: BMY), she held a pivotal role in evolving the company&rsquo;s U.S. oncology strategy, resulting in
significant and sustainable growth including an expanded market access as well as product launches. Annemarie Hanekamp holds degrees
in biomedical sciences as well as organizational leadership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Buyer Supervisory Board Nominees
shall receive no compensation for their services as members of the Supervisory Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The adoption of these proposed resolutions
is a condition to the consummation of the Offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>tm2529451d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html><head></head><body link=blue lang="EN-US"><div><div align="center"><div align="center"><div style="font: bold 10pt Times New Roman; text-align: right; position: relative">Exhibit 99.2</div><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="tm2529451d1_ex99-2img001.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
V79174-S25050
1. Conditional resolution to enter into a legal merger of
CureVac N.V. with and into CureVac Merger B.V.
2. Conditional resolution to approve (i) the Legal
Downstream Merger, (ii) the subsequent sale and transfer
of all outstanding shares in the capital of CureVac SE
by CureVac Merger B.V. to BioNTech SE and (iii) the
subsequent cancellation of all outstanding class A shares
in the capital of CureVac Merger B.V.
4. Conditional release of supervisory directors from liability
for the exercise of their duties
3. Conditional release of managing directors from liability
for the exercise of their duties
6. Conditional appointment of Sierk Poetting as supervisory
director of CureVac N.V.
5. Conditional appointment of Ram&#xF3;n Zapata Gomez as
managing director of CureVac N.V.
7. Conditional appointment of James Ryan as supervisory
director of CureVac N.V.
8. Conditional appointment of Annemarie Hanekamp as
supervisory director of CureVac N.V.
For Against Abstain For Against Abstain
! ! !
! ! !
! ! !
! ! !
! ! ! ! ! !
! ! !
CUREVAC N.V.
FRIEDRICH-MIESCHER-STRASSE 15
TUEBINGEN 72076
GERMANY
CUREVAC N.V.
The Board of Directors recommends you vote FOR
proposals 1 through 8.
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor,
administrator, or other fiduciary, please give full title as such. Joint owners should each sign
personally. All holders must sign. If a corporation or partnership, please sign in full corporate
or partnership name by authorized officer.
! ! !
VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above
Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by
23:59 p.m. CET on 20 November 2025. Have your proxy card in hand when you access the web site
and follow the instructions to obtain your records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can
consent to receiving all future proxy statements, proxy cards and annual reports electronically via
e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote
using the Internet and, when prompted, indicate that you agree to receive or access proxy materials
electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions. Vote by 23:59 p.m. CET on
20 November 2025. Have the proxy card mailed to you in hand when you call and then follow the
instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided
or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717, by
23:59 p.m. CET on 20 November 2025.
VOTE BY EMAIL
Mark, sign and date your proxy card and return it via email to egm2025@curevac.com by
23:59 p.m. CET on 20 November 2025.
SCAN TO
VIEW MATERIALS &amp; VOTEw</font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="tm2529451d1_ex99-2img002.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">V79175-S25050
Important Notice Regarding the Availability of Proxy Materials for the
Extraordinary General Meeting:
The Notice of Meeting is available at www.proxyvote.com
CUREVAC N.V.
Extraordinary General Meeting of Shareholders
25 November 2025
This proxy is solicited by the Board of Directors
The undersigned hereby registers for the extraordinary general meeting of shareholders of CureVac N.V. to be held on
25 November 2025 at 2:00 p.m. Central European Time (the "EGM") and, for purposes of being represented at the EGM, grants
a power of attorney to each civil law notary and candidate civil law notary working with NautaDutilh N.V. (each, a "Proxyholder")
to represent and to vote, as designated on the reverse side of this ballot, all of the common shares of CureVac N.V. that the
undersigned is entitled to vote at the EGM, and to exercise any other right of the undersigned which the undersigned would be
allowed to exercise at the EGM. This power of attorney is granted with full power of substitution. The relationship between the
undersigned and each Proxyholder is governed exclusively by the laws of the Netherlands. The EGM will be held at the offices of
NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands).
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this
proxy will be voted in accordance with the Board of Directors' recommendations.
Continued and to be signed on reverse side</font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:avoid;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>tm2529451d1_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MERGER PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">between</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CureVac Merger B.V.<BR>
</B>as New Topco</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CureVac N.V.<BR>
</B>as CureVac</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>22 October 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MERGER PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THE UNDERSIGNED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Alexander Zehnder,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">acting as the managing director (<I>bestuurder</I>)
of <B>CureVac Merger B.V.</B>, a private limited liability company (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), having
its corporate seat (<I>statutaire zetel</I>) in Amsterdam, the Netherlands (address: Friedrich-Miescher-Strasse 15, 72076 T&uuml;bingen,
Federal Republic of Germany, trade register number: 97691682) (&ldquo;<B>New Topco</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Malte Betram Greune,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Myriam Mendila,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Alexander Zehnder,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Thaminda Ramanayake,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Axel Sven Malkomes,</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">acting as the managing directors (<I>bestuurders</I>)
of <B>CureVac N.V.</B>, a public limited liability company (<I>naamloze vennootschap</I>), having its corporate seat (<I>statutaire zetel</I>)
in Amsterdam, the Netherlands (address: Friedrich-Miescher-Strasse 15, 72076 T&uuml;bingen, Federal Republic of Germany, trade register
number: 77798031) (&ldquo;<B>CureVac</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Baron Jean Raymond Ghislain St&eacute;phenne,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Mathias Peter Hothum,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Craig Allen Tooman,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Klaus Christian Schollmeier ,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Debra Stephanie Barker,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Michael Brosnan,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Birgit Hofmann,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Mehdi Shahidi,</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">acting as the supervisory directors (<I>commissarissen</I>) of CureVac.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New Topco and CureVac are hereinafter collectively referred to as
the &ldquo;<B>Merging Companies</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>A.</B></TD><TD STYLE="text-align: justify">Pursuant to and in
                                            accordance with the terms of a Purchase Agreement entered into among BioNTech SE, a European
                                            stock corporation (<I>Societas Europaea</I>) organized under the laws of Germany and the
                                            European Union, as the buyer (&ldquo;<B>Buyer</B>&rdquo;) and CureVac as the company, dated
                                            12 June 2025 (as may be amended from time to time and including the annexes, exhibits, appendices
                                            and schedules thereto, the &ldquo;<B>Purchase Agreement</B>&rdquo;)<SUP>1</SUP>, among other
                                            matters, (i) Buyer has agreed to make a tender offer (the &ldquo;<B>Offer</B>&rdquo;) to
                                            purchase all of the issued and outstanding ordinary shares in the capital of CureVac, with
                                            a nominal value of &euro;0.12 each (&ldquo;<B>CureVac Shares</B>&rdquo;) in exchange for
                                            a number of American Depositary Shares of Buyer, each representing one share in the Buyer
                                            with a notional amount of &euro;1.00 (a &ldquo;<B>Buyer ADS</B>&rdquo;), equal to the exchange
                                            ratio agreed in the Purchase Agreement, per CureVac Share, without interest (the &ldquo;<B>Offer
                                            Consideration</B>&rdquo;) and (ii) Buyer has agreed to provide a subsequent offering period
                                            with respect to such tender offer (the &ldquo;<B>Subsequent Offering Period</B>&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> The Purchase Agreement is available at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>B.</B></TD><TD STYLE="text-align: justify">As promptly as practicable following the closing
                                            of the Subsequent Offering Period, Buyer shall effectuate, or cause to be effectuated (in
                                            which case CureVac and its subsidiaries, including New Topco, shall effectuate) a corporate
                                            reorganization of CureVac and its subsidiaries (the &ldquo;<B>Post-Offer Reorganization</B>&rdquo;),
                                            consisting of the Legal Downstream Merger, the Post-Downstream Merger Share Sale and the
                                            Cancellation (all as defined below), in that order, provided that each step of such Post-Offer
                                            Reorganization is permitted under applicable law (including Sections 2:316(4) and 2:318(1)
                                            of the Dutch Civil Code (the &ldquo;<B>DCC</B>&rdquo;)). The Post-Offer Reorganization shall
                                            be subject to the conditions set forth in the Purchase Agreement and if these conditions
                                            are met, several steps shall be taken, including the following steps in the following order:
                                            (i) the legal merger contemplated by this merger proposal (the &ldquo;<B>Legal Downstream
                                            Merger</B>&rdquo;), which shall become effective as of 0:00 (local time in the Netherlands)
                                            on the day after the date on which the deed of merger to effect the Legal Downstream Merger
                                            is executed (the &ldquo;<B>Merger Effective Time</B>&rdquo;), (ii) New Topco shall sell all
                                            outstanding shares in the capital of CureVac SE to Buyer against payment of consideration
                                            by Buyer with a value equal to the excess of (1) the aggregate Offer Consideration for all
                                            CureVac Shares over (2) the amount of cash and cash equivalents of CureVac, including any
                                            receivables, and any other assets net of any liabilities of CureVac, provided that such consideration
                                            shall be payable by Buyer in the form of (A) Buyer ADSs to enable New Topco to distribute
                                            to each holder of class A shares in the capital of New Topco (&ldquo;<B>New Topco A Shares</B>&rdquo;),
                                            pursuant to the Cancellation (as defined below) determined as of 00:30 (local time in the
                                            Netherlands) on the date the Legal Downstream Merger becomes effective (the &ldquo;<B>Cancellation
                                            Effective Time</B>&rdquo;) a number of Buyer ADS and an aggregate cash amount (as compensation
                                            for entitlements to fractional Buyer ADSs), determined in accordance with the Purchase Agreement
                                            (the &ldquo;<B>Cancellation Proceeds</B>&rdquo;) and (B) a loan note with a principal amount
                                            equal in value to the remaining part of the consideration payable by Buyer with respect to
                                            the outstanding shares in the capital of CureVac SE (the &ldquo;<B>Post-Downstream Merger
                                            Share Sale</B>&rdquo;) and (iii) the subsequent cancellation of all then-issued and outstanding
                                            New Topco A Shares, effective as of the Cancellation Effective Time, against repayment in
                                            kind consisting of the Cancellation Proceeds (without interest and subject to applicable
                                            tax withholding) (the &ldquo;<B>Cancellation</B>&rdquo;), in each case on the terms and subject
                                            to the conditions set forth in the Purchase Agreement. Buyer shall cause to be effectuated
                                            the election by New Topco to be disregarded as an entity separate from Buyer for U.S. federal
                                            income tax purposes (the &ldquo;<B>New Topco U.S. Tax Election</B>&rdquo;) as of the day
                                            following the completion of the Cancellation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>C.</B></TD><TD STYLE="text-align: justify">The Legal Downstream Merger,
                                            if effected as contemplated by and on the terms and subject to the conditions set forth in
                                            the Purchase Agreement and this merger proposal, shall be a legal merger within the meaning
                                            of Section 2:309 of the DCC pursuant to which (i) CureVac, as the disappearing company, will
                                            merge with and into New Topco, as the surviving company, (ii) all assets and liabilities
                                            of CureVac shall transfer to New Topco by operation of law under universal succession of
                                            title, (iii) New Topco shall allot class B shares in its capital (&ldquo;<B>New Topco B Shares</B>&rdquo;)
                                            to Buyer for each CureVac Share held by Buyer immediately prior to the Merger Effective Time
                                            in accordance with the exchange ratio set out in article 12 of this merger proposal (the
                                            &ldquo;<B>Merger Exchange Ratio</B>&rdquo;), (iv) New Topco shall allot New Topco A Shares
                                            to the other holders of CureVac Shares immediately prior to the Merger Effective Time in
                                            accordance with the Merger Exchange Ratio and (v) as a consequence of the foregoing, immediately
                                            following completion of the Legal Downstream Merger, each holder of CureVac Shares will come
                                            to hold a number of New Topco A Shares or New Topco B Shares (collectively, the &ldquo;<B>New
                                            Topco Shares</B>&rdquo;), as applicable, equal to the number of CureVac Shares held by such
                                            holder of CureVac Shares immediately prior to the Merger Effective Time.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>D.</B></TD><TD STYLE="text-align: justify">None of the Merging Companies has been dissolved,
                                            has been declared bankrupt or has been granted a suspension of payments.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>E.</B></TD><TD STYLE="text-align: justify">No works council has been established or is
                                            in the process of being established which would be entitled to render advice in respect of
                                            the Legal Downstream Merger.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MERGER PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Merger proposal<BR>
Article 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is proposed that the Merging Companies enter
into the Legal Downstream Merger in accordance with the terms stipulated by this merger proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Articles of association<BR>
Article 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New Topco&rsquo;s articles of association currently
read as reflected in <U>Annex A</U> and shall not be amended in connection with the Legal Downstream Merger. This Annex constitutes an
integral part of this merger proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Equivalent rights or compensation<BR>
Article 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.1</B></TD><TD STYLE="text-align: justify">At the Merger Effective Time, there
                                            will be no special rights vis-&agrave;-vis CureVac, such as a right to profit distributions
                                            or rights to subscribe for shares held by any party other than as shareholder of CureVac.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.2</B></TD><TD STYLE="text-align: justify">No party is entitled pursuant to Section
                                            2:320 of the DCC to receive an equivalent right in New Topco or compensation for the loss
                                            of such right.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>No benefits conferred<BR>
Article 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No benefits shall be conferred in connection
with the Legal Downstream Merger on managing directors or supervisory directors of the Merging Companies or on other parties involved
in the Legal Downstream Merger, provided that the managing directors and supervisory directors of the Merging Companies may (continue
to) be granted compensation for their services and provided, further, that CureVac&rsquo;s advisors are paid fees for their services
rendered in connection with the preparation, negotiation, finalization and implementation of the Purchase Agreement and the transactions
contemplated thereby, including the Legal Downstream Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed composition of boards<BR>
Article 5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Merger Effective Time, the composition
of New Topco&rsquo;s management board is intended to be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Sierk Poetting;</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Ram&oacute;n
                                            Zapata Gomez;</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Malte Betram
                                            Greune (subject to potential resignation prior to the Merger Effective Time);</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Thaminda Ramanayake
                                            (subject to potential resignation prior to the Merger Effective Time);</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Myriam Mendila
                                            (subject to potential resignation prior to the Merger Effective Time);</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Alexander Zehnder
                                            (subject to potential resignation prior to the Merger Effective Time); and</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Axel Sven Malkomes
                                            (subject to potential resignation prior to the Merger Effective Time).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Financial information<BR>
Article 6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial information pertaining to CureVac
shall be incorporated in the annual accounts or other financial reporting of New Topco as of the first day of the financial year of New
Topco during which the Legal Downstream Merger becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Measures in connection with share ownership</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Article 7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.1</B></TD><TD STYLE="text-align: justify">Pursuant to the Legal Downstream Merger,
                                            New Topco shall allot (i) New Topco A Shares to the holders of CureVac Shares other than
                                            Buyer for each CureVac Share held by them immediately prior to the Merger Effective Time
                                            and (ii) New Topco B Shares to Buyer for each CureVac Share held by Buyer immediately prior
                                            to the Merger Effective Time, in each case accordance with the Merger Exchange Ratio.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.2</B></TD><TD STYLE="text-align: justify">The New Topco Shares to be allotted
                                            pursuant to the Legal Downstream Merger shall be included in the register kept by New Topco&rsquo;s
                                            transfer agent and registrar for further credit to the respective (former) shareholders of
                                            CureVac entitled to such New Topco Shares. The allotment of New Topco Shares pursuant to
                                            the Legal Downstream Merger shall be recorded in New Topco&rsquo;s shareholders&rsquo; register
                                            and with the Dutch trade register.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.3</B></TD><TD STYLE="text-align: justify">The New Topco Shares shall not be admitted
                                            for trading on any stock exchange at the Merger Effective Time. Holders of New Topco Shares
                                            shall only be able to transfer their New Topco Shares in accordance with Dutch law and pursuant
                                            to the execution of a notarial deed executed before a civil law notary officiating in the
                                            Netherlands.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.4</B></TD><TD STYLE="text-align: justify">If and to the extent that any rights
                                            of pledge or usufruct vest on CureVac Shares immediately prior to the Merger Effective Time,
                                            those rights shall pass by operation of law under universal succession of title, to the extent
                                            allowed under applicable law, to the New Topco Shares allotted pursuant to the Legal Downstream
                                            Merger in exchange for those CureVac Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.5</B></TD><TD STYLE="text-align: justify">Subject to the Post-Downstream Merger
                                            Share Sale having been consummated, effective as of the Cancellation Effective Time, each
                                            then-issued and outstanding New Topco A Share shall be cancelled against repayment in kind
                                            consisting of the Cancellation Proceeds (without interest and subject to applicable tax withholding).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Activities<BR>
Article 8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until the Merger Effective Time, New Topco will
not have any activities, and New Topco does not intend to discontinue any activities of CureVac which CureVac has immediately before
the Merger Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Approval<BR>
Article 9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under CureVac&rsquo;s current articles of association,
a resolution of the CureVac&rsquo;s general meeting to enter into the Legal Downstream Merger requires a proposal to that effect by CureVac&rsquo;s
management board which, in turn, is subject to the approval of CureVac's supervisory board. Such proposal is made by CureVac&rsquo;s
management board, and such proposal is approved by CureVac's supervisory board, as a result of all CureVac&rsquo;s managing directors
and supervisory directors signing this merger proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Impact on goodwill and distributable reserves<BR>
Article 10</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>10.1</B></TD><TD STYLE="text-align: justify">There will be no impact of the Legal Downstream Merger on
New Topco&rsquo;s goodwill.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>10.2</B></TD><TD STYLE="text-align: justify">New Topco&rsquo;s distributable reserves shall increase with
an amount equal to the value for which CureVac&rsquo;s assets and liabilities will be incorporated in the annual accounts or other financial
reporting of New Topco, plus the nominal amount of the single New Topco Share held by CureVac that will be cancelled pursuant to the
Legal Downstream Merger, less (i) any increase pursuant to the Legal Downstream Merger of the statutory reserves that must be kept by
New Topco pursuant to Dutch law and (ii) the aggregate nominal amount of the New Topco Shares to be allotted pursuant to the Legal Downstream
Merger in accordance with the Merger Exchange Ratio.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shares without voting rights or profit entitlement<BR>
Article 11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of the Merging Companies has issued non-voting
shares or shares without profit entitlement. Consequently, the Legal Downstream Merger shall have no impact on the holders of those types
of shares and no compensation can be requested pursuant to Section 2:330a of the DCC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exchange ratio<BR>
Article 12</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For each CureVac Share not held by or for the
account of any of the Merging Companies immediately before the Merger Effective Time, New Topco shall allot one New Topco Share to the
holder of such CureVac Share, in the manner described in Article 7.1 of this merger proposal (i.e., in a 1:1 exchange ratio).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Profit entitlement in New Topco<BR>
Article 13</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each New Topco Share to be allotted pursuant
to the Legal Downstream Merger shall entitle the holder thereof to share in New Topco&rsquo;s profits as from the Merger Effective Time
in accordance with the provisions of New Topco&rsquo;s articles of association set out in <U>Annex A</U>, subject to the Cancellation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cancellation of shares<BR>
Article 14</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The single New Topco Share held by CureVac immediately
prior to the Merger Effective Time shall be cancelled at the Merger Effective Time pursuant Section 2:325(3) of the DCC, notwithstanding
the Cancellation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>U.S. tax treatment<BR>
Article 15</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For U.S. federal income tax purposes, the Merging
Companies intend for the Offer, taken together with the Legal Downstream Merger, the Post-Downstream Merger Share Sale, the Cancellation
and the New Topco U.S. Tax Election, to qualify as one or more &ldquo;reorganizations&rdquo; within the meaning of Section 368(a) of
the U.S. Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;), and the U.S. Treasury regulations promulgated under
the Code (the &ldquo;<B>Treasury Regulations</B>&rdquo;), and the Purchase Agreement is intended to constitute a &ldquo;plan of reorganization&rdquo;
within the meaning of Section 368 of the Code and the Treasury Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>(signature page follows)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify"><I>Signature page to the merger proposal
of New Topco and CureVac (1/2)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify"><I>Management board of New Topco</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A. Zehnder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Management board of CureVac</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Name : A. Zehnder</TD>
  <TD>&nbsp;</TD>
  <TD>Name : T. Ramanayake</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Title : CEO</TD>
  <TD>&nbsp;</TD>
  <TD>Title : CBO</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Name : M. Mendila</TD>
  <TD>&nbsp;</TD>
  <TD>Name : M.B. Greune</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Title : CSO and CDO</TD>
  <TD>&nbsp;</TD>
  <TD>Title : COO</TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name : A.S. Malkomes<BR>
Title : CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For approval by the supervisory board of CureVac</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name : Baron J.R.G. St&eacute;phenne</TD>
    <TD>&nbsp;</TD>
    <TD>Name : M.P. Hothum</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title : Supervisory Board Member</TD>
    <TD>&nbsp;</TD>
    <TD>Title : Supervisory Board Member</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name : C.A. Tooman</TD>
    <TD>&nbsp;</TD>
    <TD>Name : B. Hofmann</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title : Supervisory Board Member</TD>
    <TD>&nbsp;</TD>
    <TD>Title : Supervisory Board Member</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"><I>Signature page to the merger proposal of New Topco and CureVac (2/2)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name : K.C. Schollmeier</TD>
    <TD>&nbsp;</TD>
    <TD>Name : D.S. Barker</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title : Supervisory Board Member</TD>
    <TD>&nbsp;</TD>
    <TD>Title : Supervisory Board Member</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name : M. Brosnan</TD>
    <TD>&nbsp;</TD>
    <TD>Name : M. Shahidi</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title : Supervisory Board Member</TD>
    <TD>&nbsp;</TD>
    <TD>Title : Supervisory Board Member</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>tm2529451d1_ex99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTES TO A MERGER PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">between</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CureVac Merger B.V.<BR>
</B>as New Topco</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CureVac N.V.<BR>
</B>as CureVac</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>22 October 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTES TO A MERGER PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THE UNDERSIGNED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Alexander Zehnder,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">acting as the managing director (<I>bestuurder</I>)
of <B>CureVac Merger B.V.</B>, a private limited liability company (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), having
its corporate seat (<I>statutaire zetel</I>) in Amsterdam, the Netherlands (address: Friedrich-Miescher-Strasse 15, 72076 T&uuml;bingen,
Federal Republic of Germany, trade register number: 97691682) (&ldquo;<B>New Topco</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Malte Betram Greune,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Myriam Mendila,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Alexander Zehnder,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Thaminda Ramanayake,</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>-</B></TD><TD STYLE="text-align: justify">Axel Sven Malkomes,</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">acting as the managing directors (<I>bestuurders</I>)
of <B>CureVac N.V.</B>, a public limited liability company (<I>naamloze vennootschap</I>), having its corporate seat (<I>statutaire zetel</I>)
in Amsterdam, the Netherlands (address: Friedrich-Miescher-Strasse 15, 72076 T&uuml;bingen, Federal Republic of Germany, trade register
number: 77798031) (&ldquo;<B>CureVac</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New Topco and CureVac are hereinafter collectively referred to as
the &ldquo;<B>Merging Companies</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A.</B></TD><TD STYLE="text-align: justify">Pursuant to and in accordance with the
                                            terms of a Purchase Agreement entered into among BioNTech SE, a European stock corporation
                                            (<I>Societas Europaea</I>) organized under the laws of Germany and the European Union, as
                                            the buyer (&ldquo;<B>Buyer</B>&rdquo;) and CureVac as the company, dated 12 June 2025 (as
                                            may be amended from time to time and including the annexes, exhibits, appendices and schedules
                                            thereto, the &ldquo;<B>Purchase Agreement</B>&rdquo;)<SUP>1</SUP>, among other matters, (i)
                                            Buyer has agreed to make a tender offer to purchase all of the issued and outstanding ordinary
                                            shares in the capital of CureVac, with a nominal value of &euro;0.12 each (&ldquo;<B>CureVac
                                            Shares</B>&rdquo;) in exchange for a number of American Depositary Shares of Buyer, each
                                            representing one share in the Buyer with a notional amount of &euro;1.00 (a &ldquo;<B>Buyer
                                            ADS</B>&rdquo;), equal to the exchange ratio agreed in the Purchase Agreement, per CureVac
                                            Share, without interest (the &ldquo;<B>Offer Consideration</B>&rdquo;) and (ii) Buyer has
                                            agreed to provide a subsequent offering period with respect to such tender offer (the &ldquo;<B>Subsequent
                                            Offering Period</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> The Purchase Agreement is available at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>B.</B></TD><TD STYLE="text-align: justify">As promptly as practicable
                                            following the closing of the Subsequent Offering Period, Buyer shall effectuate, or cause
                                            to be effectuated (in which case CureVac and its subsidiaries, including New Topco, shall
                                            effectuate) a corporate reorganization of CureVac and its subsidiaries (the &ldquo;<B>Post-Offer
                                            Reorganization</B>&rdquo;), consisting of the Legal Downstream Merger, the Post-Downstream
                                            Merger Share Sale and the Cancellation, in that order, provided that each step of such Post-Offer
                                            Reorganization is permitted under applicable law (including Sections 2:316(4) and 2:318(1)
                                            of the Dutch Civil Code (the &ldquo;<B>DCC</B>&rdquo;)). The Post-Offer Reorganization shall
                                            be subject to the conditions set forth in the Purchase Agreement and if these conditions
                                            are met, several steps shall be taken, including the following steps in the following order:
                                            (i) the legal merger contemplated by the merger proposal (the &ldquo;<B>Merger Proposal</B>&rdquo;)
                                            to which these explanatory notes relate (the &ldquo;<B>Legal Downstream Merger</B>&rdquo;),
                                            which shall become effective as of 0:00 (local time in the Netherlands) on the day after
                                            the date on which the deed of merger to effect the Legal Downstream Merger is executed (the
                                            &ldquo;<B>Merger Effective Time</B>&rdquo;), (ii) New Topco shall sell all outstanding shares
                                            in the capital of CureVac SE to Buyer against payment of consideration by Buyer with a value
                                            equal to the excess of (1) the aggregate Offer Consideration for all CureVac Shares over
                                            (2) the amount of cash and cash equivalents of CureVac, including any receivables, and any
                                            other assets net of any liabilities of CureVac, provided that such consideration shall be
                                            payable by Buyer in the form of (A) Buyer ADSs to enable New Topco to distribute to each
                                            holder of class A shares in the capital of New Topco (&ldquo;<B>New Topco A Shares</B>&rdquo;),
                                            pursuant to the Cancellation (as defined below) determined as of 00:30 (local time in the
                                            Netherlands) on the date the Legal Downstream Merger becomes effective (the &ldquo;<B>Cancellation
                                            Effective Time</B>&rdquo;) a number of Buyer ADS and an aggregate cash amount (as compensation
                                            for entitlements to fractional Buyer ADSs), determined in accordance with the Purchase Agreement
                                            (the &ldquo;<B>Cancellation Proceeds</B>&rdquo;) and (B) a loan note with a principal amount
                                            equal in value to the remaining part of the consideration payable by Buyer with respect to
                                            the outstanding shares in the capital of CureVac SE (the &ldquo;<B>Post-Downstream Merger
                                            Share Sale</B>&rdquo;) and (iii) the subsequent cancellation of all then-issued and outstanding
                                            New Topco A Shares, effective as of the Cancellation Effective Time, against repayment in
                                            kind consisting of the Cancellation Proceeds (without interest and subject to applicable
                                            tax withholding) (the &ldquo;<B>Cancellation</B>&rdquo;), in each case on the terms and subject
                                            to the conditions set forth in the Purchase Agreement. Buyer shall cause to be effectuated
                                            the election by New Topco to be disregarded as an entity separate from Buyer for U.S. federal
                                            income tax purposes as of the day following the completion of the Cancellation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>C.</B></TD><TD STYLE="text-align: justify">The Legal Downstream
                                            Merger, if effected as contemplated by and on the terms and subject to the conditions set
                                            forth in the Purchase Agreement and the Merger Proposal, shall be a legal merger within the
                                            meaning of Section 2:309 of the DCC pursuant to which (i) CureVac, as the disappearing company,
                                            will merge with and into New Topco, as the surviving company, (ii) all assets and liabilities
                                            of CureVac shall transfer to New Topco by operation of law, (iii) New Topco shall allot class
                                            B shares in its capital (&ldquo;<B>New Topco B Shares</B>&rdquo;) to Buyer for each CureVac
                                            Share held by Buyer immediately prior to the Merger Effective Time in accordance with the
                                            exchange ratio set out in article 12 of the Merger Proposal (the &ldquo;<B>Merger Exchange
                                            Ratio</B>&rdquo;), (iv) New Topco shall allot New Topco A Shares to the other holders of
                                            CureVac Shares immediately prior to the Merger Effective Time in accordance with the Merger
                                            Exchange Ratio and (v) as a consequence of the foregoing, immediately following completion
                                            of the Legal Downstream Merger, each holder of CureVac Shares will come to hold a number
                                            of New Topco A Shares or New Topco B Shares (collectively, the &ldquo;<B>New Topco Shares</B>&rdquo;),
                                            as applicable, equal to the number of CureVac Shares held by such holder of CureVac Shares
                                            immediately prior to the Merger Effective Time.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Reasons for the Legal Downstream Merger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Article 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Buyer wishes to acquire, directly or indirectly,
all of the business, assets and liabilities of CureVac and its subsidiaries. An efficient manner to transfer all of the business, assets
and liabilities of CureVac and its subsidiaries is to first implement the Legal Downstream Merger, followed by the Post-Downstream Merger
Share Sale and the Cancellation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consequences for activities<BR>
Article 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until the Merger Effective Time, New Topco will
not have any activities, and New Topco does not intend to discontinue any activities of CureVac which CureVac has immediately before
the Merger Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Economic consequences<BR>
Article 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Legal Downstream Merger, in and of itself,
is not expected to have material economic consequences for the Merging Companies, except for (i) the acquisition by New Topco of CureVac&rsquo;s
entire business and all of its assets and liabilities, (ii) the delisting of CureVac Shares from the Nasdaq Stock Market and (iii) the
allotment of New Topco Shares pursuant to the Legal Downstream Merger to former shareholders of CureVac (in each case determined as of
immediately prior to the Merger Effective Time), whereby New Topco A Shares shall be allotted to all holders of CureVac Shares other
than Buyer and New Topco B Shares shall be allotted to Buyer. The New Topco Shares shall not be admitted for trading on any stock exchange.
Holders of New Topco Shares shall only be able to transfer their New Topco Shares in accordance with Dutch law and pursuant to the execution
of a notarial deed executed before a civil law notary officiating in the Netherlands. Subject to the Post-Downstream Merger Share Sale
having been consummated, the Cancellation shall cause, effective as of the Cancellation Effective Time, each then-issued and outstanding
New Topco A Share to be cancelled against repayment in kind consisting of the Cancellation Proceeds (without interest and subject to
applicable tax withholding).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Legal consequences<BR>
Article 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.1</B></TD><TD STYLE="text-align: justify">The Legal Downstream Merger will, <I>inter
                                            alia</I>, have the following consequences at the Merger Effective Time:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>a.</B></TD><TD>CureVac, as the disappearing company, will merge with and into
                                            New Topco, as the surviving company, and CureVac will cease to exist;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>b.</B></TD><TD>all assets and liabilities of CureVac shall transfer to New
                                            Topco by operation of, and to the extent permitted under, applicable law under universal
                                            succession of title;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>c.</B></TD><TD STYLE="text-align: justify">all CureVac Shares will lapse, the
                                            single New Topco Share held by CureVac immediately prior to the Merger Effective Time will
                                            be cancelled pursuant Section 2:325(3) of the DCC and New Topco shall allot (i) New Topco
                                            A Shares to the holders of CureVac Shares other than Buyer and (ii) New Topco B Shares to
                                            Buyer as described in articles 7 and 12 of the Merger Proposal, in each case on the other
                                            terms stipulated by the Merger Proposal.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.2</B></TD><TD STYLE="text-align: justify">Following the Merger Effective Time,
                                            creditors of CureVac will be able to recover their claims from New Topco as they could recover
                                            such claims from CureVac before the Merger Effective Time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.3</B></TD><TD STYLE="text-align: justify">Unless a counterparty of the Merging
                                            Companies exercises the right provided for under Section 2:322 of the DCC, it is anticipated
                                            that contracts concluded with the Merging Companies will remain in force unchanged following
                                            the Merger Effective Time (other than in accordance with their existing terms), provided
                                            that contracts concluded with CureVac shall have New Topco, instead of CureVac, as the contracting
                                            party with effect from the Merger Effective Time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Social consequences<BR>
Article 5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New Topco has no employees and shall not have
any employees immediately prior to the Merger Effective Time. To the extent that CureVac has employees immediately prior to the Merger
Effective Time, the employment or service contracts concluded with those employees, as well as their other conditions of employment or
service, will remain in force unchanged following the Merger Effective Time with New Topco as the contracting party, subject to the provisions
of such contracts, the Purchase Agreement and applicable law. It is anticipated that the Legal Downstream Merger will not have material
adverse implications for the interests of the employees of CureVac. No works council has been established or is in the process of being
established which would be entitled to render advice in respect of the Legal Downstream Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exchange ratio<BR>
Article 6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.1</B></TD><TD STYLE="text-align: justify">For each CureVac Share not held by
                                            or for the account of any of the Merging Companies immediately prior to the Merger Effective
                                            Time, New Topco shall allot one New Topco Share to the holder of such CureVac Share, in each
                                            case in the manner described in Articles 7 and 12 of the Legal Downstream Merger Proposal
                                            (i.e., in a 1:1 exchange ratio) (the &ldquo;<B>Merger Exchange Ratio</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>6.2</B></TD><TD STYLE="text-align: justify">The following method
                                            for determining the Merger Exchange Ratio has been applied:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>a.</B></TD><TD STYLE="text-align: justify">New Topco has no assets and liabilities
                                            and is not expected to have any assets and liabilities until the Merger Effective Time;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>b.</B></TD><TD STYLE="text-align: justify">New Topco&rsquo;s assets and liabilities
                                            immediately following the Merger Effective Time shall have the same value as CureVac&rsquo;s
                                            assets and liabilities immediately prior to the Merger Effective Time;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>c.</B></TD><TD STYLE="text-align: justify">without prejudice to the Cancellation,
                                            the New Topco A Shares carry the same rights as the New Topco B Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>d.</B></TD><TD STYLE="text-align: justify">consequently, there is no necessity
                                            for determining an exact exchange ratio in relation to the Legal Downstream Merger in order
                                            to compensate holders of CureVac Shares for the loss of their respective CureVac Shares by
                                            allotting a proportionate and equivalent number of New Topco Shares, whereby New Topco A
                                            Shares are allotted to all holders of CureVac Shares other than Buyer and New Topco B Shares
                                            are allotted to Buyer, in exchange for such CureVac Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>e.</B></TD><TD STYLE="text-align: justify">the above considerations result
                                            in the conclusion, that the Merger Exchange Ratio can be, and therefore has been, determined
                                            to be 1:1.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.3</B></TD><TD STYLE="text-align: justify">Because of the reasons described in
                                            article 6.2 of these explanatory notes, the Merger Exchange Ratio is considered to be suitable
                                            and appropriate.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.4</B></TD><TD STYLE="text-align: justify">The method applied to determine the
                                            Merger Exchange Ratio as described in article 6.2 of these explanatory notes does not lead
                                            to a specific valuation. As described above, any valuation would be irrelevant for the above-mentioned
                                            method for determining the Merger Exchange Ratio.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.5</B></TD><TD STYLE="text-align: justify">Because only one method was applied
                                            to determine the Merger Exchange Ratio, the relative weight of multiple methods is not addressed
                                            in these explanatory notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.6</B></TD><TD STYLE="text-align: justify">No particular difficulties arose as
                                            a result of the valuation described above or the determination of the Merger Exchange Ratio.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>(signature page follows)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature page to the explanatory notes to
a merger proposal of New Topco and CureVac</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Management board of New Topco</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A. Zehnder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Management board of CureVac</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Name : A. Zehnder</TD>
  <TD>&nbsp;</TD>
  <TD>Name : T. Ramanayake</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Title : CEO</TD>
  <TD>&nbsp;</TD>
  <TD>Title : CBO</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Name : M. Mendila</TD>
  <TD>&nbsp;</TD>
  <TD>Name : M.B. Greune</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>Title : CSO and CDO</TD>
  <TD>&nbsp;</TD>
  <TD>Title : COO</TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name : A.S. Malkomes<BR>
Title : CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2529451d1_ex99-2img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2529451d1_ex99-2img001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U$# 2(  A$! Q$!_\0
M'0 !  (# 0$! 0            8'! 4( P(!"?_$ %T0  $$ 0,# 0,%"PH"
M! H'"0$  @,$!081$@<3(3$(%"(5&3)!41@C,U=A<7:5EM/4"18W.$)55I2S
MM"12%V*!TC0U0W)UD9*ALM$E4U1S='>"P^0F1$7!8['P_\0 %@$! 0$
M              $"_\0 &1$! 0$! 0$              !$!03$A_]H # ,!
M  (1 Q$ /P#^J:(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B BB>O>K.B^EL=.
M36&J<3IIMPN;6^4[C(#,6[<N <07;<F[[>FX^T*'_===%/QIZ4_6D7_S06XB
MJ/[KKHI^-/2GZTB_^:?===%/QIZ4_6D7_P T6+<1:'1>O=-]1L*,OI;.X_4.
M,[CH?>\;9;/&'MVW:2TG9PW'@^?(^U;Y$$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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MG8$^!Y558GV5L+C*&"P]G,19%N+U&-1UO?*QDLR1B-K9('R.E+Y&E_ \W;[
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MKP=;:#" \,).Y\CF0W<;^2!ZD*+ZBZ!T];8+16!U'EVVX<%/-9LP4G6J_O\
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M/=W/N<P=G$?D V4<T[:ZF9RA#:99M0Q/A=*'78Z;><HCFXL 8-Q$7=CU ?\
M2\@()#+H#-Y#3N,K6<@8;U/*27HG^_SS]B,B01L[CMG2\>3?IC;U'H/+0NB-
M28G/MO9G*2R4XZYCCI,RUFTWNEL8=(XR!O+?B\AIW#>7CU\:BI1ZF7[SN>1R
M6/Q[98&Q]YF.-AS"6]XOXL<W<?'QX_5MN"5J:D_4W.U;L4LV4@EKO:R?L>Y1
MMY,]W<6PNVY%Q/>!Y? 0=@?1!ZOZ4Z\?08]^I>[DV2.)F?D)OB:71EW;=V^4
M7-K' ANX;N-OK6QCZ9ZI=!5;<R3\A:J7(K$5R7-V02P1%G$QM8&;M))Y;?'M
MYV).VGSF/ZKY;#YBK9][DBLLL0QUZ;:+'!QY"+9[G?@2TC?TD! \^3M8&K9M
M09G TI]-UYJMUL\S2;,439(P(IF->&R^!N_@1]H/GP2BHM:Z9ZR=[K7@U#.V
M%H@$MIV:M]PL$0;-&&;;$NDY/$O(.&_'P MACM"ZLHYRI-/EG9#%0R/'NKLM
M9C?Q[CS&\O#29"UA:TL<=G?63Q&\?UCA>I.1::D8MY"*"<OK/_X$1RALD^SK
M /$[\.QL&  ^>0]5MLI8ZDBC792KWSD'7GFQ*74.PR(/'%L;3\1C<PD[N/,%
MOU[[(C'U[TUUEJ#5#\AB\LRO$R?NPR.REB)S8BR)KH6Q-86L)XR'N-/+XU]#
MIGK2HV1]'48CL/+29);<CC(3#!"]TFS '.#62.:2/+@PG;<D9.A*G4.IG\97
MR]BT["P5^,S[8K2NF?\ ? >3V$/#N7 M(!'';<;[[8-' Z^Q&9RV2AER%]XE
M,<=>U-4#;47?M/ #MB6 ,DAX^A&^Q! V!7Y'TWU?2HWI<AJC)3-C?/,SW3(V
M)'NV9+VBU@:#OR?'O'N6G@/7Z][+#JZ;I9DJEB"=FHG5 ]L\-HASYY?C>QCF
M_$QL9<6 ^NS? V WP]#5M=F_>LZFMWJL;Z,L<+YC4[4+Q(XMD>V/<<^+AY]"
M&^0/1:FGE>I^=PE+(U1)'-<A;)#'"VKV(SW"UW>+_C+3&&O86?VGD'P $1^V
M>EVMYK(GASQI-D>T21PY2=TS(VOL%C>^YA=)P[S-@\;'R#X:-_UO3WJ.YMB4
MZ@AAMR3O?'QRME\$(='Q<1&6;G9VSFL+BT'????82&QD==6='Y22+&6ZV8DM
MQQU(^Y4[L4/;CYR;$NC=\?=^%Q!(/U>%$Z><ZB9#4=;#OR$T.0,,;[T=849(
MJK>57D1X<]LG%UCP_=I_L [!%2:OTXSMC2F'IWLO,_*4L@;OO$E^:;M_>WM
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M !V.Q)(W*V\?6_&3ND;#ALQ,^)KS(UK(!Q+&%TH\RC<L#?.VX.XX\EZ5.M^
MNWG58H+YD%D4VDQ,V?.2SC&WX]]RV1K_ +.._G=K@-':UCHF?#B&71_9J,E?
M&(KN-KM9"^.+[V7QN>"WDT[,:=G.&X V7X_5>E9LWC)&:;NLMUK3G4V5JU6-
MERP'&,N!Y[C@;#R.9:/OCCY*(F.=ZDTL#-E&/H7;+,<Z..:6$P@.E>UKFQ,#
MY&N<\M>T[ ;?5OOX4<R772J[&S38K#9&S((FS,EF9$V+A]Y+GG[Z';#WB,$
M;[D[ [%;N0:2U1I7^>&1P-6:M+1%N5]ZG%).(F-Y\7;<MRW8^ 2/L4>R68T\
MZ_B<;+H.&9G;;+%1?5JNEBE>/O+6CGVV[QUY'$\QL(V#UV""2:LZJXK1^7^3
MK-:Y:G[#I]Z@C> 0QSPP@O!:XM8XCD #MZK72=7H[.2HT*6(NMG?>BJ7#9$0
M;5YRRQ[.+9#NXF%^W#D/3<C=:KJ-J;#T]/X35U'35',V\ILV.2U0,L_:]VEE
MX_"USAN&EN_HT.)/@([7&D)K<>4FT@9+50RV/?VU:KS"UCV]V=CR\.+0^;U
MY$EQ#2@WF2ZQ8S&:C=A78K+3V18-<200QO8XCMASA\?+B#,P'QOY/C8$K&BZ
MVXZ+3L>3O8K(597-C)IL[4C]WLE>T AX!\0N^L>H_+MH,YU4TS:EMR4-,'(Y
M;'R.LLGEKUW1M'*)ILB02?$T\V#=A+CQ]/"^<CJC2$,PDAT/'8N-CL"C"['5
M>;^!L%[PXR -9][F.QV<=SX^+9!/]/:^KZ@S<^+&-OT)XA*0^T(N#S$]K) "
MR1QW:Y[1Y !^HE:S#=31EL+J&^:,]>#$P"867M81.#%W"6QB3<;>FQ<-_M^R
M.T^M6G:,5.Y+IZW';M1O[=BK7@VL2F2)L[&$R!P^^.:27AH/#?<[#><U*.*G
MTW/D<;@H&F_1#C4DJMB=,W@2R*1NW_6(V/IN4'GI[7U;4DU^*OC[T$E6,RM%
M@1CWAHDDCW9Q>=OBB</BX_45#JO7R"O4%S+X._2JSLK&N(NU*>Y+")!$3W/+
MCOX( ;MMN05FZ:U;,&8,_(]"M=MY!V+R3&0.K25'=E\X8&D'GY)._(#X]QN2
M5CZMR^G-(:A@P%O2^,=A)<?):YBNS\..361!G';XF-D:#]NS?K02:YU(JU<!
MB,HW%9.?Y3D='#3;'&R=I:R1[N0>]K1L(G>CCOXVWW6GAZY8:Q7K68\;E'4[
M6[H+)CB;&^,2=M\I)D';8UVP)DX_2&VZB474;2^J<'AZN:TI8L28UD=AV/IU
MHYJ<<[X^(A',@'X9MP2&M\CSOX6VLZIT/#%4FET.\MR\SS'PQM:1TXB<&NE+
M6O)(:YX\$<OB\-/E!LCUTQE2M3=?Q.0K6+/>V@B=#,6%CI0T.VD^$O[+N)(V
MW\;^"5[5.N&&L9<XZ7&Y>K8C=(RR7UV2-K%KY6?'VWO]3"_8MY#TWVW4,N:\
MT:_+6!)HQT0M5624K-;&5I;4K9O>.Y* 2X<2T.^$CD>XX%AY$*4:8KZ?PNDL
MGE,%IYOREA#9 ;>@ABM%X+I'C:,;QAW(EK=F^' AH!"#/L]:<15=:#\?D>,9
ME; XMA;[VZ-[&/;$#(#R!D;L'!I/G;<C985+K77S5C'18NA:LLM7*\4EB6)D
M<<$4SGAG(=SD7'MN] 1]NRB-#5NDI<AEG3Z3Q]Z*[<FN]^1D,DMRL7;,D'<#
M02Z?X6M+O3;8D[!371V0T/JK*468[35:M?J567(#+CX6/JQN9&^,@C?B2)O&
MWUM?Z;>0R\IU@QN.U':PL>+RV0MP3QUB^K#'VW2O[>S YSV@':5IW=L/78G9
M8%CK]I^""!PI92:Q-QXU8X6&7XHVR-_M[>6N<1Y\]MX]0-_/*:CQF,UYGY+6
M"K3&@RJ3/#C2^S9ED+!$.^=HP0XL #G ^ =P H^SJ3I 8JS+FM&-CCBFDK67
M1T:SF0]AUDPQO'/<N#(7D<0YH+_!&Y16^=UWQ^/I9.W>QM]U>E(>Y)7B8.VQ
MSGMA:]KWM=S<8R-@" =M]ELZ/6/%WM20X+Y,RL.2=((IHW0QN%8D[-,A8]PV
M=MONWD!]>RB6<UIT[S%1\>7TQ+1ELQOB=)/CH6311R=UCI \$_"7-+>0)\R-
M_P"8E;+&:RT?4N8ME#1DT%Y[I68QL5*K')(6O<)NV>X.&SFNWYEN_P!6Z(WF
M6ZTX#"Y>UC;4=UEFLYS) (FD!P<T-;]+U<UQ>/\ JM<?&VR,ZJ,RFC?E[%XJ
M\=KM:J*MN)K))!+)$W=GQ\3\,G@\M@1L=MBM9@=9X#6^K\::&G(I(+K);3LK
M;JQ![YHHHFMXGD7\FLG+"7-'C<-)'K\:\UAC^EKHL;7TY1&%;1GR![;&QQPV
M(W,[(+ W8!S]AR]0[AM^0,\]<<"RS6ADK7HQ+$)'R<8G-K_$&N;+QD):6@\C
MXVX@D$K/T?U8Q6M<C9J4:61C$$1E-BQ &Q.V#26@AQV=\8\. W\[;[%:K3=3
M%9_5&5H6=&8FO+4A=%=MFK&X31RC[VQGP[N#H]^8/H0&^?5,IFAIK^?=VCIS
M%17,7#"X2QO[;K41C!/<<(]P0&[!OD?"WR/J WKOB3!!([#9ACIH&VFQED'+
MLN:',>=I=MG;\0-]]_4 >5[6>M>(AEFJOJWJ>0BF$4D$\+'EGQN:XGA)L0"S
M8D..Q>SUW6J^1ZND)LKA,7IW W,=0PK[+F2U^V\DM#&,F>&N#NX(Y-SQ]&#?
M?=;#%0U9=0Z<IUL#@FT;6,=:?%'3 EJ1'@\@.]-G3%AVV&Y:7>K4&##U_H-R
MCH;.'R<<$\<,]-L<+))7PO8'.E<&R'X0'L\#X_)^%2C0NO':VNY/A0FHTX(J
MTU<V>'<E9*PO#SQ>X $;; ['[0M#K!FF= 9'&N;HVA/5D;9O3R4J, DA,+6'
MN_$6^C7'?;=W@ !;SIUD=,Y%N3.F\1%BQ'*UESM58X-YAN"QW'U<T;;[^G(;
M%!,41$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0?,C>4;A
ML';@C9WH?SJGZ&I#I7 QY3'Z:PT$+,H:(GQE1[(K$3G1-=*Q[6[1M!!:7O\
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M,1B.YY;DEA()]?._KY4H1!HM1:)P^JVUADH)9178^-@BLRP[L> 'L=P<.37
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M$1$!$1 1$0$1$!$1 1$0$1$!0?4'3,9V;4LPR3JTV5]RD@>V$.]UFK.YQO\
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M0" ?!&ZAF8ZY=*<_E:>3R&B=66LC4G;9AMOT)D^ZV1H+6DN%?<[ GP=QZ>/
M5^XK+T<[0BNXV[7R%*4;QV:LK98WC\CFD@KR@U#B[.6MXN')4Y<G48V6Q29.
MPS0L=]%SV [M!^HD>41$K;-.=0=,5=76ZV=?CH8/?&491=K2$1.+VEU+=KG2
M!S=V@LY$ANV_A5-A>K_2_3N!DPV-PO5"ICWD'@S"ZB+V$$N^!Y:7-W))/$CE
MOYW5]T];Z=R%.I;JY_%V:MR<U:T\-R-[)YAOO&QP=LY_PGX1Y\'[%YX#7^E]
M66IJV$U)B,S9AW[L./O13O9L=CR#'$CS]J"J.GN8Z:=0=14\=B-.:JHVJ4#9
MFG*XG*X^M*(I>XTS.F:V.=XDD+QW.3MRX_:O3J/F^GF@,Y+CLYA]993(6X8K
M0NX^CE\F8FMD<Y@CLQ!_9(>">#'-/D;C8A6IG-?:8TSD8,?F-1XG$W[#><-6
M]>BAED;OMNUKG D;@CP%G9?4.*P%:&QE,G3QL$\K8(I;<[(FR2.^BQI<0"X_
M4!Y*"E\%[2N@--8J#&X[3VNH*D._!CM'9>1Q))<YSG.@+G.)))<222225;-[
M6E#'Z*_G1+7R+L=[HR[V(L?-);X.:"![N&F3GL1NSCR!W!'A8>4ZLZ'PF6DQ
M>1UGI_'Y.)P8^E:RD$<S'';8%CG@@G<>-OK7U5ZK:)NV+L%?6& L3T8WRVHH
MLG YU=C#L]T@#MVAOUD[;?6@@'W66CO[DUU^Q65_AU+>G?63!]3KMRKB:&H*
M<E6,2/=F<#<Q[""=OA=/&P./Y!N5)-.ZOP.L*S[&!S>.S<$9XOEQUN.PUI^P
MEA("VZ"L]:>T'IO0>H[.%R.,U59MUPPODQFF+]V \FAPXRQ0N8[P1OL?!W!\
MA:/[K+1W]R:Z_8K*_P .KH1!H-9:UH:&TU-G,A7R-FG$6!T6-Q\URP>3@!M#
M$USSY/G8>!N3Z*MONLM'?W)KK]BLK_#JZ$00[IUU4Q'4^&]+B:6;IMIN8V09
MK#6L<7%P)' 3QL+Q\)W+=]O&_JHUJ3VD]+:6SU[$7,3J^:S3E,4DE+2>1LPN
M(^MDL<):\?E:2%:R(*?QWM2Z1R>0JTXL-K5DMB5L+'3:.R<; 7$ %SG0 -'G
MR2=A]:V?7'^:V.QF+S&JJ>;R%:"5]6"'!XZ>[*V25G(2%D$;I&%O:!;(./%W
M'SN0MUK/.YZMJ; 87!38ZK+D(;4TDV1JR6&CM"/9H#)8]M^YY.YVV]%$=-]6
M<YK+4M3'515Q+9,=%8>UV(M9!O?=+8B>#/&]C(V!T&X+P.0/U(*XL=4]$6X\
MW%/=ZK2PYJH*EZ-VBK7WXB#LB7?W#D'[;'P0W<?1VW"MOI3:Q.O&5-35;FI;
MDV+%C&,?J3%'&S$/$+W?>G5X2YHXL >&[>7C<D>(WD>LVH=.:-;D<A9P%O+6
M<C;K5JP@?3C,-6243$E\[^3G-B :!ML^1H/(*9X36.5UWG+3M.V\96P-'W;G
M/:JOLRV^[$R;[WQEC$;>$C ''GN2?  \E0G5/M Z)EU%1]\Q6NC:P5Z62,U=
M(9*2)\G;DA=\0KD/;L]Q!:?/@[D>N@Q6K^GFN(<!HZ"GK^N&PV,;7GMZ7O5F
M<;#>+G22R5@QNP]''8#Z]U/\3UGDR66P^,]QF;:MY^YBIGNQ]EM<10^\\7,G
M+>V7GLLW <?5WC[,K475Z'!]4<9IKNT/<GF.O<?+,!8CL3AQKAC=_+?@ =X/
MF:/T\H,+5^;PO1_44&I,]8U1GK=Z&2C59CL))>%:$/;(6$5*_(#?CLZ0GT.Q
MWY;U[+UCZ>_S:I8BM2ZCTGT;CK]3(0Z,R/O$$SGO<7#E4+"-I'MV<T@M.Q^U
M;JO[1&:ET?!:FQM"MG?<[EN6 A[HBQD#IJ\C!R!+7<>+O/TF/ /C=67IO4^9
M&?R6"S9HVK=>C%D8+F/A?!')&]SV\'1N>\M<UT9\\R' _5L0@B>B]$:7ZB:<
M=J!\VH;QO^^,LRYVDZE:G,C&PNYP.AC+ UL3 SBUH\;_ !$[J#97K'T]S45I
MMREU)FDLXV#%RS'1V1YO9%(7A_\ X+MS+G'<[;?8 MM@NOVHLOI)V1,=,3.G
MQD/?;A+GWEUDGFP5>YW9N+>!;(PAK^7CZ)4HS6NM7X?)6MKV'L4:^GILWPDP
MMBO,\Q[#MD/L[LW)W^)NX'C;?R@B&C-2:-U[JZI@J,NOX*$UV7)PXC*::LTL
M='..4Q<9Y:K7 <^3VL=)MS( !\-6WU-)HGH;J[3.0LU]6VKU7#'&0C$86SD8
M9HF\&A\YKP. E 8 #NW<$^" -MKU#ZOY72TV+AJ0UF>^5*EA\SJ,]UT9EL-C
M=QAB<'R;!Q(:WSNM'6]H3,PUIK-_&T64G:?;D*UN/F&NMN%AT37M+CQ9(R#<
M#?DUQXDDD(-#8ZR]/I,!!C:]/J12EK9&7*5;\.C<CWZ\\DDCW%O*H6$??7MX
MN:06G8[GRIQCM$:7SFC)]6WIM0Y6*W3N6K;\A2=%=L,DA;&X.K"%KVN:R%H8
MQK&GP/#B=S(M;ZDU'CL;IJWAK6+K?*5NM4F9>HR6-C,1\32V>/;;SX.^_P!H
M48=UUM1U*L/N+GY(Y:_CYGNQMJ.J65V62US)2.V7$P,W >?5WV>"-!F/:%T+
MGM*_(-W']1)8#'$Q]G^9F2[SS&YK@XGW7CN2T;^/K.P"R<'GM+=:=59FAB;.
MNL"S*U1)E:=O3]C'U+K&!L9!ELU@6O<PM81&]KBT?DW$RZ=]0<OJ7-BOFO=,
M4;%1EJECQ2E#[,9CC<9H[!D+'@%Y!C#.3/AW/D$QFSUKU)7RN<CAQ=>]5KWY
ML;"[W&Q7BKR^\1P0&6RYQCE#C(26Q@.:&E%8.NLUH_IGK&.CD3K:S5%CY9CQ
M6'T]8OT&3O#F\^[#6<[??D[MF38$@[;$!:G2?6OIWHTCY/Q?43@<?7QTC)=&
MY(B1L(<&2.VJC[YQ=Q)&P( \> I1K/JQJ?0-UV'R<N+L73)5E;DJ.'M3L$$O
M?#@:D<SI"]KH#MQ>00[?8;%957J)K&V_!VC+A*]2_@)\V^M[C++(.T(?@;*+
M ;L_N[@\3Q&P^+U0>63T#IO Z'QVIJN0U1CJF/I4;$8Q](377B%CFQ/=6=7>
MXR\)BUS>&^P V'%1%O772-;..RE*;J=1GL"'W^./1%QT=YT;0T2/#J1XO+0&
MDQ\ 0!X\#:74.K.ILCI>?5[(<3'@J,\,%G'NAD-F8$1B:1DO<XLV=(>+"QW(
M,&[AR\>VB.M62U%D,+C<A0JU,A<R=BN]L?+B^H([#H9H]SZDP%CM]]BUWVA$
M:7IPS2O4Z[/0QMO6L.(QDK[T.'SF$EQU6&27F 8WS5F/DXE[RUA>X-W'C8-V
MU&MLUH?0&H?D0R=0:>0QAHR>\X/3-B] Z2&L61R"05)(GN,4@:_;<;L:-FEI
M4_U)U#U'2&K,QCV8L8+3$XALU+,,CK-P-B9+*YDHD#8MFR;-!8_D6^2 ?$9L
M>T)EJF(ONGQM*')19&['68>?;L4XFVN$@\[\P^MQ>-_&X/CD-BHG9ZK:!LXR
M'&N'4TT76A=NQNT5><Z_/W6R]R1YI<FGDT?@RP    ;!=1CR%7&2ZAYVEFL7
MB8L7#/9SL,,N+LM8\PQ[-!L]_P ^.#3S;L1SY!OJ"59"((B("(B B(@(BUNH
M-2XC26+ER><RM+#8V+;N7,A89!"S\[WD ?\ K0;)%6GW3?1[\:^A_P!HZ?[Q
M/NF^CWXU]#_M'3_>(++15I]TWT>_&OH?]HZ?[Q/NF^CWXU]#_M'3_>(++15I
M]TWT>_&OH?\ :.G^\3[IOH]^-?0_[1T_WB"RT5:?=-]'OQKZ'_:.G^\3[IOH
M]^-?0_[1T_WB"RT5:?=-]'OQKZ'_ &CI_O$^Z;Z/?C7T/^T=/]X@LM%6GW3?
M1[\:^A_VCI_O$^Z;Z/?C7T/^T=/]X@LM%6GW3?1[\:^A_P!HZ?[Q/NF^CWXU
M]#_M'3_>(++15I]TWT>_&OH?]HZ?[Q/NF^CWXU]#_M'3_>(++15I]TWT>_&O
MH?\ :.G^\3[IOH]^-?0_[1T_WB"RT5:?=-]'OQKZ'_:.G^\3[IOH]^-?0_[1
MT_WB"RT5:?=-]'OQKZ'_ &CI_O$^Z;Z/?C7T/^T=/]X@LM%6GW3?1[\:^A_V
MCI_O$^Z;Z/?C7T/^T=/]X@LM%6GW3?1[\:^A_P!HZ?[Q/NF^CWXU]#_M'3_>
M(++15I]TWT>_&OH?]HZ?[Q/NF^CWXU]#_M'3_>(+)>QLC',>T.8X;%KAN"/L
M7%?4+H]=^0O:D&*T3.VS?%-F#-3$GE8;[K&)!5XL^,<MPX,W\[[KHO[IOH]^
M-?0_[1T_WB?=-]'OQKZ'_:.G^\17*?6+I)U'-G6S;SLOKB6WTZ@J5+-7!&$-
ME&1A?[JT1 A\@:USMOI;;G;8*PIL1DM&^UU)<TAA<KFH=0Y2-^HF9C3+Q6H,
M;7X^]U,F6AH&P#>UN[<EP&RNK[IOH]^-?0_[1T_WB?=-]'OQKZ'_ &CI_O$%
M&]6O9RR_6_VE=50V9/D32TV"Q(DRDV%-A\[XK$KS'5LN<UL,@V')P#R X> J
MXP/1/6=+JU%GK.#R/R7+K7/-I/@P[HK=&>6%S:MZ6<-+Y*CB2/[+ =CN5US]
MTWT>_&OH?]HZ?[Q/NF^CWXU]#_M'3_>(.5M&:*M3Z2Z.:.Q?3C.:?ZBZ8SU>
MYG,[/A9((88XW/-J;WWCPL"<'PUCG%W+R/"W/2S0F<Q?M&1:VR.A<O#T^U#D
M\E!A\1+3F+\'9D#&OO3URW[RRSVY/+@ P.&^W,KI#[IOH]^-?0_[1T_WB?=-
M]'OQKZ'_ &CI_O$%6>SKT.ET5UHUW-=@RCL#IN;W#1T5^%S:]2K:'O%D5G$
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M^G.;UYI^UHE^.BAQV ER,3[1M.<(R\,+(G<?/)SF[;[[JI\WT2ZKZ\Z?=/\
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MQV>B(B"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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ML$?TS^U)^FTW^YN(O'9Z(B((B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("\WP
M1R/8]\;'O9]%SF@EOYEZ(@(B(.,OY5_^J]5_2&I_I3KLJ+\$S\P7&O\ *O\
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M=TB-P/-W)N^VY) V#IVKG\=>S%_$U[L,V2H,BDM56.WDA;+R[9</J#N#]O\
MS2M@N=O98Z>ZJTCJ;6F5U'A,[AXLG0P\$)U#FH\G:FG@CG%EW<;-*0SG("T.
M</#O 'T6X>HM$=5+G7":[7=G/DU^<JS5LI!G!%B8,.(0VQ5DIB8.=.Y_(AXB
M)W+2)&\=D%]Z=UG@]72Y./"Y2MDW8VRZG<]V?S$,S?I1N(\<A]8^I>>-U[IG
M-9JSA\?J/$WLO6+FST*UZ*2>(M\.#HVN+FD?7N/"K_V8NF%_I7H'(XW)P7*U
MRQF\A;$=O)/N_>GV9'0N!=(\-Y1EKB 0222[XB2J<PW1#6MS6U*O)H=F%-#J
M!;U-_/&>Y4+G472.<(86Q2.F)D:0US7M8T#UW0=98//8[4V+AR6)O09+'S\N
MU9K2!\;^+BUVSAX.S@1^<%9ZY<TQTLZM6VZ,&6RN;H2XS Y5T[G9PNB?E'6^
M5+WAK)29FB,[^0YH XG[%%=-]-.MM/0_:S$^J[X^4\?)EL/!EFUK=N!C)!:]
MSMNR4SAS<8G$<ZX(:0UC-R$'939HW2OB;(TR, +F C=H/H2/R['_ -2^UR9G
M.D&O,=JCJ=E-(8W46/MZBQ&*=C[<^HB]S.UQ%JHXOLNX6"S=K)=G-:2[C(W<
M[Y6!Z7=3\Q=T_5N6-5X/1_\ .BQ:?C[&IC)D:N,]S(9%8L,L/=*UU@;A@DD+
M0X;D#T#JE%2/LXZ;UQIK(ZTBU9#EI*$UX2X[(9W(=^W8:XO+FF)EJ>*-C-VM
M:8^UR&V\8(41ZE=,>JN5O]4,K@LKFHK-J_0CP5-N9>V!U ,@-QL,3;$0CD<Y
MCP"7Q.]>+V<RXD=.(N6-)Z$ZH8O,:$EU -6Z@P-:*T'58,JRE/1MNM!T$EQH
MR$ALP,BW:&F>8[#XFN)4;K=-^NYT]J2"&74E3-RX&Y7MW+.I6219+)NL-=7F
MQ[>^?=6MCY#TA&Q#>)(W179:+D_$](.JNG=927*62U/9QS<M?BB;>U.^S'\G
M/QOWH\))SN[WPG8D<V^/1@"U&ENBW63"V\'>FRNJY[5;^;L\T=S5;YXG3<G#
M+<V.L%KV\ WX2"T_^3!.Z#L=?A.PW*XZQO3/KPS"]266LMGCG;F-N0T707FQ
MU[%AU@.KRUYG9!YA<V+=NS8*[0/!Y$ G:9OI=U4Q(N8^L[5F;TG%J:&T*=75
M!9DK5%U$!XCM26&O:QMO=QC=(W< [#CX(=0X#4&-U5B*^4Q%V'(XZP"8K-=W
M)C]G%IV/Y""/^Q;%<@])>E75+1%_H]!/C<R*>,J/KYJA/EV-Q]0.GG>9MX+;
M3-/LZ,<7PRL<'#8L(*FGM<9K4^ GT2_1F>DIZBRMN;!,Q#+QC-EEJ(L]Y;$#
M\;J[^$G(#=HY>1N@Z*1<OZCZ==5JO4^L,5:U#>HU[6);C,U\OAN/KT8FM;>C
MN573!T\TI#CS,4A)<T\V\2METEP/5JCU+PD.I:F99I[%C.-MY&UF8IX+YFM-
MDI%L0F=(X,BW:.; 6>0 !ZD='+\)V&Y]%1?6O1/4C-=1<"_1V2R$&FLQ#'C\
M\Z#)F#Y-CBL,F]YA9S![DC!+"3&.7Q-)\!0G%=,.JN6USDJ^8DS\5*V_,1Y3
M)R:B/R=>J2APH15*\<_.N^/=N[A'&1Q=NY_)%=4131V(FR1/;)&X;M>P[@C\
MA6'F\]C-,XR;(YC(U,5CX=C+;O3MABCW.PY/<0!Y('D_6N,ZW1_K)B]#=-,-
MAF:DT_3Q.(-*[7K9-MF>OD&RM_XC_P 9PL? 6@\6N=*UK=QV!N-N@_:9T%F^
MI'1?(Z>P<3K66L6:3AVW11N 99B?(\=WX-PUKG;.W!VVV/H0EUKJOHBCC,?D
MK.L<!7QV0<64[<N4@;%9<#L1&\NV>0?&P)69D-?:8Q.8J8B]J/$TLK;:U]>C
M8O11SS-<=FEC"[DX$@@;#RN>]5=']1:.U_;RC=)6.K^+OZ7^0H767XZ">G/W
M9'N,D;A!$(I!(T.=$WD.V-VGU5:9WV3>HO#3O.LS.PX33>#I6J0GK<,I)7NO
MDGK,ED(DB+&.:6R L#N.Q)W(0=VHOQIW:"06G;T/U+]1!%5W7[K?%T,T_A<E
M+2I6QD\G'C _)9-N.K0%S'N[DDSF.#6CAMY'UKXJ^TIH5ERGC\AF8H,E+'#W
MG4HI[="*:2'NLA%UD79<]S/B:WD'.&Q#?(""U$4:Z>]1<#U3TW%G]-6IKV(F
M<6PVI:DU<2C8'DP2L:7-\_2 V/GSX*A74WVAL;TTZE:5TE8Q<UUF6<SW[(QR
MAL>+9+*(:[Y 0=Q)*> \C;8E!;2*M:7M&:!R.IIL!5R]JQDXW6V-;%BKCHYW
M5F[V&PRB+A*8_0ACG'?QY/A:*Y[56B:U]DC\HVGB:U:]-D_E&C>K7JAK"%SA
M[LZOOMQG83R+3LYI:';G8+G155C_ &GNGF5NTJ-/)Y&SDK=M]*+'1X2\;8>Q
MC'N+H>SS8P,DC=S<T-V<#NMUTFZPXGK#1S5K$TLK2CQ62GQDHRE"6J7OC<6E
MS>;1N"0?'TF^C@T^$$[151UZZ_TNA57"23XBQFY<A.\S0U9 QU6G&T.L6G;@
M[MC!;N/KY#RM16]JO2M#J!JG3>HK'R/#C+L%6GD17GEK6!+4;8!DF;&8XG'=
MX:US@7<?&Z"[D5/Q^U%I"WF-%4J-/45R'5;YA1NC 78XN$<8?W#SB!+' C9S
M00!NXD-&Z^<M[3^CZAKO@OFK'%D!4R,.9Q]^E9KL->6</9"ZOR<2R%Q&X:T@
M.V=N TA<2*%]..L6E.K+;QTQ?GN>Y-ADF;9H6*CNW,TNAD:V:-A<Q[02U[00
M=CY4T0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!
M$1 1%SKD_:7R&GNL.O<3F6UZ>CM)0MGGF@P=ZQ-*PU1,=[3#[O$[D=@Q^Q=X
M ]4'12*BF^UKAAF*6!ET;JN#5%NW%4CP;H*AL 2P.GBE+FV#&(W1QO._/<%I
M! 5X6+$52O+/,]L4,3"][W'8-:!N2?\ L0>J+E?IK[<5#45/5=K.8^%_N]BM
M+@:."D;-9OU;,[H*[7![PULQ>T<@YS0 ]I.REF9]LG2NGM,29K)8+,T&5\E:
MQENG;GQ\-F"2MP[Q$;K0[P',;"'FX['QZ;EB_$7.#/;%Q&$J7S=Q&>U&^O)E
M;3YL5CZ\#*U*G9$4CWB2U\7$.:=QY>/(8T_"OO5'ME8^KA-3V].:3RF<L8+(
MU<?-%+:I5W.[TS8Q((G3]YK/B'%SHVAY(V/'=P$=&(O*I,^Q5AED@DJR2,#G
M02EI?&2-RUQ:2W<>AV)'V$KE#->VA:=J/JEBL?'AVU\-BLE8T[:;+W9K-FBT
M"P)X^7AO(DLV W:QWJB.M$7.S/;,P6)Q-=N<TUGL=G!-2K2T[7N==G_$P&6*
M<S/LB&.-X8X#G(UW+9I;OX7TSVOZV,PNJ\KJ#1V1Q57#9V;#0@Y/&M=9[<?-
MSF]RTP%X'G@TN)Y-X\OBXAT.BYRC]L+$09Z_5KXG.ZH;9(FQM7%8^O"^.!N/
MAN/+Y);0#_@EY;[,V(+=CL"Z^=*ZCIZQTQA\_C^9H96G#>K]UO%_;E8'LW'U
M'9P\(.1OY5_^J]5_2&I_I3KLJ+\$S\P7&O\ *O\ ]5ZK^D-3_2G7947X)GY@
MB\?:(B((B("(B N,/8(_IG]J3]-IO]S<79ZXP]@C^F?VI/TVF_W-Q%X[/1$1
M'+O4/VG=3:4Z[9'2%.?3DE6EDL/3@PDU>8Y3)1W&CO/B>)@T=GZ9^]N&WKMZ
MF,3>U?U"J:0P6;RMO1FG:^9K9.]5NWJ-DUG&H_MQT0?>6[SS$.<"#X V#'E=
M78O1F'PVI,UGZ=/M9;,F$WK!D<[N]IA9'LTDANS21\(&_P!>ZW1:'>H!^ORB
MN/J_M@:RL=08<6ZA@8)#D,93_F@ZO-\LS1VJ3)YI&O[O$=ESB#]Z(V]2T[;Z
M67VTM;_S<GO0V-%V'_)\&1MN:TP'!.=.624)VS6V-FMAC2YK#)"7%COA]-^P
M<+HO#Z=S6<RU"GV,AFYV6;\QD<[NR,C;$T[$D-^!C1LT >-_5;DQM<""T$$[
MD$>J#B[77M>9;)Y6SIW'6:TE#(8>>&4/QQH7J\SL4^TV=F]Q\@'+8 &$-&^P
ME<YI)G'0[KCG,CU$TOH/)W,9/1ETM2MUA4 MW)'BI"^5]N06.=<[O^$/@(>#
MN)-_"Z:X@$G8;GU*<6AQ=L.1&V^WE!2>"M9ZA[7&=Q=O4N0R6$M:59D:^*FX
MMK4W^]"/X&M W.P.[G;N/+;?8!4GJ;J'U%R/6273@UKBADJ/4&&KCZ+Z$D?N
M]1^-ED:Z6)E@.FA)WV!+>3V.//8AK>V5\AC0XNV'(C8G;RB./Z/M8=1\MIV?
M,4L/@9H\9I-F=O5F5;#Y)YW6;%8B/:7X(FF$2G<.=Q:YNY)#AGXGVO,O1O4_
ME?(Z6R>F&YM^,FUCCH98<=9:<>ZPP1%T[PV1LP$1^-X<3L '>!UFOD,: !Q&
MP]!LBN+]'>V=K+4N7TC%;&F,6[*W,%4=B9*5GWJ[%>+>]:KO[^S8XR2P M?\
M0^)WHTRSV0^H^K[HTYIG/W*63QE_ W\Q4L".7WR(PY'L%DTKY7"7<2@@AK./
M$#SZJ],]TDTYJ?6&.U)E(K]R_CY8[%:O)E+/N4<T>_"7W7N=DR-W.SBS?Z_4
M!3)!Q'T7ZW7Z'M#:K_G5K*X=/0G*]V&[?,C:W"Y''#[S5)(H[!W&,L_"AVYV
M/A=N+\#0'%P !/J=O5?J((B("(B B(@(B("^3&USFN+07-]"1Y'YE](@(B("
M(B B(@(B("(B"+ZVZ>8W7MO35C(36HGX#*1Y:L*[F@/E8Q[ U_)IW;L\^!L?
M3RH-J3V8--ZGU3D,K8RV:@HY"_'EK>#KS0BG->CB[4=@[Q&0.#0T\1(&$M!+
M3LKA1!HM"Z/I=/M&833..DGFH8BG%2@DLN:Z5S(VAK2XM !.P\[ #\BK;7WL
MG:$ZF9K4V8U"S(W<OFXX8F7O>0V3&MB;M&*NS=F[.W?\8?\ $2?3PKF1!RA0
M]C_+7=>V8<CEK-'04,.6CK0P9GWBT]]\ 221M%2(0$_$]P<^8<CLW9NX4DI^
MPQH6I3R,'RMG2+]>U7F,1IUV@6(X(Y"R.*LUC#M6C( ;MN7;@[^.BT15):K]
MDW2^KLU:R%G+9>$VLI7R\T,3:A^_0QPQL[<CZ[I81M W<QO:X\G G8@">]/N
MFM3IQ-J'Y/R5^S3S&2ERIIVS$Z.K-*2Z41%K&NXN<=]GN=M]6RF"(BL.H?LY
M:+ZKZJ=G-65;.:D&-=BX*<TW&O68YQ<]\;6@'F[< ESB-FM\#ZX;B_8RTWBI
M80W5^K+--D].V^E:GJ212V*M=L%:5_\ PW(EC6@[;\7$#D' ;+H%$%$XGV0M
M,X3%XVK2S^>J3TLC<R M535@+C:B[4\0CC@;%$QS/_JF,(/Q @G=:G%>POH;
M%4):K<QGGME=$YSF>YP;F.M/6:>,59K2>%EY+B.3G-:22>6_1B(J$Z!Z38CI
MUD[M[&V+LTMO&X[%O;:>QS1%39(R(CBQOQ$2.Y'T) V 4V1$01$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!167I=I:P_5;IL1
M%.-4M:W,LF>][+8;%V@"TN(;\ V^$#[?7RI4B"N-->SSH+2>4HY.AAYW9.E9
M][@O7<E:M3B00N@;RDEE<YS6Q.<QK'$M:#X /E3;4. HZJP.0PV3B?/CK\#Z
MUF)DKXB^-[2US0]A#F[@D;@@K8H@I[7GLNZ&U/@VPXO3N(Q65JTA1I6G0SB*
M.,21O >RO/"YY!B86OYA[2-PX'??0Z-]C71N.TE\F:I[^H\A-/=FM7*URY1;
M*VTYKI82&6"]\?P,\2O>26\B=RK_ $05K'[./3N*O>A;I[:*[5NTK#??;/QP
MVY!)9;^$\<W-!W&Q&WPD!>=KV;>G]]N9%O%7+CLM7CJ3R6LO<E?'#'()8XX7
M.E)@:V0!P$1;L0/L5G(@QJU".KCXJ373/ACB$(=+,]\A:!MN9'$N+O\ K$[D
M^=]U6EWV7>EM_3V/PLND*K:-!LS(3#/-%/M+&^.4/F:\22<FR/!YN.^^_J 5
M:B(*F;[+?3EN#OX@8S)BAD'QFXSY>O\ *RQC.VR&1_?Y/A:SX1$XE@'HU>F2
M]F#ISE+]JW+AK<,MFPZS(VIE[E=@>^+LR<61S-#1)'LU[6@!X Y [!6JB"M<
M1[.73O!7X;M'3W8M0PN@9)[[9=LQU5E4C8R$?@8V,W]?&_TB2IUI_ T=*X#&
MX7%P>ZXS&UHJ=6#FY_;BC8&,;R<23LUH&Y))^LK8(@XR_E7_ .J]5_2&I_I3
MKLJ+\$S\P7&O\J__ %7JOZ0U/]*==E1?@F?F"+Q]HB(@B(@(B("XP]@C^F?V
MI/TVF_W-Q=GKC#V"/Z9_:D_3:;_<W$7CL]$1$1:UD,G!U.QE'WQAP]G$6YS3
M$ #N]'-6:'F3?<_#,X<0 /4G?QM*5XOIP26H[+H(W68V.B9,6 O:QQ:7-!]0
M"6-)'U\1]@7Y2I5\=4BJU((JM:)H9'#"P,8QH] &CP @]U!<W=RN;Z@_S=J9
MN?3U6OC67S+3BA?/:<^5[.(,S'M#&!@WV;OO(WR!ZSI5]KL5=3:CK8"/2.)U
M3?J5Q>D?FI!%#48]Q8WB[M2NYO+'^ T#9AW/H"&MU+UFM:8&5L?(C+N+QUN3
M&F=U[A9EL,K&;\$(N(8=N/+EN-^7'9>$O6'.27'89NG*,6==&Z<-=EG>[MA]
MW$W+N]C?G\7'CPV\$\MEN\Q:Z?XZQ=RN6Q^*9=KN?C[5EV/[CVN%4ROBY=O=
MS>QO^0CX?7PM/J'6.@,WC;&V!@S]OM=^*G<P\D;9Y&0.>R+G)#Q;(8@XM:[X
MN+AL-G(J*8CK)J-VE<19;"RVQU61]^>>VUDQ+,7%:WAVA+02YY/Q<O/Y#L)'
ME^NUO"XJSD_YOQV<;'-9I0/.0XV);$$#Y7!T?:V8QW;> X.)^B>.Q\9=[4&A
M&,,,NFZMC3].I!D3:JXHV8H3)$YK-XXHG<=H(_+CL TL;Z$!;S#0:%U5FLC-
M0PE&];#'06,A\D'M2M #'QBP8^$G@!I:''Z.Q^B0 C&H^N]O2M')B_@ZORKC
M9'FQ1K6[$X= V"*8R,<RJ=MA,QI[@8T$_3\J2X?5UNCHK5>:MAV0?B[F3='$
M7!A='#))PCWV\>&@;['_ +5$=,ZQTCU8?@G9+1>/=D,G-89/#?ABF? 60M<U
MY)9\8DB$>Q\>  ?H["5,UCCG-LX?Y#A%JSFY,3/C?AX2\VF5\[OAV<UT),AW
M'DG8G?RB-!5ZVYVWE+6/@T3/=M56\)F4IIY&MF-;WAC>Z:[8N)#HV%Q>'<G>
M&$#<_53KG8N03V8L+5EJ8_W9N3<V]*R6%\T[HN$<4D#7.<TM/(/[9WW W(6_
MU9=Z?Z>R-RYGJ>,ANQ5863SS4.;S!*\PL;R#"7-WY-(&_$;[[ J/9/4'3O 9
MVA7ATYC[4U.W#2KNH8ATDM69\\C21QBV:T2-<>37'XN7C?R2OS2/5VV=.N;:
MJB]?AO5:8EFL"/NFS8?&TG9AV#0!Z [[?4L33?6//7/YNU;6*JSYW,U871PM
MOF.FUSC9<7%W8+VGA7/C9VY+0 /+EN- Y'1.OK-2P=.8^#/5!))%W<46]ML5
MA[>4,KXP'<7G?=A/%S_JW\_62RG3/&LO8R[@Z\/":*.2E)I^;E,]\K^V8V=G
M>4&3F0Y@(W)._G<D8E'K?>R$L<D>G86T(?=&7IG9$\XWS6Y*I$31%M(&OB+N
M1<S=I'@'PMUU1Z@Y+0-S#V(*5>YBGQW)[P?,YDW"&!T@$8X$$_#]9'_]UILO
MU(T-BL349B<97N.F=0@;6CQ,K(X6&WVHFRGM<82Q_<+62<2'-.P!4AUCJ?2U
M7+1T]15H+KZTD#JD0HRW)Q-*)@WBQL3MB6Q2 %I)V#M]O&X9VCM7W<]DLIC,
MGCJ^.R%".O,X4[AM1/CF:XMV>8V'D"QP(X_8=SNH/7Z\93)6VQ8_2$LT%B\:
M-2W9FGKPN<+!A/<>ZMQ!\%P$9D\ [D$>=EIOJ/H+3\MRCA,><50;7K7N[1P\
ML45AT[G1QL:UD>[I-V!O';E]6WPD#+LY31V/P<^I\1I^I=NVK[(&QLHMKV)K
MQF$;6R=QH<QXD/DN&X\GS]81F?KMF:4]JW8P-7W"*G$T5X+4LLOOCKSZA'PP
M$F/DW?<-+MO/$D\1*]&]2<MJO4$6-FTT[%,93-JU+:GEC>W[]+$P1Q/A8YP=
MV@[=X8=G>FX7ZZC@8XQ'J[3F HWI:UI[8*K3=C=5:6R3[N=!'ZN?R+=O)._D
M[[>-'J'H' 2OAQL79D@;'6XX[#6''8Q^\-C;VXCRV8\R$#?CR).VZ#QS?4O*
M8S5E[#8S$1Y.R+3HF^^W_=XHVLILG)!;"]WGEML=_)WW \#587K)G,MD71Q8
M2A)'D+%.'%1R7WQ["6E[R[O.$+MMFAVW$.W.P_*MK3U]@<H^.]7PE>SD[&6]
MQ:8V-?)(PPA_O <&<B#5XNVVW(V8OEN6Z;9B44_D.*S9G+*CZ+M/3&9C80PL
M$D1AY,8P2Q\7. :.0V*#>5.HD4_3I^J)H(Z98V1CJ\LKWL[S)71< ]D;G.#I
M&[-+6$G<;-W.RU=;J':U/TFU+G8:SL3D:,-^'@.9[<L(> X=R-CO5H.SF-(]
M"%^WM4X&#6+^G-[!58L)\D,LL?(UGNA')_WCM<=ALR)SQ]6S3X&RTVA>J>B[
M>E!7?A8=.T;=BQ"<;%1=)"8N]VN[.(X^$;9"1OW-AN2"3L2@Q6]?;S)+$4&F
M+%V"&P,<R\]TT43K/<BB'=>8.VQA?(?+7O=LWZ/G8>F3Z_SX7'V'V\+5-^E>
ML5K=2I<GL<8HGL89FO96( )?_P"5[8!&W+UV_<YK#I=9I9:UV6UI+<$L=O(U
M].23/[,;A&][^5=[71@M#.3@6GB1YX^,:FSI+I.B<9>J5\FZI9EXS7,&9>Y,
M^=D<C(.W (W;2.B860CX2&[C<;HJ58?6US&=';.IK;'96Y3KVK!B<\1F;MR2
M<6\MCQ\- WV*CN7Z\933#,E-F=+UXJ]&Q+3<ZEDGV'OF95]Y #>PWX"TAI/J
M';[-(\G+ZH]4,1TUAQF(?A<9/C<E4GG-*Y9;4[S6OC!@B@,;A+*\S>(SQW((
M)\J0ZCR>G\3FC3S&$IMIV:-G)NN3PL<'OC8V.9KFEOTNRX#??RT.'H$1%7==
M,O!'?=:T>^JW'TI[UAT]F:#FQA:&=ILM=CW!SG@%SFL#>+_78;^.1Z^9?%9N
M[@Y=(MN9NI))RKXRW8MLD8R&"4\71U2X//O#6AKVM;X)+QN%.],Z:Q5G2-9U
M? 5-.OO4>#Z]>O$70-D;N8SNSB=B1N"T@D>05A:<Z,:5T_CY*LF*IY3G:-SE
M;I5P&2<&LW8R.-K&?"T#X6C?SOON@V>B-67-71Y6Q/C&8ZK5O34X";!DEE[;
MW,<Y[> #/(\#=WU^GUUGJSK'GLAI=GR;BJ^/?EX>_CK3<D[NB%MJ&%YD'8/:
M>1,TC;GL=_(+1O==2E7H,>RM7BKL>]TKFQ,#0Y[CNYQV]2222?K*U=?0^G*M
MBW/#@,9%-<<'6)&4XPZ8A_,%YV^+XOB\_7Y]4&WKL='7B8[?DUH!W<7>=OM/
MK^=>B(@B?5/J)4Z6:(OZCMU+&0%=T4,-.KQ$EB:61L<48+B .3WM&Y.PWW5>
MV.NVL]*W,5+K;I=+IS!7K\&..3JYZO>,$LSQ'$7Q-:T\2\M!+2=M]]BLOVM(
M)I.B>0GB@EGCI9'&WIQ#&9',@BNPR2OXM!)#6-<X[#T!5?=9NO73[J_AM.:8
MT3JS':IU!8U+B9H\?BY#-+VX[<<DCR&CX6M8UQ).P&R*ZD1$1!5KU+ZMY'2.
MJ<-I;3>E)M7ZER=:>\VH+T5*&&M$YC7R/EDW\\I& - ).Y]-E92Y_P"K6L\+
MTN]H[1NJ-5Y"+!:<DTYD,<,K<W;7;8=/7>V-S]MFN+6.(WVWV.R"8=/NK^7U
M!K>UH_5FCIM':@9CQE*\8R,5Z"S7[G;<1(P#BYKB-VEOH002K07/.A>H&GNK
MGM0?+VC<K!J/!X[23Z5K)4"7UXYWVVO;%W-N)>6M<=@=P NAD!$1!2C.NFL=
M393,C1/3"34F%QF0GQCLG:SM>CWIX7<)>$3FN=Q#@0"=M]O13SI5U&K=5-%U
M<_7HV,8]TLU6Q1M%KI*\\,CHI8RYI+7;/8X!P.Q&Q5&](NNV@.CT&L=-ZWU7
MCM*YV/565M&AE9#!(Z&6RZ2*1H</B:YK@01N"IY[);)'](??3%+%7R.9RE^J
MZ6,L,L$MV5\4@#@#LYI#AN/0A%7*B(B/E[VQ,<][@UC1N2?0!1[1NM8-;U9+
ME*A<@Q_@P6[)B#;+3Y#FM;(Y[1ML=I&L.SAX6^MUF7:LU>0$QRL=&X#["-BJ
MYZ;=()^G,['U<AC>#*E?'B.IBC7;)7B+R'2;3'G,>6W<\ ;'X/*"RT1$$7QF
MO(<SDK,5/%9"7%UI98)<VXPQU&OCW$@'*02. <"WD&%NX/GP2OIW4_1S* O.
MU9@Q2,AB%@Y&'MEX'(MY<MM]B#M]AW45R&CWXO'Y/2MG4]"KIS,LN&&K-4(N
M1"9QYADO=#7-;).-MX]]G!OGU7M0Z1VWZJ9J'+9BK;R B[!94QY@BX"!\3=F
MF5Y#OOCR3OY&S=AMN0W><ZIZ=PN5Q^,&3IW,E<D#!4@MQ=UC3"^42.:7#9I:
MSU/CX@?1,9U5TUF+$\-7*4Y)*LW8M_\ %P[5W=CO^3S^(!N_EN_HX^C21"JO
M0>UCZ^-QS=25ODVO8%GA)CM[$DXH&H=I.[L&[?'MQ)&VV^WE>V1Z"2Y.A-CY
M<\QM-TC)F%E(]P/%#W0[DR;%IV:_;;[6DG?<!.']3M'1THKC]5X1M25[HXYW
M9&$,>YH!< [EL2 YI(^K<?:OG/\ 4C X*'(@9&I=OT8VS38ZO9C=8:PEH#BS
M?<#XVG<_:/M"C3.CUFYG\AG,IF:UC)7JMBK(*M Q0M$D,432UKI7'<",D[N/
M+EMX 46I]&WZAN6YG:Y=D:V/;/C]G03.;"?O6[-G3]H<.UM\# ?)Y$D%!;V2
MUA@</D!0OYO'4;QB=.*UFU'')VP"2_B2#Q :X[^FS3]A6%_TFZ/&.]__ )UX
M3W'N]CWGY1A[?<X\N'+EMRX^=O7;SZ*KNH6ACUB.<R.G=;5<W7@@>(<52L&=
MD<WNLL0B/&P(6\S)RY/C+AZ<MO3.FZ4ZH@SFG<O#D<=-E8[<3IYOD[C6K0Q4
M9X6;Q=_DYQ=+L7->/4>-FG<+)FU[IR*Q'6;G<9)=E@]YAJMNQ"2:/B7!S07>
M06@D'TV!.^P6%9ZK:1I5+<UC4>*CEIU76[-9MZ)\L4;6ASB6M<?0$>GVC[0J
M]K=%:^-P-G%LU;2;A([4%B\^2J.]':BA8P#N=T-C82V-W M) ) =L[<;R#H<
MR#!1X[Y7!+9[,SIFU=B[NTC5VVY_5N';_7MMX]4$H/5;1;&1.DU9A(#+$R9K
M)<A"QW!S0YIV+M_((*S3KO33;#:YU#BA.ZO[XV,W8^1@XEW= Y?0X@NY>FPW
M4.H=.J]+-T?E#.T9<NRW7R[J\=<1ND;!4]U):UTA<&[N#N7G8G;Z]U%\5T"Q
MT,)K#4]>_6R=(^Z\S,=Y/<_=N]#&VR(G-X$'RQQ^(CEL1L%E_P#2KI!\^+AA
MU)C+3LE:-*J:UN.0/F#"\LW:3YX@?^TW[0O7/]2=,Z<9E&W,YCF6\;7?:L4O
M>XQ.QC6\CNPNW'@CU^T?:M!#TY$VH*V8QF:K.-6] ]T7N_<8.S7DK21[MD&S
MMGD_]4MV(*Q<MT:LY:>Y"[-Q1XJ6Y<R$40HDV&3V()(G<I>YLYC>Z\AO$$_"
M.6P\ANV]38'4]-.AQEC(WL]"ZQ7J8Z>!X$;0TO=W))&,( >WPTDG<[ @$K:L
MUU@FRUH+66H4;=J62*"M/=A[DQ9(6'B X\O(]!Y!\$ [A:;7/3VUJW2M+!P7
M:%>.%C6FW:HNFGB>UH#)J[A*SM2-\D.^+8D?9L8R/9_:,RRX_,NM0/)-BO.V
MPUKR+<MF-P$5AC2YKIB/C:\$M! 'D$)IC>IFGLOF74:>4I683#%+'=AM1O@E
M?)(]C8FN#O+]XSX'VK%DZK8JMJFSAK5:W3C@LFF[)S]IM0S"N+!9OW.8VCW/
M)S WP1NM)C>B@P^=TQEZ>7;'=P6*KXF,/J<HI8F%W<)9S^$O#O!!W:1ZN!<T
MY65Z*8?,3:PMSMK?*F?=NS(^YL,]1O9CCX!Y.[F[Q[D;@$.(_*@D8ZCZ3-&&
MZ-3X8TYI3!'8]_B[;Y -RP.Y;%VQ!V]?*U476C1MFW'5@S]&:U+:L4HX188"
MZ: $R-W) 'IX)\'<**9KH+;U%GILWD<]!+D+39(+<%>O9K59:[XXF%G"*TU^
M^T0W+GN!!(X^!MMI.D=T.X09BM%79?N68V.I.<YL5F)S'QD]WRYI=N'?8-B#
MZH)53ZB:9N3/KMU!BA<CA-B:K[_"Z2%@:'.+@''8 $$GTV\[[+VHZZTWE,5;
MRE/4&+MXVH=K-R"Y&^&$[ [/>';-\$'R?0A5[D>@\;M(.Q?RE).Z.:Q:WKU6
MMDE<^H:X8.4@;OZ'XCL=MCL/*]-.Z(U7E\%JY^0OG 97-9&"Q'-#!V7"***!
MA!;#8<Y@>(G-W;-R .^X] %@4M:Z>R5FG7J9W&VK%V,S5HH;<;W3L!(+F '=
MPW:X;C_E/V%?=+6&!R5F6O4S6/M3Q2/B?%#:8]S7M!+FD [@@ [CZMBH1I+H
M_>TID<)9BS['>Y/L.MOCKS"6\R6:>412.?.\.:QT^X+P]X+20X<RO ]'LQ6R
MLU['ZCJ4]IY9:U$X^62K7$L<C)2UCK&X<XO:[X2UF[/H;N)03>KKW3-[),QU
M;46)L9![.XVK%=B=*6\ _<-#M]N!#M_L._HO =3='FM'8&J\(8)'NC9+\HP\
M7.: 7-!Y>2 YI(^H$'ZU6& Z"Y1]3(X;*96*+!LMQOB?!4#;5DLQL=7NB02D
M,:3S/$M+OAVWV*D.DNAL&"O5+>0NQ9*>.I-2G=PL.-B-\<<8W,T\I;LV,C9N
MPV=ML-O(33(:[P6)N6(+N6H5&5XVR32SW86"+D6AK7 NY GDT@D;'D//D+]?
MK_3$=J:L[4>);8@A-B6(WH@Z.(-#B]PY;AO$AVY\;$'T5=TO9_EHXU\9SL=[
M(O@,3KMJI('<Q(UT<K3'.Q[7L9'&P%K@?AW^O9?EWH'?RF$?A[VJ([=%TMBV
M9I,=_P 3)9FKOA>][Q+Q<S>1[N(:#Y:.6S?(6?C=4X7,QP24,O0NQSR&*)U>
MRR02/#.9:W8^3P^+8?5Y]%M%7F*T-89U@R6H'Q25\5%2CCKQ/+.,MMP#))VA
MKB1M$R*/X@/[6WCRK#0%5NO.L.9PNNVZ/TCHN;6.<CQ[<G<#LE%0@K0/D=''
MN]X)<YSF/\!O@-\E6DN=]6]1--](/:@RF:UIEZ^FL/E=*U*M+(9 F."::*U.
MZ2,2;<>0$C#Q)WV.Z"P.F/5F_K/46=TUJ'2TVD=38>*"U-2==CN1203<Q'(R
M6/8'S&\$$ C;Z]U9"H'HUJ_#]3/:"Z@ZJTO>CS>FW8;%T&96J"ZO).Q]A[XV
M/VV<6A[-]M]N05_("(B"CZ77G6NKGY"YHOI7+J'3U:[8HQ9*UGZ])]A\,CHY
M'-B<UQ#>;' %Q!.V^P5C=,.H-/JGH7%:GHUIZ4-UCN56UMW()&/<R2-VQ():
M]KAN#L=MU0?1#K]T[Z1Z-R.EM::MQVE]14<YE73XS)R&&=K7W9I&.#2-W!S'
MM((W!W\*QO9*J6*G033IL5Y:QL26[4;)XRQYBEM2R1N+3L1R:YI\_40BK@1$
M1$3ZI]1*G2S1%_4=NI8R KNBAAIU>(DL32R-CBC!<0!R>]HW)V&^ZKVQUVUG
MI6YBI=;=+I=.8*]?@QQR=7/5[Q@EF>(XB^)K6GB7EH):3MOOL5E^UI!-)T3R
M$\4$L\=+(XV].(8S(YD$5V&25_%H)(:QKG'8>@*K[K-UZZ?=7\-IS3&B=68[
M5.H+&I<3-'C\7(9I>W';CDD>0T?"UK&N))V V174B(B(XR_E7_ZKU7](:G^E
M.NRHOP3/S!<:_P J_P#U7JOZ0U/]*==E1?@F?F"+Q]HB(@B(@(B("XP]@C^F
M?VI/TVF_W-Q=GKC#V"/Z9_:D_3:;_<W$7CL]$1$$4<R>M(\1J?&X>WC+T4>1
ME]WK9'[T:[Y>VZ3M["3N \6.\EG'QZJ1H"C.>T3\JYN+,4<Q?P63;![K)/1$
M+A/$'%S6O;+&]IXDN(( (Y'SL=E)E&\]K5F'S$.)J8K(9W*/A]Y?5QPB!BBY
M<0][I9(V %P( Y;G8[#8'8-%G^C./U'D+4]G-9:.M:E?9EI0NA$3IG535=)N
M8B[?MN].7'D =OJ63CND&"QFM)-2PMY79.!>V6M7D^-L0B#Q(Z(RM/!H!#7@
M>/3R=Y%/JS#4\K5Q5K*TJF6LM#HL?/9C;8?OOMLSEN?0^F_H?L6/5U]IB\+Y
MK:BQ-@8]ADN&*]$X5V@D%TFSOA (().WH4$%R7LW::R6#&*=<R J]^Q,>8@F
M.TK!&& 21.:!&QK6QN Y- ^D=R3,-&:#AT/'-6HY2]-C'N?)'0L]IT<+WNY/
M<UPC#_+BX[%Q Y'8 ; 8^(ZIX'-MMSU;M:6A6NOI&\VW$87%E<3N>UW+X@&D
M@@;D<22-@2,G%=2-/9G%5\M6RE0XB>C\H-O268F1MBW W=N[<;$[$D; ^"=_
M"#34.BN&Q.3P.1HWLC4NX>A)CX9HWQ'N,<TAKY Z,M<]G)W$[ ?$=P1X6TL=
M.*,NL'ZFCO7JV5?3;4Y1F,L!!&\H8YA'<+1P)]./@ >JR['4/2M3%U\G/J7$
M0XZPYS(;<EZ)L4CF_2#7%VQ(V.X'ILLQVK,(W*5<8<Q0&2M1B6O3]Y9W9F$$
MAS&;[N&P)W'V'[$&HU?TSP^M\MCK^2,Y=3AG@[,;FB.9DK.)$@()/'Z3=B-C
MY\K45>B>)H4J,-;)Y..Q396:RXY\3Y7OAG?/W'[Q[.<]\C^7C8[^ %+-.:EK
M:BTQ2SC0:E2S7%C:=P';;MO\1]!LL=G4#2\C*#V:CQ+F9!YCIN%Z(BRX.#2(
MSR^,[D#QOY("#PP&@,?IVWC[%::R]]*K8J1B5S2"R:9LKB=FCR', &VWC?U]
M5%].^S]@--YCY2@NWY;(EBEW>VNWF8Y7R-YN9$UTAW>07/)<1MY4R.N=."I>
MMG/XP5:,G9M3FY'P@DWV#'NWV:=_&Q\[^%CQ:^P\^5@JQ7*\M6>D+L609.PU
MWM,HB: _?8DN< -O7T]4$<EZ'XLRR&OF,O3@GL1VK5>%\/&R^.T^RSD71%P
M>\CX2W=NP.Y&ZD5_0./R.J(L]+-9;<BD@D#&N;V]XFSM;XX[^18?OY^IOIYW
M]LGKW3^'R&-HV\O4BM9&VZC7C[S=W3M:7.9Z^" /3[2!]87XW7F C;0;<S&/
MH6+SBVM7L780^8A_#X-G$.^+8>"?)V]?""-_]"F,B[7N^5RE4Q1PMC<QT)<R
M2&=\T<HY1GX@97C8_"0=B#ZK;-Z:8XZ6LX:6Y=F?8MG(/R)>QMD6NX)!,TM:
M&!S7!NP#>.S0""-]]O1U?@LGEY\33S6.MY2OR[U*"U&^:/B=G<F [C8D [CQ
MN%\Y;6&'P6;Q&(OWX:V0RSWQTX)'@.F<UO(@#\W_ +R @CV9Z729^E!'>U5F
M9+D4=B 7V,J,E,,S6MDC($'#;X6D$-Y CUV\+!RG0C3V5I002R6'.@MMN1R3
MQ5['%PK,KD<)8G,(+&#U:2#Y!'HIGB-5874%BU7Q>7H9*>J>,\52RR5T1W(V
M<&DEOD$>?K!^Q?5O4V(Q^7JXJUE:5;)VAO7I2V&-FF'GZ+"=W>A]!]1^Q!%[
M_1O!7LC:N"6Y5?8Q!PYCJ.9%'&PMX]UC6LV;+QV;N/A#0!Q6#I7H9B]%7A=P
MN6R&/MOE>^9]>&I&R9CFPM,9C; &-;]X806M#MR[XO*E$'4/2MIMYT.IL/*V
M@WG;<R_$17;OQWD^+X1OXW.WGPON'7VF;%6I9BU%BI:]N8UJ\K+L9;-*#L8V
M'E\3O/T1Y0:?6'27#:VMW+-Z>[%+:CK1.=6E:PM;"Z0[-/$D<VS2,=]K7$#8
M^5K)N@>FI=019C9[K+9I97,GK5K#'!\QFX 21.X!KB=BS9VQ.Y/@B75];Z=M
MVK5:#/XR:Q5>V*>*.Y&Y\3R_@&N .[27_" ?K\>J^K6L]/TK->O8SF-@GL3.
MKPQ26XVNDE:[BYC03N7!Q ('D$@>J"N=;=%K5[$Q8S3MR6G'/4EQ]RU+<:QS
MH'S&0AS/=W\]B]^W%T9\[%VQW&YI="=.X_+6K\/<8^>\W(;-KU@]DHG;.0)1
M%W2TO;Y:YY\$@;;#:9ZBST.F\8ZY,Q\Q,D<$4,>W*65[PQC!O]9<X?F]5B1:
MOJR96G2,9:;<UBM%*V1DC.[#N7,):3LXM:]P!\C@X$ C9!K-<],J>O+<,]G*
M9''AM.QCY8J1AXV()BPR,?W(WD;]L>6%I&Y\_9Z:HZ;8_6&.J4LE;NR0U+C;
M<)8Z-KFM XF D,\Q.:7-<#NXAQ^+?8C:9?6&'P6:Q&)OWX:V0RSWLIP2/ =,
MYK>1 !_)_P"\@+5Z7ZIZ:U3IYV7AS%""&&!L]N.6W'RIM.^W=V=\'H1Y^PH)
M-3KOJP=N2S+;=R<[N3!@=L22&_"UHV .P\;[ ;DG<GW6+C,I2S5&*[C[<%^G
M*-X[%:1LD;QOMX<"0?(*U5'76&M:8;J">Y%C,67O89\A(V%K2V0Q^23L-W-\
M>?.X0;]%H+VO]+XP43<U'B:HOL$E0SWHF"PTD .CW=\0)( (W]0O#.=1,'AZ
M><>S(5;]W#UGV;>/JV&.L1M:-SNS?=OU>NWJ$$F1?C7<F@_:-U^H"(B B(@(
MB("(B B(@(B("(B B(@(B(.?Y]$:WEU94O,IYGWV"2T+&1ER[37E8^_7?&((
MS,3&WL,>" QG@<2'$A?3] ]0HLAA^&3S$<<@DEGF%U]ET%CWHN!<TVXV]LPA
MC0WC(T .^ $^;^1!1D6B=16:&E;-G'9\ZAQM_N7K-C-&2&25U>:,SQL%CCVA
M(YAX<6GB[;AX(7SAM%:TNY#"16/YQ8[&,-7Y7%K.E[[$S63=V2-S)W.;$7&,
M%K2W?=OP#B5>J(*LZE8/5>1U!/)B8\I*Q]*&/&S4,D*T%.T)7&22Q'W6=QI:
M8_'&3PUPV!/GY@Z;9&'I)J33\#)6WKUR[/'%=NOF;*Q]E[VL+W.=Q;(S8'[.
M9W&^ZM5$%>Y++ZAMQX*[1TKF<?%C[A%K%^\5&/FB->5@X\9RQS6O,9V+AZ @
M'90";1/4:7!5[4MC+#(MAQL4]7Y5>\N8UCO>@UK+,0+^?;)=W&EP:0''<@]
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M3F-QDNH10='3JXRM,V)T7.>.RV>-WP2-=\3F[<6N!\DAP*T>D=%Z]RV1ACU
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MNM5'7S3<Z82BNUC7/<.U#*!MS:-WEC=R/B4KQVB=/8>$PT<%C:<1#P605(V
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M8WJ=JBG1N18UV-:S'8J;(S27XI[#Y^Q3I/#!]^:&%QG?N0-O /'?<G,J=?\
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MD#[4G MY./%O$'R !]6^?T-RT][+7;6K77;-F$Q0.LP32"/_ (MEAA<UU@M
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M@O=LO'3?7/4>L;;:6+EQ#3+:C$=V>GS:(7U)YP#'%;>.>\('F0'9QW:"%?P
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MAE;/6\36)"PBU*[XY9F\7$[.>]_TMCOOXVV)D2+Y$C2\L#@7@ EN_D ^A_\
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M;)P=N1S!]3ONIBB"/8[0>&Q>G;>"ABLOQ-F%U=]6Q=FF:V(MXF-A>\EC>)V
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MCNMV/O!E!>&@'9GJ2/0J?TIWVJD4TM:6G(]H<Z"8M+XS]A+'.;O^8D?E7NB
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M6M!))V 07$B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MXG+#((A*6EXV(>XD#QX(!&$?9JTP-/U\0+$T=6!X<"RE1!>T1NC:V0>[\9"
M\D/>"X'R#Y.\2M^S]J%W&*L,1'0$U>Q9K.ECE?=D;&]C^3Y:C]F;N:\,D;*
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M7/V^!S&\?!82 1;B"$Z8T$[%Z[U9J.TV)KLL8HH((I2]K(V, <\[M'%TA Y
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MS7-(/UA53[-.I\/B=.:SIWLM1IVX=8YKNU[%ED<C.5M[F[M)W&[2"/R$+/\
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M1 1$0$1$!$1 1$0$1$!$1 1$0<9?RK_]5ZK^D-3_ $IUV5%^"9^8+C7^5?\
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M8;GT7Z@(OS?=.0V]1]B#]1?A<!ZD!8V4R=;#8ZU>N2B&K6C=+*\_V6@;D_\
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M$QS@S<\>(W!\ CQNM;F.B,F PM>U%5QCQ$Q[\G6CAFD&3=[]'.QDHCA>][>
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MOWW ^D-B?.VQ][]HW^Z^EWZRR/\ #J0Z;_K%Z_\ T:P'^XRRLM%4G[W[1O\
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M9:K3HM_X=U'_ $MM?Z%=66@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M ,;]1/UM6_A4^:KZ9_XWZB?K:M_"KL]$+KC#YJOIG_C?J)^MJW\*GS5?3/\
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M (WZB?K:M_"I\U7TS_QOU$_6U;^%79Z(77&'S5?3/_&_43];5OX5/FJ^F?\
MC?J)^MJW\*NST0NJ"Z#^Q%TP]GS..SV#I7\QJ0M<UF9SMD6+$37>'!@:UK&D
MCQR#>6Q(WV)"OU$1!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
41$0$1$!$1 1$0$1$!$1 1$0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2529451d1_ex99-2img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2529451d1_ex99-2img002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U$# 2(  A$! Q$!_\0
M'0 !  (#  ,!              <(! 4& @,) ?_$ %40   & @$" P,%#08&
M 0$"#P ! @,$!081$@<A"!,Q%")!%1DR45<6&",S5F%Q=I25EM/4"3<X0K.T
M%R128H'1D24T-4-3<G."H2958W1UDK&RP?_$ !8! 0$!
M   ! O_$ !@1 0$! 0$                100$A_]H # ,!  (1 Q$ /P#Z
MI@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M #$<<G%:QVVX\=5:IEU3\A4A1/(=)3?EH2WP,E)4DW34HUI-)H01)7S,T98
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MF9E\2/L$SQJ3*/!)F37.%>Q-8UD1X]F$9F?YRJON1)D,&39>>@S47;23+?Q
MBTH"M^/^+&U?/IA99!B#-#C&>R)3,.>JP-;D5*4FN*;J?+(B-Y)&>N7N_G$B
M]$NJTSK+TS<R]RH*EARY$I-:DGS<4_&;6I#;Y^Z7$U\3/CWT6NY@B2P'S<Z%
M^*#-L)Z8Y_(R[([#(+"TI'+;&'9[QN.)?*6Y"-A!G]3ALJU^<2%T"ZW9KTWZ
M)9C(RS(J_),AJ\P=I"F9E>'#9026D&HB<X.*7I7+3:$F9[,_@8+%X0%(,N\9
M'4'+>FN)7V%4U35RW<S;QJT-5AYS;KA++BAI2HY_@G4GW<T2T?!)^HZ'JUX]
MRZ6YI;T+])0J>QR/%<NF)E_[/)?>=0E;C4!LV3\[RR/Z2C1R]"(C BWP"KEW
MXG[S,<BZBXU189[7C>/4Y3I]\FW]F=*._ 4^WY:20:B<,ST1D9\2+EZZ(<S-
M\7,GI9T9P&?6U]%+9D8TU:N0<ARI9VKJ-'MMM),+4ZK1;\USBDS[>I&!%R0%
M*<N\0DK&^N5AU KJVSNZLNEL:[8Q]IY1<E.2RT9D1&1&DE>\HDF9$DQ87P_]
M6IO63IX>1/'CCKJW5):3CMJN:P1<4F27%*:0IMPC/2DFGMV/X@)1 4$Z;]:<
MBZ;Y/UPZE9E0?*]I'OON<A18M^\Z29"ULI:@M-K0326O\WG<25V,N/?O+MMX
MN,CP2/GE7FV#1*K+L;Q[[I8T2!;')B3XW+@:?-\I*D+2KL9<3WZD!%G@$==,
M,[R[/NF:\EGXI&H;.8VJ34U;UCYA/,*:2MA3SB4?@S49F1D1*XE]8I;?=<NJ
MV:=#*:_OV&'I;'4N-"AG53_*=E<)#J51%)2TA*6RXI22S-1J(]J(M /HN J=
M>^.";@='G#&88C!JLMQVWA5*(;-QS@O*EH-;3BI*FDFA"4I4:C-'P[>O:1?#
M/XD&.O\ 'R>,N/6-6F.RFH\EZDL?;H$E+J#4VXRZ:$&9>ZHC2:2,C2!$V
M@
M                    #ANK72"FZR55-7W4F=%9JK:-<L*@.(0I3S"C-"5<
MD*V@]]R+1_49#C#\)>('3*K?E&[\@\N^[3EY[/+VWER\O\5KR=_Y=<O^X38
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MCKP
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M<>XBL/Q$N+<9<C2B23K+K;BFW&U<3-.TK0HMD9D>MD9D-\
M
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M Q"5&EU%M3N?*<R035PTPVZHGGE/[(F7GD\2\WALU$9F@SXEV$@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\1P_Y@??-]'OM7P?^(X?\P!)8"-/OF^CWVKX/_$</^8'WS?1[[5\'_B.'_,
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M@@'F  "       "F'@(_OG\4GZ[/?[F8+GBF'@(_OG\4GZ[/?[F8"XN>  "
M
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MBP  0
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M>:C3H[<EI$ELVW$I6DE$2DGW2>C[D?H @KKUX><KR/JEC?5;IE>UU+GE-&5
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M?5*+UKZ6X_FT."]6Q;AE3R(CZR6MLB<4C1F78_H[_P#(#MP
M                                !3+^U?\ \+T7]88G^D^+E-?BD?H(
M4U_M7_\ "]%_6&)_I/BY37XI'Z"!<>8  (       *8> C^^?Q2?KL]_N9@N
M>*8> C^^?Q2?KL]_N9@+BYX  (
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MI,R[_ ]>@V4'I_B]99U]E#QNHB6-=$]@A2V(#2'8L;_\2VLD[0W_ -B3(OS
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M6OI&>S]?B.\'JC1F84=J/':0PPTDD-M-))*4)(M$1$78B(O@/:"
M                               *9?VK_P#A>B_K#$_TGQ<IK\4C]!"F
MO]J__A>B_K#$_P!)\7*:_%(_00+CS  !       !3#P$?WS^*3]=GO\ <S!<
M\4P\!']\_BD_79[_ ',P%Q<\  $
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M01G^?1#; R
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M@Q<K>9M<=4VA"4)]E0LB=^B2C(R/EO9ZY'L1]'P'XE7))&7H9;[C]!
M                                  %,O[5__"]%_6&)_I/BY37XI'Z"
M%-?[5_\ PO1?UAB?Z3XN4U^*1^@@7'F  "       "F'@(_OG\4GZ[/?[F8+
MGBF'@(_OG\4GZ[/?[F8"XN>  "
M      -18XC16]Y774^EKIMQ6\O8;"1$;<D1>1:5Y3AD:D;+UXF6Q^EB=&62
MJR(J:O+(%1_9#MBBH]J-G>_*\W7+AOOQWK8VP .4;Z3X0S#CQ&\-Q]$2-..S
M8835L$AJ6?K(2GAI+O\ WE[WYQZ8/1K :O+G,IAX5C\7)7%J<7;LUC*)2EJ^
MDOS"3RY'L]JWL_B.Q !#_BDZ(SNO_36/C%?8QJM]NTBSS>E(4M!I:7R-.B[[
M,=CC72#!\.<LW:/#Z*H>M$FB>N#7,M'*2?TDN<4ER(]GLC[=S'7@ TU=AF/U
M&-%CL"BK86/DVIDJF/#;;BDA6S4GRB(DZ/9[+6CV8T^*=&L"P1FP:QW"Z"C;
ML$&W,3 K662D(/U0OBDN2>Y^Z?;\P[$ '*/=)\(DXW"QUW#<?=Q^$Z3\6J75
ML'%8<V9\T-&CBE6U&>R(C[G]8BK&_#YDEMXC"ZIY[944URGANUN/0:6&XUY+
M*UJ,G'U.*,U.$E1I]WM[QF6A8  &/85\6V@R(4Z,S,A26U-/1Y#9.-NH46E)
M4D^QD9&9&1]C'&7'0;IKD$6JC673_&)T>J;)F R_41U(BMD>^#9&C2$[,SXE
MVW\!W8 ,557"76*KE0V%5ZFO9SB&TDVC;UQX<-:XZ[:UK0YS"^DF$=.'I;N*
M8A1XV[+[/KJJ]J.IPOJ4:$ELOS>@ZT '&4'1; ,5R1[(:;"<?JKUTS-=C#K&
M6GS,_I'S2DC+?QUZ_$94[I5A5FW<(F8?02T7+J'[)+]8PLISB#VA;Q&G\(I)
M^AJV9? =2 #D,SZ/X-U&*']U.'T>0G#+C&.RKVGS93_TI-23T7YB[#:5^#XY
M4VLNT@X_5P[.8PB+)FQX3:'GV4%I#:UDG:DI(B(DF>B+T&[ !QE5T8P"CI[:
MHK\*H(=5;K\RP@,UK*6):O@;C9)XJ_\ )#VXGTBP? ZR=78YB%)20)Y<9<>#
M7M-(DEHRTX1)]\M&9:/?J8ZX '#8]T+Z<8E*B2J7 <9JI41Y4B/(B5##;C+I
MEHUH42-I49=MD?IV'19)B%#F<5B+D%)77L9AY,EEFRB-R$-NI^BXDED9$HMG
MI1=RV-N #B:OI70=/JJ\7T]QG',7NYS2C2]'KD,M./:/@;Q-$E2D$H]F1']>
MM#A/#KT L^F%_FV999/K+7.<OF)D3WJ>,IB(PV@M(::)9FHRWM1F?<SUZZV<
MX@ PKFEK\CJY59:P8UG72D&V_$F-)=:=0?JE2%$9&7YC'/4/2'!L7^2#J<.H
MJY5.;IURX]<RA<,W/QGE*).T<M^]QUOXCK@ :%K <88.[-K'*EL[Q7.UX06B
M^4#T9;?]W\*>C,O?WZC7X1TAP?IH_*>Q/$*3&WY1:?=JX#4=;A;WI1H21F6_
MAZ#K@ <SF73'#NHOLOW5XG1Y/[+R]G^6:UF7Y/+7+AYB5<=Z+>O71#(J<"QF
M@Q]VAK,=J:ZC=2I+E9$@M-1EDHM*(VDI))D9>NR[C?  Y/"NDN$]-G)3F*8C
M28VY*_'KJX#4=3I?4HT)(S+\WH,&-T'Z:PY<B4QT_P 7;DR)"9;KR:>/R6\D
M^27#/A](C[D?J1]_4=T #4U6(T5%8VEA6TM=7S[19.SY46*VT[,61:)3JDD1
MN&1&9;49CEXGA_Z8P9CTMCIWBK4EZ0F6MY--'Y&\D]I<WP^D1[,C^!GL=\ #
MU2HC$Z,[&DLMR([R#;<9=22D+29:,C(^QD9? QRN&=(,&Z<S)4O%</HL<ERB
MT\_5U[4=;A;WHU(21ZW\/0=> #54V)T>.3+*74TU?5RK-[VF<_#BH97+=_\
MQCJDD1K5_P!RMF-9F'2S"^H4B*_E6(4.2OQ4FF.[<5C,M3)&>S)!N),TD9D7
MI]0Z@ &GJ,.H,?I5T]71UM;4.)4E<")$;:842BTHC;21),C+L?;N,&)TPPV
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MO9.2R<^6%UC)RN9=B7YG'ER(B+2M[(=D
M                 IE_:O\ ^%Z+^L,3_2?%RFOQ2/T$*:_VK_\ A>B_K#$_
MTGQ<IK\4C]! N/,  $       %,/ 1_?/XI/UV>_W,P7/%,/ 1_?/XI/UV>_
MW,P%Q<\  $
M
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M_P +T7]88G^D^+E-?BD?H(4U_M7_ /"]%_6&)_I/BY37XI'Z"!<>8  (
M   *8> C^^?Q2?KL]_N9@N>*8> C^^?Q2?KL]_N9@+BYX  (T5UB$.]R+'KE
M]U]$JD=>=C(;4DD+-UHVE<R,C,RXJ,RT9=_K]!J+7I147%7F$!Z1-2SE#R7Y
MJFUH)3:B:;:(F]I/1<6DG[W+N9_H+G.NEIDV'TC^1TF4*B/M*9CP,?."RZW8
MR5N$E+*U*(W#->]%P4GCW,]D1C09GGEM3]3;:/=Y3?8;C,6/!5%DPZ I$!QQ
MSGYWG2U1G$-D1^67O+01;!7?5/3 \>R:;95&2VU=73IBK"52(3&7%<?41<U$
M:V5.()9ER425EWV9:V>^GR.@AY5C]E36"%.0;",Y%?2E7$S0M)I5H_@>C]1'
MW7_+LIQ/'\<<PU4==O.NV(I,R$$M$EORW'%,[/Z)K\LDDHO3>QJG.OL)J\:M
MSD.*Q1>+_*WLS;!*D>TG*2R31%Z^9R5Y?#?T@1L'/#W!LRG*N\JR"\D2JDZ3
MSI*XS9MQO,0X7%+;*4\]H+:C(][/?PUTF6=**7-)EK)LERS58U:*IQ+3A))#
M:'5.H<0?'9.$M6R/9E[I=AH5]=XU38%7Y%C-QCE@HXRR9E''=(V'GDL$]S:=
M4GBAQ:$K+?)/,CT9'L9=MULKXEQ(IZZGL;JV1/<KV8T8V4$^MME#KRR6XXE*
M4-DXE*C49>\?$B,P&"[X?:ZWD7<K(,CO<BG6M<U6.293C#1LMM.^:TMI++2"
M0XE?O<M'L_4O0AO4],W9U=$BWN4W&0'$L8UBP]*;BM*0MA1*0G\$P@C29E[V
MRV?P-(Y@O$=7S#0BJQ>^MI"*YVSEL,ICH5$;:><9>0LUO$DW$K:47%)GR^!F
M7<:G,>OAV/3?)I5?66^/2G,9DWM-.E):W)80DOPJ$H6I2%$:VU<5D1Z67;>R
M(KOKSI@C)<LKKFSO[.5&K9"I<.J-$9###QM*:Y$M+1.F7%:NREF6S[[(B(N$
MRSI:]BL*HB8E RV1)C4A4JIU--KFDOL(WY;<HY)D9:,U&3C*.1<E:/T(;M/7
MV!31WBR2AN,?>16%9Q42DLN+GM<T-Z;)MQ6G.;C2>"^)_A$_GU^3_$'"IHDU
M-GC%W#N8TF%&^1T^SO/N^UK-$=:%(=-LTFI*DGM1<32>^VC,C8],>D,?!Z2A
M*1)==M(6.QJ![RUD;)I;VHU)V7+?)2NYGZ:[;&/5]"XV,.P'<;RB[Q]QBNC5
M<A4<HKWMC+!&32G"=96DG$DI1<D$G9'HR/1:[&P8M\BQEHHLI_$[)]*%K4;3
M,EZ-Z&I!;-39J]2W[Q?'1B&ZCJ5EMC1L5,>Z;EOV>6.T-9E"H;9*=B--*==?
M)LB)M2R-IYHE$DD&:25Q,NQAV>;=!X&:.9&C[HKNF@9(REJXA5JV$HEFE!-D
MODMI2D*-!)2? R(R26R]=R,W"0W 3$(U>6EHFB,S[ZUK_P"1%V.SLHO3RO%Y
M>7.0)^.V#:%7[,*/YTB*Y'2\GDA23:0LN1D:B1HR1LDEOMQO_$G-++IQA]C\
MHVB&)U[*BR;V@H3FOOUR$R/(DE'2R]Q\PT,GLD:][9:(R 2I$Z14D6JQ&N-R
M7(BXS'7&BH>6@_.0N.IA1.Z26_<4?T>/?_X&NKNBR8>'V&)R,LO;#&I%<NK8
M@2"B[BL*3Q(D.DP2U&E/NI-:E=O7D?<;_IQ>1;_#HLV%D#^5-FIQ!SY#"&'E
M+2LR4A;:4-DA23(TFDTI,C+OW'$9'UZE557ES#6*3H^1TU.[;,0),F(Z3K:-
MI-2C;?,D\%<34DU$9D9<>1@.IR+I>FVOX-Y5Y!:8U<1H?R<N57DPY[1'Y<B0
MXAYIQ)FE6S2HB(R-1^I&9#4W_0UJZO+BU:R[(:Q^Z@L5MHB*N-PE,MI4DNRF
M3\M9DM>UHXG[QZUHM=-43[?,<!B2T$[B]O.BH7MUMI]4=1Z,U$DEJ0>R[EM1
MZV6_B0X[ISF&1>TYQ$D/R<YA4E@S#@SV&8\>1)6:$G(:/1MM*-E2NZB)/^9.
MC4GN'@[TM18=9\7MFZ9ZLI,3JEQ8SZGVS:F.*)*&4I;2LU:90;WO+)/=SW=]
MS$B9=C47,\7MJ&:X\U#LHKD1Y<<R)Q*%I-)FDS(R(]'VV1B(,NSW+B9Z@Y55
MW#<*HPN4;"*8XC:T6"6F6WI!NN*+FDS)PTHX&DBXD9\MZ'HN>I.5N5&59Y!N
M$1Z'';4X2:$XC:D2X[2D(D+<=,O,)PS4X:.*B27%.TJV8*D2\Z6E.R-J^J,C
MM<9M/8D5\AVO3'<3*80HU-DM#[3B>234O2DD1^\9'LNPX/K-TXMKU^_C8[ R
M?VO(*M,";,@3:]FODF25H0<GS3\]!I)1\E1TD:DGKOHB*1,]ZCMX/84%<BGL
M+NSO'W(T*+ )LMK0V;BC6IQ:4H3Q29[,_A^@96%9[%S2BF3VX4NND0)+T.;7
MS"1YT=]KZ:#-"E)/L9&1I49&2B/?<$:>'TG.L9?=K,CLZ>RE0X4-^3$;C.)4
MF,VM"2)#S2R(E>89G\>Q:,NY'C5W0RHIF<79@65@PQ1PY%>;:O)64Z.^I*W6
MWB4WVY*01[;X:[D6B[%I:?Q&IOT4!P,%R1U611ERZ=*SB(]J;023<-1F_P#@
MN)*(_?UR(RUL^PD?#,LB9SC%?>06WF8\Q!J)F0DDN-J(S2I"B(S+DE1&1Z,R
M[=C,!S%%T@^1L8FXRYE=Y8XZ]7N5<>!***?LK"D\")+J62<4:4^ZDUJ5V]>1
M]Q[LQZ3M9EC<;'7L@M85 F*B')@1D1C3*;3KZ2ULJ6DS(B+:%)_-H]&6OM+7
M(<XZBW&-4UXYB]511XZYLZ''9>F2'WB4I+;?G(6VA"4)(S,T*-1K(BXZ/>;=
M9V]@2ZG'?9K7.,C=BNRE>SIBL.J8;41*=<-2FFDGM:4D2=<C]"(B,R#O4MDA
MLD%V21:+] CO_@E A5.,QZ:[M:2PQUAR-"M(YL./FRYKS&W$N-*;6E1I2?T"
M,C21D9?'5N>(FOFD2J'&KO(6TTS-\\Y%2PV345PW"T?FNIVX1M++@6S[#UJZ
M[24YE9,IQZ6_B<7&6\B1:-*9YN(43BMDDWB5Q-*"21<"/EO>DZ,!TF,]'Z?%
MYE+,8ESY,VM7->5)DN(4N6]*-*GG7M((C49I+7'B1>A%HB(NQLH#5K72H3Y&
M;$EI;+A)/1\5$9'K_P &."_XN37,*BY,UA-Q[')(WFVGY4)APF.)*0XKF^1)
MYD?NHWRV7O$D>GIEGJL[S3))466Z]1.5=3.@,ND1>6E]MY2CU\#/2=]S] &T
MQ+I5%Q9['7W+BQMI-%7O5<5V7Y*=L.&T>EDVVDC-),((C+7QWLS[:ICH5#IW
MX$O'\CNL?L8S3\=<R-[,ZJ0RZ^M\VW$NLK0?%Q:C29)(RV9;/9[Y;I;U&D9/
MF5VW99S-=EPK>RBHQQNO82QY++KB4?A29Y[)*2/\9W/_ .!W3?6*H=HL4M2B
M328R.*Y+BH-".3:41U2#)?O:(^*3+L9]_P W<!V\9E3,9IIQY<E2$$E3KI)Y
M.&1=U'Q(BV?KV(B_,0X;%>E+F&,O0:K+;N/1<7BBU)IBJ;A^89G^#<4P;FD&
MHS02E&1>A[(B(:2HZ_?=%#IE5>%WTJ?<Q56,& I<5IU<(B1_S*S4\26TF;B4
MI2H^9G_E(MF7N1U^@V3E!%I,<NKFUN&9CK<!M++*XRHKB6GVWU..$E"DK7Q[
M&9&9=C/9;#WQO#]C,"HMJR$]80H5M4'4SVVGDG[3]+_F5F:#,Y'OKVOX\O>(
M]%K=5/3*+"?L),ZSGW$VPJFJB6_)\IOS&FS=,E$3:$DE1^<HC,NW9/8CV9\V
MCQ"5ME"A+I<?N;J>[%>F2JU@F&GX+;3JF7"=\QU*>9.(6@DI4KD:#UV[C-R+
MKA7T%%4Y"FHG3<7L([$KY7:>C(0VVZ9:/RENI=4:242E$E)Z(^VS(R :Z)X<
M*4XK$2WO+J^AQJ9V@CQI:V&VV8CGE]B\EI!\R\E&EF>^PS%]"8EHQ9ED&37F
M229=4[2M2IIQT.1(SNO,\LFF4)-:N*3-:TJ,^)?#9'XIZ[Q%6TAK[F[E-/&N
M_D"1<K)@F&Y1N$VG2?-\Q2#6I!<R3V-1?4K7AU_E9'08DN]Q_*9E&Y'>BQU1
MF8D9YMWS9+;1J4;K2E$9)</6C(MD6R,!N,FZ3L7MPFT@W]MCLY< JN4[6FR9
MRHQ&9I2KS6U\5)-2]+1Q47,^_IK5L^'K'&,:31IF6GLB:!G'26;S9N>S-+-:
M5;X?C-GW/6OS#TY!G[/21R05_<7N1N5U'(M7C*-%23S:7VT[XMH1^%+F1$1:
M2:=[V>ACS?$(JLD6T>7@N1L2:F&FTGMF<0_(A*Y<7N1/Z4?N.?@TF:OP:NWH
M9AT&<]':G/+"1/E3I\*:Y&C1VW8JF],G'D>T-.)2M"B-1.>I*VDR+6OB,6#T
M0KF9$R7-O+BVGS+:'<OR92V2-3\8DDVDDH:2E*-(21I(O_)'LQZ;SKS4T]A.
M2U565C45JX[=G<QO)*/#4\2%((TJ<)Q>DN(4K@E7$E%ZGLBVV8Y%-+-L9QRO
M4XE4A$BTEFT9$M<>/P(FDF>B+FXZV1GOZ)*+X@-(OI^]?>(!C,)-6_ A4U6J
M$P^Z\V:)[ZU'Q=2VA2C(FD+=22EDD_PRM%HMGV6?T$7*<,N*N9 D6<>3'4DX
MD1U+3SAEW3Y:U*2E*R,B-)FHB(R+N(8;ZXY1;5^'V3V-V,%Z1ELRH571%1U*
MG-MHF)0C?G*2GBII!K4I22VDS+MH=RCKK$>BQ6&,>M7LD?G2*XZ EQTO-NL)
M)3JE.&Z31-DE2#Y<^_F)(BV>@'(8WT8L,SO\HGY?]T3<&QJ(U2TJ\EPCL"4V
M\IXG4>Q[9;)"N!I/NHU$9J^ D9/3-V=71(M[E-QD!Q+&-8L/2FXK2D+842D)
M_!,((TF9>]LMG\#2-OAV81<\Q9JXKFWHQ.FZTJ/*21.L/-K4VXVLB,RVE:5$
M>C,NW8S(1CE62]0< Z$Y1<Y'9Q&,BBFPJ/,ALH<2RV:(Z'%<31Q,_,-\RV1]
MC3^@!V&1]&JG(I=M-.?8P+*=.BV34V(XV3D.1';)MM;1*09=TD9*2LE$9*46
MM'H;"+T]-<W'Y]M?65W8TLA^0Q)DHCM<S=:4T:5)::07$DJ/6B(]^IF."/J)
M,@XC#;Q[+',PN+JX:J(<^W@MLMPUK0:UJ4VTVUS)*$+41?$]%R(ADO92K$#R
MJO7U,?R7)H5/(F)J9\:&VIA;;?+S$)9909I+:?=4:_I%W ;4^A%>=Q[26072
M*XKU.1(J4*CDP4PE\S,U>5YBD&K9\369%OMK2==GAV)Q,)H&:B"X^[&:=>>2
MN0HE+VZZMU6S(B+7)9D7;TUZ^HBC ^LUQ(Z&OVEUY4O-H)-P5M(;)M,J6\E!
MQ%$@O0G">95HNQ;5]0\L9O>I>:=#L6M*:R@.Y2\4DI\I]E#;;II3(0@THXF1
M?A4LGHB]",!W=GTHJ+6+DC#LB:E%]81[*2:%H(T.,DR2"1M/9)^SHV1[/NK1
MEVUBY1T:J<GL;*R5/L:^TER(<MJ;$<;)<-^,2DMK:)2%%W):B42R42B,RT,J
MRO9=#U3IH#KRG:N_AO-M-*]&)3!>9M/YEMJ7O\[1?68]743JDCILIJ184<U^
MF]SS[-F1&2AKDOCV;6ZEQ?'9*5Q2?8^VS[ /3:=*7[AFGDR,ONONBJ7G78EZ
MVW$2\E+B22XR;9,>4ILR(NQH,]D1\MD1C-M>G2[=6,27LCM/E:A?4^W9$W&\
MR02T*0XAQ/E>7I25:]Q*3+1:/Z]"GKO$5;2&ON;N4T\:[^0)%RLF"8;E&X3:
M=)\WS%(-:D%S)/8U%]2M<[U&ZW2W*Y2:&HN&8#620J960-^3[.ITIK3;Z"3S
M\SA]-LU\-<MEZ=P'?8UTHJ,5L*>9$D37':MF<PR3RT&2DRGTON&K22V9*21)
MUK1>NS[CB<FZ7*Q!%6K%H6729[+$QA4ZBF5K:U-//F^;+_M9I3Q\Q9FE3:#6
MG1]^_>9)CSD>(\ZTPN4XA!J2PV:24X9%V21J,B(S].YD7UF((Z6=7+-K$H4N
MSI<@M\HR.TG%$K%R8RN3;+JR4I'X7RV66TDE)[,C-6M$HU$9A)?1S#)'3SI?
MC6.2UI7+KX:6GC0LUI)?<U$2C[J(C,RV?KK8TMMT)KK69:-_+MQ%QZVFE86.
M/,J9]DDO;2I>U&T;J4K-)&M"5D2CWZ<E;QT]?X<EZH@0\9NY=]/F2H"Z@B80
M[$?CDA3J7EJ=)LB)#B5DI*E$HC+6S,B/?9GU-^Y7)J?'8F/V=_<VL:1+CL03
M90A*&3;)9K<=6E*?QJ=?7Z -Y3XG$I+^_MV''UR;IUIZ0EQ1&A)MM):3P(B(
MR+BDC/9GWW^@:OJ+T^5U%J'JE^_LJJJE,KC38D%N,I,II?91*4ZRM23ULMH,
MM;/XZ,L/$NK]1F4NCBQ(LUB1:1ID@FY*$I5&5%=0R\T[I1Z6E:]>[LCXGW]-
MZN!UUA7=S15=3C]O8R[5$E\N!,H1'9CR?9W7'%*<+1$K1D2=F9&6BWLB#:2^
MCU)+H<JJ#?G-Q,C6A<HTNI-;?!EIDB;,TGHN+*?I<CV9_P#C5_\  >O^5_:2
MR"Z17)O$Y$BI0J.3!3"7S,S5Y7F*0:MGQ-9D6SUK2=8F.>(BLO6*.PDX_<4N
M/W:W&8-Q8$P3*W4(6LTJ2EQ2T$9-.<5&G1\?7NG?['\0U<B'"LK/'+NGI+.,
M]*J[*2AE:9J6V5/<2;0XI:%+;0I:$K26R+OH^P*V\[HQ5R**- BV=G72X=N_
M=PK..MHY$:2ZXXM?'DV:%(,GG$<5)/:3T??N-JQ@!.S,<G6EW8W-E1O/OLRI
M"6&S=-UM39DM+324Z)*SUHB/L6S/X\^WUL2N@IIYXQ9',O'B:J:]F3$=7,3Y
M9NFX3B7C;0A*",U&I1:UHN1F6_17]?(5W95575X_9S+B64DWZ];L9ER)[.\3
M+R5&MTDK4E1^C9JV7?9$9;(S)?1&O3-195-W:T=TW.F36[**;"UE[4HE/,FA
MQI2%-F:4F1&DS(TD9*'LJ^AV/5S5>EUZ=8+C)GE(<EN(4J<N9KVAQ[22VI6N
MW'B1>A%HB(MQFV?MXA*J:^/5S+V[MEN(AUL$VTK63:>3CBEN+2A"$D9;,S]5
M)(B,ST(OS/JU8Y9*PNNIJ?(8*9>0.UEPQ'D1H\F.XRPZXJ.I9O?'BASDV9DI
M'HKWM&'3UWA\K6IU:];9%>9#$K*Z14PX%@XP3+<5Y!-K0KRVDJ6?%*2YJ4:M
M%Z^N\UCHUSPZ?BMEE]]<4<B(F"TS***3D=M)EQXN(8)2E$1$6UFKMZ[/N,//
ML[N,9ZNXK5UM=87C4^HL'3K(2FD$IQMR-Q<6MU24I))*67KW-6M&/!'B$K;*
M%"72X_<W4]V*],E5K!,-/P6VG5,N$[YCJ4\R<0M!)2I7(T'KMW =%FW31.>2
MX:;"^LVZ=A^/)54,(CDRZXRX3B%&LVC=+WDI,^*RWK1:[[W^58S7YGCEE1VK
M1O5]@PJ.\A*C2KBHO4C+N1EZD9>AD0C=_KW1PCEVD1%W>1I*:A,6'&99XF<W
MF3'E$HTJ(U&1<^:M%HM:+8V*^N42)66!S<?M8M]#LV*CY"VPN0](>2E;)(6E
MPVS2I"N7(UEQ)*MZT RJKH\RQ.DSKG)+G)IZZURI8D6/LZ518[FO,)!--(2:
MU<4[6HE&?$O0MD?98]2,8U05E1%6XY&KXS45I;QD:U(0DDD:C(B+>B+>B(<[
M@74A.;6.05KU)8T-I1/-,3(T\VE$:G&R<2;:VUJ)2329=^WZ/4<K4>(>/?UM
M;*K\2O'G+=QQ%5&<5%;<F):(_.=]YXB;;09$7)9ER-2>)*V0#H+?I4IS(I]U
MC^47&)3+$T*GMUJ8SK$I:4DDG%-OLN$ESB1)Y(X[(BY<M$/5E72!O)[)R<C)
MKJJD2ZQ-38K@G'(YS!&HRY\FE<%[<<]YOA],_P VM3'\042WE54&BQ>[NK6?
M#D3#A-%':5&)A[R'FW5N.D@EI<]W1&9&?H9EW'MK/$!4WUC3Q:NFM9:9U;\K
M/R%)::;KXY.K:=-\UN$9*0M"B-"249Z/6]'H-W3](*&GCR8^Y4V-)HHV//,2
MEI-*XK*7$IWQ21\E$ZKD?IZ:(AE8+@LS"8R8B\JN+ZO893'BQ;-$8_(0GLGW
MVV4+69$1%M:C[%WV?<<5(\3--75:;*QQ^YKH,N$=A5NR/9R^4&>;:-EIT_*/
M\,VK\+PTE6SUI1%T-GU8>K&J>*K%K-_(;1#SS-,Q(BJ63+7'F\ITWB:)'OH(
MO>V9K(M>N@P(?AYQJNPW(\<C2;%N+=S2G+D&ZA3L925I6TAK:.)-MFA/%"DJ
M+6R/>S'X_P! J^>JUES\CO9MY/?ARRMU.1T/1'XQ+)EQE*&2;3V<41I4E25$
M9D9'L]X2/$= LT+51XM?7GD52+B43"8[7L[)K=;4A7F.IVZE3#A&A.]F78_B
M'_'A36;3VGZ=]K"XV-M9!\N&;7XM?F'S-/F\^)I02222.7+>^VC!4E8Y53::
ML3&GW,J^DDI2CF3&F6UF1GV3Q:0A.B_1OZS,<_-Z2T=E!S*)+.2_'RIXI$U*
MG"(VEDRVTDVC))&DTDTA1&>S)1;WZ$7.K\0E=71)Z[K'KFEF,Q&9L6 ^4=QZ
M<VZZEEM+?ENJ23AN+0DT+-.C6G?;9EY8%GEQDW5_)ZJQK;"B:@T\!XJR<II9
M)<<=D;<0MI2DJ)1)21]^QIUHOB1U&"]/&>G]+15%?<6<BMJ*\H#<>6II1/:,
MC)YPTMD9N%HR]TTITH_=WHRUU'T<JL8FY;-J+*SKIV1.^:Y);<:4J%[REFF.
M2FS2E)K<<69*)7O.*^&B+]N^JQ8[F4"AGX_/818OG%A3O:(IHD/>6IQ)$V3W
MF)2HD*22E)(N1=]$9&/1TEZC76?8C9VMGC<BMEQ9TV,S&)QC<@F7W&TI3IY1
M$KW"29J-)&K9E[O<!(22TDBV9Z+U/XB,SZ%Q&VM1<CN(3\:U?N*R2R4?S*YU
MXW#>0C;1DMM?FK(TNDOL9:,C(C'"5O7'*;QCIQ:/8W8QW[2VL83E5#6Q_P X
MEMI_@>S>4E*4F@C4:U%W2>B,C(C[EOKM$F1:YF!CMK.R"6]+851H5'0]'5%6
M2'S<<4Z31)2HTD1DL^7-.B]=!U6#8+&P>)/)$V7:V%C*5-G64\T&])>-*4[,
MD)2A)$E"4DE*2(B27YS&ARGHZWD.66&10LHO<?GV%<W52TURHYMN1T*<46DN
MM+XKVZKWR/9? 8.==5#>\/M]G.-O.0GFZMZ5'7)92;D=Q&TJ2M![3R0I*B,N
MY;+XCGF.I$V+BT5O'\P=S"ZNK6/4Q)=O ;9:@N+0I:UFAIIGF24(6K1GW,DE
MLMF ZQKHI#I;&++Q>^M<2\N!'K'F:\H[K<AA@C)GDE]IS2TDI1<DZ,R/OOMJ
M0G62>86THS,EI-)G\>Y:$7U%\G'KVZII'4M_)\@8KW9!U$Z/#:6RI*24;B"9
M9;/B7)/91K^D7<<UTEZWVTSH;+NLJ-N9E59&:6XEELFRFJD-I<B&E!=B\SS4
M-]NW)*OJ =Y_P7Q]R@Q>E?5+E5^/Q'83#3RT_AVG(ZHZR=TDM[0H_H\>_P#\
M#TPND"F\.L\6L,NO;FCF5ZJQMF644EQF33QVEQ#"5*62>Q*6:O3N1GLQY]!\
MAO<HZ75<_)934V\\^9'E/L-$TA:FI;S1:278BT@A^9CU>1C%Y8U<''+;(WZJ
M"FRLE5QL)**RKGP+\(X@UK43:S)"=GI/PV1&&OS#H%79:F_CHR*\I:W((Z(]
MM!K5L)1+X-DV2^2VE*0HT$E)\#(E$DMEZ[D?Y-856>P.(\Z*;/D*0YWYHX\3
M(_TD. Q?K;&S.]BUM-CEQ+)RKBV[\I1,-M1V9#:ELI4:G2,UGP-/%)'H^YF1
M=Q@3/$+7TL;(CN<?M:Z=2LQY+L!#D:2\ZT\]Y*#3Y3RD\B7V-)F1^FM[ 9N/
M=#85)+ICD9#=7%;1(6BGK)RV#9@\FS;(R4AI*W#2VI2$FXI6B,_4^XW-1TLJ
M::+A<=B1,4C$VU-03<6@S<(V#9/S=)+9\5&?N\>_YNPXO-NO=I08EE3\7#K&
M-DE(U'D*K9SD9238>4HD/<D/\33M"TFDE<B,O0R[CJJ7JDN]S-_'&,;L6Y4%
MME=BX[(BE[&;K?-)&DGC4LM=C4@E)WV(ST>@[P  !3+^U?\ \+T7]88G^D^+
ME-?BD?H(4U_M7_\ "]%_6&)_I/BY37XI'Z"!<>8  (       *8> C^^?Q2?
MKL]_N9@N>*8> C^^?Q2?KL]_N9@+BYX  (BW*^F.67?4R/E4+*J9$6"P35;5
MVM"]+3"<46G7DJ1,:(W%D?'D:=I3V+U5O8]1,#RC/J^;1_=-65V-6,<HTUE%
M,MR8IM1:=)MXY'!'(MD1FTHT[^)]RR.HG5)'3934BPHYK]-[GGV;,B,E#7)?
M'LVMU+B^.R4KBD^Q]MGV&1GO4=O!["@KD4]A=V=X^Y&A18!-EM:&S<4:U.+2
ME">*3/9G\/T /=EN"(R;[EDMR_8FZ*T9L4I\OS/-)MM:";WR+COGOEW]/3N(
M_NO#+$M,MRRU9OGH,&\AI0S7M1B/V"84A$@Y+:S5HR4XTA9MFG7+F>_>,AO6
MNNT*9#@LPL?MI>22ITBN^YXO(3(9>8(C>-Q9N$T2$I4@^9+,C)Q&MFK0]M%U
MWH[>:]#E0K"EEQHTQZ6U/0V7LZXIH\]I1I6HC4276UD:3-)H41D8#"D]&[3+
M7;N7F5]$L9TVF<I(WR57JBLQ6UJ):G>*W7%*<-:&U?2(BX$1%ZF>GM?#8U/Q
MW$FG9U5<7U&[*D/RKZF3+B6+DD^4A3D<W"-!J7I23)9FGB1>\6QN&O$?C)X;
M49&_%LHD:>B6M<5YE/M$0HQ*\WS4$H]&2B2@B29[4X@OCL>,_P 0L&C@62[G
M&+RLL890W"JU%'>??;E/>2TI!MNJ09^9M*DFHC(R^)&1F5G4O1U%5(E/I?K(
M)R:$Z542GJ_9(K:C=<<-U#?F*T7X3Z._4C/EWT6OR3H*>0XU#J2OCBG'Q.3C
M!/IB<C/S4LI\\BY]N/D[X=]\OI=N_59#U$+%<5KK2RI9[=G8/M1(U&RIER4Y
M)<,^+1*)?E[T1F:N?$B29F?81MU/ZS6TG$)U=6X_?5&1,6U=7V$5I^*B1'9D
MOMDEQMWS>!DZDUH2M)[2K>^.MD&;D?AZL.H<*4SF621+-QNJ^2Z]<.K\E+7X
M5ITWWD+=<)U1K8:VGW4Z)1:][ML*?H8<6LBL/(Q:ID,6L*R-S&<>]@2\4=SG
MP<+SE<C4>]'OW=GV4.[MKB7C&+QY$:GG6SS;:$*C'*82Z@N/=3KKKB4GK7<R
M49F9]M^HCQ'7N9<W&!HHL7FS:V_?F1Y:ENQB<C.1R<);9'YY$9I6V9FHN233
M]$S,P1VG5;$+O.\.D4E'D*,9?E+0E^8N(J0:V-_A&B)+K2D\R]WFE9&1&>M'
MHRY][I1=2\2IJ]=W2P;2@FM2Z634TCD>+&)M!M^4N.J4LUI-"UI/BXCLKMHR
MV-5C?7R?)J)[]QB5@S9*R"11U==%7'4Y-6A;A$G?GFE)H0VI2UJ4E/8S3OT&
M=+\0,2$AJ(YB]V>2*M4TRJ%!1S?1(4PI]LS7YOE^6IM)F2R7HOCHR,B#5Y!T
M'R2]Q^SC'F4%NRO;-$^]=73.*C3F4-);1$2TF4A;;7%".7X51J]XC/2C(=TF
MES:-C46)$O\ '&+1E>C?3C[Q1#9(M)0E@IG))EV][S#+MKB0YRUZ]QZB?>-.
M8M=K@T$AB-;V*/9_)B&ZVVLC(C=)3A))U/+@D]$1GW[;RIO7.NBWCT5%-9R*
MEFS33.W;9LE&3,49))OB;A.&7-26S62.)*/6]$9D5G8[TO72=/[R@<NGW;.Z
M5,D3+>.T3"BD2.7-QI!&? D[+B6S,N);,SV8XK&?#:NH18)D65-&;EXT_CGD
M45&4)!)<-)G(5MY9K7[O<C[=_P!)GW6-]6JC*G<8:@QY9OWL61,0TM"25$0R
M:4N$][WNF3BB;T6_>W\"V.81UUEU5]GS5[C<V)5X_*C18;K!L..S''D->6T2
M2>,S6XMTN/9)$1ER,CV".DL</RN;TI/&XN4Q*?(SBIBE>1*U:FVTEHC4ADWM
MDHT%K?F=C/9>FAZL(P;)<,P[Y"8N<?:3&2VB N!1/,MLI)6W/,0N8X;JEEOW
MN23V9J/D,[#^HOW27L^BL:.?C=[#8;EJA3U,N>:PLU)2XA;2UI47)*DF6R,C
M+TT9&>H9ZX5K^0LPTU%E\CO6BJ5J^/R?9ES$F:302?,\WCS2IOGPX\BUZ=P&
MNRCHG97<S)HD')6:[%\H?1(N*Y=<;LA2B0AMTF'_ #4DV3B&TDKDVO7<R,M]
MO"WZ&SITBYK(N1,1,+N[%%E85*JXUR361H-QMJ1YI)0VX;9&HC;4?O+T9<NV
M=(Z\5E):6T+(ZF=CJX%>]:$<AV/(-UAI24KTEAU9I7M:-)41;Y%K9[(M+G?5
M/(H5?BL\L4O:/VG((D8H*W(JY$YIQIX_+TAY24'R)&^:DD7KOL>BMKU;QW(;
MK.NG,G'G_8GX$R8\[+>AJDQD).*M))>2E23)*MZ(R4D]Z]?0]OA_3VVQ:"\A
M=Y&E2K.PDV5R[[ :4R''4<4I9+S3\E*.+9%LW#,D:/N>RV.(=08V3UUP_*@R
M:*5325Q;").4VI3"DH2YRY-J4E230M*B,C]#[D1D9#E)76 [?"WK\Z+(:/'G
M2C.P[=)Q"=DH<?;0@TM*6M24K)9'[Z2/@9_15H@1M,7Z3?<W]P/_ -5]I^Y6
ML>K?_L_'VKS$-)Y_3/AKRMZ][Z7KV[[' \(L,%J:JI:MV)5;%*4;Z%0C2X\M
MQXW$*2OS#)!))2B,M*Y;(]IUH]!>=;Z9O$CF$S:QWY#MC"-F,VT<J*N(AY3[
MADI1H+CY6R,]D9K1LNXRNGF33+S/,GCKF2)%<S65,B*W(XDI!NMO&M1\2UR5
MQ3O7;9=@&1D6 73>7OY1B-W$I[*9&;BV$6S@JEQ9:6S4;2^*'6U(<3S47(E&
M1D>C2>B,N?SKH?*SFVH,@GO8S9Y#7PW8,E%OCYRZ]]M:TKVAE3W-I:326E>8
MK9&HC+N6O3C/56THNE$.^L*J?D>I%@<F4S)BM>4VU+>2DOPSJ.2N"2)))(]\
M>YEVWLK3Q#XY5XI>7QP[*2S5G$,HS#2#?EHDM(<96RDU%LC2L_4R,O+7]0*V
M=5TI163;:0W)AQ4V%%'IO9*^![/'8-LWS-QM',]),WSTC?;C](]]M$YT/GM,
M,1(E_'1$<Q).+3#>@*6M:4(62'VS)TB0>W#,TGRV6B(R]1W5)G%?D-_*JX!.
MOG&A1IRY22+R>+_,VTD>]\N*.6M:T:>_<<?0]?(5Y+K%*QVXKJ6RGOU<:XE^
M03*I+1N$I)H2Z;A)/R7")9IT9E\-D8(Q\QZ'/Y)/QR2S8U3OR35+J_)NJCVY
MI)J)'_,,H\U)-N^YK9\NQZ_3MNDG2/\ X6M+1\K?*G*KKJS9QO)_^RMK1S^D
M?T^>]?#7J>Q@U77F-:JJ9!8O=,4UVM;--:/'')J>X2%+0DD^;S;\TD*-!N$D
MC[;-.RWZL$ZO7^1],F<EFX;+*8J4^P<9J5$91P0ZM).<ER-$DN))/9[Y>A<>
MX#/PGIUD^&V%E'+)*B9C<ZRF6"X2J5U$Q/M#BW#04CVLT>Z:O7RNY%Z%ZCGJ
MGH/>QTXS!G9;$?IL:C2H=?'8JE-NN-NQUL)-Y9O&1J0E1?12DCT>R+9<=I#\
M0,&Z<QUBDQRYN)=S!>L$LL$PGV9IETFGO-4ITD\DK/6DFKE_EV.BQGJK49;+
MQV/7-275W54JW09I211V2-"=.^]V4:E\2(M]T+^H!H?^$EO1'B<[&K^)$NJ2
ME31.N6->I^/,CD3>C-M#J%(42VR41DLRTI1'O9&7)-=)LFQ//L.+'K=)RH]=
M<2+"VGUJGHDF3)DQW5I6A#B/+VHU*01+V1(U[VC,2+:]4T4.;UN/V5'-ALV4
MGV2'9*D1E-O.^6I9?@TNFZ23)"B)1H+N6C(MD8TF,>("!D2J20]CUQ3TMT;Z
M(-K/\@FG'&D+6M)H0ZI:=I:<-*C3H^!_66PY=[PLL,2JNR9D4%S;MQWV+!63
MT"9\>2MV0N0IUMOS4FRHG'7-$2C(TJ(C[D2AYYCX8UY1+N38LZ.%'LXD6,2U
M8^3K]>3*4EY<17G$3+2C+EPT9D:E=S,R,LR/UEGY9G'35$.FN*.CO7Y3[,F8
M3/EV$=,1Q:#,D+4IL]\%DE9),RU\2,B[B\ZE*A96[CE/CUEDEG&8;DS?8EL-
M-1&W#42.:WG$$:E<5&24[/2=GK9;*US_ $@\[';"J^5M>UY(G(/-]F^AJ6B1
MY.N??Z''EOX[U\!T'4;#/^(&)2*3VSV#S7XS_G^5YFO*?;=UQV7KY>O7MO??
M6AJ)O5ANHS>)CMG13J\IRW6H4U;\9:)"VVU.'^#0ZIQ)*2A9I-22]-'KMO38
MWXA:R\CU$^;06]!2W$%Z?7V5B3'!Y#3?F.$:$.*6@^!*47))$9)/\VR-AU)Z
M0_\ $*=/D?*WL'M5([3<?9O,X\WVG?,WS+>O*UQ_/O?;0RLCZ7?=!-S*1\I^
MS_=%1-TO'V?E[/Q)_P#"[Y%RWY_T>WT?7OVCR^ZWV$^_QQY=3D.+TDNDM;4E
MN%&4N4PW'0M"TD2UDAQ.R42'"+Z1;(_>(LGJ5UU>@]/LN/'JJ\GNT],3LJ\9
M)@BA/N1R<;Y)-9*6M*5(6ORT&2247KZ$5E%X<(T/,Y-S':Q:S8GJC.2TW^.I
MFR&W&FD-&IA[S4F@E);2?%1*)*MF6]Z'>Y1C4QW-,7R2N;)YZ ;T&6SR))JB
M/DGDHMF1;0MMI6OB1*(N^B&JR7JN6"HIU6E+.=K)7LS3ENB1&)"7'5)06FU.
MDZHB4I/(R1V(]EO1ZT%'UZG&QDCEYBL^*[#O_D.LBQUQU.S7#2DTME^'-)+(
MC4I2E&E!)[[[&"-C1='9]9.K/:+R.] JLAEWD-IN"I#IID)D<FG%FZ9&9*DF
M9*))=D:UWV6FRSPWL9#;KN$RJF;8)N)-FU'O:=,V&;;[+32V5M&X1F9>2E27
M",C(^VC+>^[QGJ977U#=V4R._1+HW76;2+.-!JBJ0V3AF:FU*2I)H4E9*29[
M(_@>R+GI'5=ZQQJ/;R<?R+&ZF3*@%#FJ.'YLDGI#:$$;1N+-"5<T\B4DE$A1
MZXJ[$';X=CR,5QR'6)CUD8V4GR;IX/L47D9F9FAGDK@7?_J/OLQK^J.%.]1,
M#M<>8GHJWIB4$B6XP;Z6U)<2LC-LEHY%M.M<B]?4<U9];J9_$HLYMFUCN6$6
MQ6;<=MKVJ$41"_/4HE*-!*0M)(+Z1&I2?@9C(Z89/,R#*<Q;=F2),&,5<J(B
M3QY(2Y#;<5OB6MFI1F>NVS/0#VV_3R_R_&SA9'D4!5M%F-3ZNSHZI<,X;S?=
M*C0[(>)SU,C+:2-*E%\=C43>DV4Y7<*GY1DU0^MJGG5$=-33NQ__ +22"4ZO
MG)<WKRRTDM>I^\,3%.JMI1]%L<R*QJI^1K<B./S9;4F*T:"2I7KYSJ.2C(NQ
M)(]Z[F7;>=9>(_&:W#K+(U1;)Z+"ELQ3CM,H-]U+K*'T.H3R[H\E?F&9F1D2
M%=MEH%>4'H0Q#R[%;H[AQ4>GKV(TFO*.1-SI##:FX\A1\CXFA+CON]][1W]P
MM]=TWPS_ (?8774'MGM_L?F?\QY7E\^;BE_1V>M<M>OP&13YC"O<@MZJ&AUQ
M58VPMZ21%Y1J=2:TH2>]FHDDE1]M:6GOW'$8UX@:_(#I93^/V]-1W/GH@VT_
MR":<<:0M:TJ0AU2TEQ:<,E&G1\#^LMD=+.QN9<]3:NWDMDW5TD-THI\B,WI+
M^DK5HCV1(;29=_4W3^H<%U(\.C^?9!DLY-O5L-W;,=LWYU-[7-@DT1%PCO&Z
MDD-J,N1EQWM2CWW(RWE3UV;M%5*SQ*\AQ+UM:Z.5(.,E-BI+9N)01>=MI2T)
M-22=))&1'LTGV'HPGK#?7W26FRR;ALM4R8CD['8EPV6TIUOS"4Y(T23]"(S-
M6_4B+N V3_2#SL=L*KY6U[7DB<@\WV;Z&I:)'DZY]_H<>6_CO7P&@M.A=W*;
M>IX65QH.*N7Z,@]D.L-R42RE)DK8\[SB3Y:G"4>^'(N6MGKOG->(2!:+JD4>
M-W=ZN?3%?:BI803$;DI)\S6Z1<R4GCQ3O9GVV1&9=5CO4RIRJVJX-8E^3[?4
M(NDODE/EM,+426R7WV2E'RT1$?XM7?MW#.PU_(9,"<[D;$>))5/D%%8CZ/A%
M)PR9YF2C(UF@B4>M?2UHM#AV>BT^DK<7<H[]B/?8^]-4S*F03=CR&93BEN-.
M-)=2HO5&E$O9&@CT9&9#+E]?L?@P\???B6#:K>W=IO)\M!KANMO&RM;WO:2@
MG."=EO\ &([=^W[+ZX17<@?HJ/'[7(KAI^0U[/$-AM)H8\LG7?,=<2DD$XX3
M9;/9K)1$6B,P'AB?1I^AR2NR"=>%86R)4^=/6W$\IN0])0RC\&GFHVT(0PA)
M$9K,]=SV,7J!CF4676;$K/')3=?['36+;LJ; 7*B*-;L7BVYQ6@R4?$U)THC
M]P^QEL9%7U[K\AMJ&KIZ"XL)]JR^^XUP9:]@2P^3$@I!J<(B4VL]:3RY:]W?
MJ.>Z9]9$WW2=Q]]^SLI=;3R)5K=0D-&49U)*439*7[JG^)<B225$G1<];(C*
MVM?T4ML8:QV909'%1?5Q3RERK*N4\Q,.8Z3SZB:0Z@VS)Q)&DN9D1>Z>_49W
M3?HR[@$VHEO7JK=Z#6S("U*B$T;RGY?M)N=EF2='[NM=_79>@P9G7^)4MV9-
M8[?6L*BB195K9I*,E+++S*72<,C<2:U$DS-24)[<3T7=)'[LM\0,+&"R&6QC
M5U=4N/K0S96D#R/+:=4E"^"4+=2M?$G$&HR3HN7QT>@X_I9T7R"\Z>X379?:
M)^0ZLG):*==:N/-)Q:'6TMO.FX9&E!.KT1-I,_=V?8^74T_1S)(I8Q%L<K@V
M%;BJ%'3ME4J0XMTF5,LN2E>?IS@A9^Z@F^1]]EZ#OKG,X5%D-%4RVWD*N//3
M'DZ3Y25MM^8:%'O9&:"69=C+W%>G;?$U_B"Q_(L1;MX<:T9*58.U;3'E-E)2
MI+2G?.))J-/ V4DZ1G_E4G9;/0(Y2;X6CL77+&3-QYRR3:_*;%<J@YTR3-@V
M74JB*>,^3A'S4LED?)*3T>CY;_)>AL[(,+K\;8>Q2EBM+\Y;E7CBF5QGN?+S
MH>I.F'"+1<C)1[][T]T:.=UIO9<6XKJ^IL45K>#)O8M])7&)_P Q;+II<<)#
MGUH26DM_3)1ZXZ':=,^JCF3*I:FSI+2IG3:=%E%DV'DFF:VDFTN*(D+4I"B-
MQ!\5DD]++XD9$5M,YP.PO;;'[VCM6:R_I?.0R[.BG)8?9=227&W$)6A7?@A1
M*2HC(T^AD9D--1=&GZZ546,Z\*;;,7S^03WVXGEMR7G8RX_EMHYF;2$H4@BV
M:S]SN9F>QH,?ZLWL?K;EM!=N,KQE<Y%=3/I:)*H\I,-I]3+BO\WF$XM23/XM
MJ+XD/?1];+&HZ,XWEUU32[E,BM]ML9T-V*PAHB(S5I#CJ#4K1&9)01[T??>B
M,CI\WZ?WMSF]#E6/W\6IG54*5".+/KU2F)*7U-*,U<76U)XFT1EH_C_X/@GO
M"RPQ*J[)F107-NW'?8L%9/0)GQY*W9"Y"G6V_-2;*B<=<T1*,C2HB/N1*$AR
MNKU/&JLNL"8EO1L:BMRY)H0G;R%QR?3Y>U%L^)D7O:[_ /R-7CO5.[N>H&8T
MBL3F'7T\6-(B/-NQB7(-Q"U<>[_JOB7'9)(M'R,NP*]4GH>V];G.:L8\)OVB
MGD%$B0";9;]@4M7!"2<]U*^>B+_(1?YAB]0>FS4==_DAVLQB:]:0+:$N%4.S
MUQ'H[262)3#1FMY"BY$HDDDR)1]RUL:K+>LUA>TSM=3^U8G?Q[ZKJY:EG%EJ
M:9E.DGFV:3=;,S3S+OW(TGV]#/82>H5WTFOK*MRVQ/**Q%')O(D]F(AB828R
MD$\RXE)DVHS)Q!I41(_S$9>A@/;T,J[U=UG>173LAY-U/8.*[)K'*TUMM1TM
MF:8SIFXTCELB)PS4?$S]#(8%QX;V)V+X3!3*J;&PQ8GFVE7M.F9#E-NE[Z5L
M&X1I/LDTJ)>R-/Q(S(=)U+ZN*PRJM4UE1)M+EC'Y%ZPT7EDT:&S2G2S4XGT-
M9&9$>S(CT>]$?'YIU4LUXTIYL[6@OEU5;/5"6<=3#2'9Z&E*)2#6KFHN1:Y&
M7$R]%; >1].<II.IN/JQEVFHD0L;DQWG8U"M%4MQ<IM7!+*'DFVKMR(O,/>E
M;+OVZ;#>AD3%-MN6;EA'=HU4\E*V20IY2WW7GGN1*[<E/+]W7;ZS&AP[K--@
MV%ZQ<U-M,K&\LD4R;K\"4>.:WR0PWQ-9.*21J0DU)29$:B]=*UE]<NH^2X!E
MF%'2(1*JUE-F7,'R26Z_%90V:_*/U):"6I9$7TN''X@/1@'0*5T\JU0J].$&
MXQ"]ABV/W)\)3K?8O^96B0GS-H(TJXDGD9\O^T]2?A90W#I7BE8_/L:V1-6B
M%:4)2:E#$E2%*89C&[R:2A3:329+/6U]M*T4A8-FS^4Y[F$-N6U+I8;%<_7K
M:26C2^RI:E<B^D1Z(RV.95U2NJ; LR9FK;E9A36:ZB(7EDDI+KZT^PJXEVTI
M+S6]?]*_J ;^AZ2(I9%J\B17Q"L*1BH.)55OLL9A2%/J-QMOS%:29OG[F^W'
MZ1[[:*=T!7.A,U;MRRY3OXHC%;)M4,_-=;0E1(>:5YFFSVLS-*DK+T';9GDT
MCI_TWL;B4HK&=70>1F:204A_B24]B[%R69>GIL<E-ZP-=/XSU980K7(G*&*P
M[D%S&\DFXAN)Y&HTK<2I>BVLTMI5Q1KXZ(R-76^'8VL5GU3ZL5K9RDQE1+;'
M<:3 ?)YAU+K;CWX91.%S;09H+B78^_<M=;A/3^]I\YO,KR'((EM.LX,6"46!
M7JBL1T,J=41IY.N*4:C=,SV?P'LONJK6-97554^EF,P+.2U#BVWM$8VG'7"]
MS39.^;Q,_=Y<.Q_#7<<3U"ZUS['I5E5]CE+;Q*J+#?<AY(:F"0\IM?'DTUYA
MNFE1DHDJ-!;UO6C(S*\Z_P .;\/,8=PNXJUMQ<@=OO:"IO\ ZE*-?F:9>E&Z
M?)*"=XIT@NR$%KMW[_ISAL_!XEK D6,>? >L9,Z&3<933K27WEO*0XHUJ)9D
MIPR(R)/8O0>&']13R6]FTLVBL<>LXT5J<ABP4RKSH[BE)2LC:<61&2D*(TGH
MR[>NQOLEN)-%4.S(M6_<.H,O^6CO,M'KXJ-3JT)))>I]]_41@C@<2Z.S\?E8
MV<J\CRHF/V,Z7#;9@J;6XU)2Z7!Q1NJ+DDW3]XB(C))>Z6]C19%X:F+6U9MV
MY--8V+-C8RR8R"E*=#6U+<2M39MFXDR6A2$\7"47Q(TZ/M)73[.X?43'OE6)
M'>B&B0]$?C/J0I;3S2S0M/)M2D*+9=C2HR,C(QR<2;G^.XKF]EDDN$XN+"?D
M5:HR$GP-'GJ+D7$M^[Y'KON1@K;9%TR*^Z/V&$,O5U,J9 7#\^LKO*BLJ47=
M2(Q.=D[,SX\__P!+XC$LNG&0Y7C9P,CR2O78Q)+$VILJ.I7#5"?:WI:D.R'R
M<(]Z,O=(TFHOCLHJPOQ$RJB'%LI-^]U)HW:J(],D5<-@W85@^\RTB,E;7!I?
M(W5'P/WT^69F?<298=;G8+LYEO"[V=(J8K<NZ:B+BJ.N):3639F;Q$ZYP+F:
M6N78R[[,B,/QCIIE-QE<:[RC(ZB8N'62ZV.U4U#L7?M'E\G%FN2YO7E%I)$7
MJ?<8-9X>V*^RP.2=VXMG'*^/"FQ4QB2BU5'3_P JXOWCX>6M2UD7O;-1%OL-
MB]U]H?EB/4Q8-C86LU#$BNB1VT&JPBNM&X4IHS61>4DDJ)1J,C(R(M;4GESO
M5'KM$5TKDV&/+G-3YN.N7L=]IM)KB-)4VG3A;/2S4LTDDB/NA7U CK,'Q7(<
M&L:ZA8<CR\7:;L)LJ>MLD.N27YBGFFD)YF9$A+CFU&1[TG6NY#D.L5=/I;^]
MG8].M8]G?TZ84F)$QB59H?-'F):-N0V:6H[OX123-TU)T:3-.B,SZ-[KO"J&
M;8KW'[BEG0H\:2S >)AUZ:B0Z;3*6O+=4GFIPN!I4:=&9;/7<:7,NL$YVO<J
MSK++$<DC6-0XN+,6RX;T1^<VTI2%M+6E23]]"BV1D?PT9&961B_0Z7"P2VJY
M-RY!G7&,P*1U<9'O0W&(ZVE+2OE[^S<,]>[]'U[]M5 \,[K:;(W;6EKO;($*
M F-0T)0X[11Y1/\ /CYRC4I>C2>S[=OJ[^S,>MTJQ^1#HZFWB5$C*HE0F^_
M^SR>,HFWT<26;A(/BX@EJ01&9'Z;29]#7]?ZJ?*C+.FM(]//]I*LMW/)\F<I
MA"UJ)"2<-Q/)+:S0:TI)1)/TV6PRLYZ0*S%_,'T6Q0W+ZHC5B"5&YE'4RXZX
MEP_?+F1FZ6T^[]'U[]O1:]+[W)LPQ>\MK:D;=I7D2/:*VG<9FN:09+8)]4A6
MF5F>U)XGLB(O7W@CYKD_4SIU"O</JW\?>F/1WXIW?D\GX:N*E.<4J7QVDST2
MM*[>A#)EWEYBMOT_5<24O';-E46;3>O+3--DW4NHT78C4TZ@]>I+3]0(D4
M!3+^U?\ \+T7]88G^D^+E-?BD?H(4U_M7_\ "]%_6&)_I/BY37XI'Z"!<>8
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MYJ:M$9V(B Z_,2DYB7F4.$HMGK6UDDC+L>R^)@-7:UN4=-\CRB_I:1G)(=A
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MH.,3LF=QV/D%:_?-;\RM;E(4^DR(C41H(][(C(S+U(C(S]0'0   BF7]J_\
MX7HOZPQ/])\7*:_%(_00IK_:O_X7HOZPQ/\ 2?%RFOQ2/T$"X\P  0
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MU?\ \+T7]88G^D^+E-?BD?H(4U_M7_\ "]%_6&)_I/BY37XI'Z"!<>8  (
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M9TGJ"NGYL6\AM+<%4CRUQT()9)2DTF?<BY$9D9&7%.I+Z7W,/%IV74DVV<1
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M+L1:+N9ZV9[S@0
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MPY*-:O?<4I1[4HS[F?J.B!
M         4R_M7_\+T7]88G^D^+E-?BD?H(4U_M7_P#"]%_6&)_I/BY37XI'
MZ"!<>8  (       *8> C^^?Q2?KL]_N9@N>*8> C^^?Q2?KL]_N9@+BYX
M(
M
M                                         IE_:O\ ^%Z+^L,3_2?%
MRFOQ2/T$*:_VK_\ A>B_K#$_TGQ<IK\4C]! N/,  $       %,/ 1_?/XI/
MUV>_W,P7/%,/ 1_?/XI/UV>_W,P%Q<\  $
M
M
M              4R_M7_ /"]%_6&)_I/BY37XI'Z"%-?[5__  O1?UAB?Z3X
MN4U^*1^@@7'F  "       "F'@(_OG\4GZ[/?[F8+GBF'@(_OG\4GZ[/?[F8
M"XN>  "
M
M                                               *9?VK_P#A>B_K
M#$_TGQ<IK\4C]!"FO]J__A>B_K#$_P!)\7*:_%(_00+CS  !       !3#P$
M?WS^*3]=GO\ <S!<\4P\!']\_BD_79[_ ',P%Q<\  $
M
M
M                       4R_M7_P#"]%_6&)_I/BY37XI'Z"%-?[5__"]%
M_6&)_I/BY37XI'Z"!<>8  (       *8> C^^?Q2?KL]_N9@N>*8> C^^?Q2
M?KL]_N9@+BYX  (
M
M                                                       IE_:O
M_P"%Z+^L,3_2?%RFOQ2/T$*:_P!J_P#X7HOZPQ/])\7*:_%(_00+CS  !
M    !3#P$?WS^*3]=GO]S,%SQ3#P$?WS^*3]=GO]S,!<7/  !
M
M
M                             %,O[5__  O1?UAB?Z3XN4U^*1^@A37^
MU?\ \+T7]88G^D^+E-?BD?H(%QY@  @       IAX"/[Y_%)^NSW^YF"YXIA
MX"/[Y_%)^NSW^YF N+G@  @
M
M
M  "F7]J__A>B_K#$_P!)\7*:_%(_00IK_:O_ .%Z+^L,3_2?%RFOQ2/T$"X\
MP  0       4P\!']\_BD_79[_<S!<\4P\!']\_BD_79[_<S 7%SP  0
M
M
M                                   !3+^U?_PO1?UAB?Z3XN4U^*1^
M@A37^U?_ ,+T7]88G^D^+E-?BD?H(%QY@  @       IAX"/[Y_%)^NSW^YF
M"YXIAX"/[Y_%)^NSW^YF N+G@  @
M
M
M       "F7]J_P#X7HOZPQ/])\7*:_%(_00IK_:O_P"%Z+^L,3_2?%RFOQ2/
MT$"X\P  0       4P\!']\_BD_79[_<S!<\4P\!']\_BD_79[_<S 7%SP
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MK1=S/9GOLB\4&11,YAHQV]8R%B+TM?R*36QR:=0Y8)(E(6LTER(]=^)&1:^
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MLE^81M[,]Z[D6B+>Q%]!I<ES2CP]=6FZLV*U5I,1 A$^K7GR%[XMI^M1Z/\
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M8G>4BITE^UGTRE-2O=-*XK4-PW29/D:32XDS2>MF1[(7$!
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M\$MY=KC>'T5!92R-,B96US,=UTC/9D:D)(S(S[Z]-]QUH
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MS(3Z  @
M
M
,             /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
